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There are over 1100 people waiting for a kidney transplant in Australia, with an estimated 
170,000 people waiting worldwide.  Most of these people do not have a living donor, so 
their only option is to live on dialysis while they wait for a kidney from a deceased donor to 
become available.  In Australia people wait for an average of 2.6 years to receive a kidney 
from a deceased donor, a similar length of time to other developed nations around the 
world.  Existing literature has focussed on transplant outcomes and the experience of 
dialysis, but there is little published research that describes what it is like for people once 
they have been placed on the waiting list.  Therefore the aim of this research is to fill this 
gap in the literature and provide an understanding of the experience of waiting for a kidney 
transplant from a deceased donor 
The thesis includes a systematic review of the literature and a qualitative research study.  
Much of the existing evidence about waiting for a kidney transplant is reported incidentally 
in studies looking at the experience of living on dialysis.  Synthesising these findings in a 
systematic review provided a baseline from which to conduct a qualitative study in order to 
produce findings that were exploratory and descriptive.    
The study found that the experience of waiting for a kidney transplant took place in the 
context of living on dialysis.  The thought of getting a kidney transplant gave people hope 
that they would escape from dialysis one day and return to a normal life.  People lived with 
uncertainty about the timing of the transplant and whether or not it would be successful.  
Waiting for a transplant had a transformative effect on a person’s relationships, enhancing 
their appreciation of family members who provided them with help and support; and 
resulting in new friendships with other people living on dialysis from whom they could learn 
and inform their own experiences.  It also showed a complex response to the deceased 
donor who they hoped for, but who they also appreciated as a person in their own right. 
The findings of this study are significant because they specifically explore the experience of 
a significant population about which little has been published.  They may be used to 
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 INTRODUCTION TO THE THESIS CHAPTER 1
End stage kidney disease (ESKD) is life-limiting, chronic condition.  In 2011 ESKD was the 
sixth-most common chronic cause of death in Australia behind cardiovascular disease, 
cancer, cerebrovascular disease, diabetes and chronic obstructive pulmonary disease 
(COPD) (Australian Institute of Health and Welfare 2014).  Kidney transplantation is one of 
the treatment options for people with ESKD along with haemodialysis (HD) and peritoneal 
dialysis (PD).   
In Australia people cannot join the waiting list for a kidney from a deceased donor until 
they commence dialysis (Transplantation Society of Australia and New Zealand (TSANZ) 
2016).  Donated kidneys are allocated by a computer algorithm that calculates the 
compatibility of an organ with a recipient.  This means that it is possible for a person to 
receive an organ after a short time if a perfect match becomes available.  It also means, 
however, that some people wait a very long time.  On average people in Australia wait 2.6 
years for a kidney transplant (Australia and New Zealand Dialysis and Transplant Registry 
2015e).  People on the waiting list for a kidney transplant must be ready to be called for a 
transplant at any time.   
1.1 Aim of the thesis 
The aim of this thesis was to explore the experience of living on dialysis while waiting for a 
kidney transplant from a deceased donor.  Much of the existing research focuses on post-
transplant outcomes, or on the experience of life on dialysis.  How people tolerate the 
nebulous nature of waiting for a kidney transplant is an under-investigated area that is the 
focus of this thesis.   
1.2 Structure of the thesis 
The thesis is presented in the manner of a traditional research report, with introduction 
and background, literature review, method, findings, discussion and conclusion.  The 
literature review is made up of two parts; a general literature overview and a qualitative 
systematic review of the literature relating specifically to the topic under investigation.  In 
total this thesis contains eight chapters.  This first introductory chapter aims to introduce 
the topic under investigation and describe the structure of the thesis. 
Chapter 2 provides clinical information about chronic kidney disease (CKD) and its 
management.  It includes information about the incidence and prevalence of ESKD, renal 
replacement therapy (RRT) options and comparisons between RRT modalities. 
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Chapter 3 describes a general overview of the literature which looks at ESKD more broadly 
and other topics related the experience of waiting for a kidney transplant.  It seeks to 
provide context to the study by describing literature about waiting for other kinds of solid 
organ transplants, living with a chronic disease, uncertainty and the experience of waiting. 
Chapter 4 is a qualitative systematic review of the literature that has been published in the 
JBI Database of Systematic Reviews in March 2015 (Burns, Fernandez and Stephens 2015).  
It provides a thorough and rigorous synthesis of the published literature relating specifically 
to this topic.  Together with the broader review of the literature it clearly establishes that 
there is a gap in the literature about the experience of living on dialysis with ESKD while 
waiting for a kidney transplant from a deceased donor. 
Chapter 5 gives a description of the methodological approach and theoretical framework 
adopted in the study, along with an explanation of the methods used for data collection 
and data analysis. 
Chapter 6 presents the findings of the study.  Following an introduction of the study 
participants the findings are organised into four themes that characterise the experience of 
waiting for a kidney transplant: life on dialysis is restrictive; waiting for a kidney transplant 
involves living with uncertainty; waiting for a kidney transplants positively and negatively 
impacts the dynamics of a person’s social relationships; and managing feelings towards the 
deceased donor.  Within those themes are subthemes including hope, fear and acceptance.   
Chapter 7 synthesises the findings in the context of what is already known in the literature.  
It presents a description of the experience of living on dialysis while waiting for a kidney 
transplant from the perspective of the person who is waiting.  The strengths and limitations 
of the study are reported along with implications for clinical practice.  Chapter 8 then gives 
a summary of the study and presents the final conclusions of both the systematic review 
and the study. 
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 CHRONIC KIDNEY DISEASE DIAGNOSIS AND MANAGEMENT CHAPTER 2
This chapter provides background and context to the study by describing chronic kidney 
disease (CKD).  It includes the physical effects of the disease, as well as the comparative 
risks and benefits of the various renal replacement therapy options.  Incidence and 
prevalence data for CKD, end stage kidney disease (ESKD) and the transplant waiting list is 
provided.   
2.1 Incidence and prevalence of CKD and ESKD 
The prevalence of CKD is increasing around the world (Australia and New Zealand Dialysis 
and Transplant Registry 2015a; Rao, Casula and Castledine 2014; United States Renal Data 
System 2014b).  This increased rate of CKD is believed to be linked to the growing number 
of people with obesity, hypertension, diabetes mellitus and to a generally ageing 
population (Eckardt et al. 2013).  The application of the standardised Kidney Disease 
Improving Global Outcomes (KDIGO) classification system (KDIGO 2013) to large renal 
registry databases in Australia, Asia, Europe and North America has found that around 10% 
of the population have CKD (James, Hemmelgarn and Tonelli 2010) increasing to 20% 
among people over 60, and 35% among those over 70 years of age (Eckardt et al. 2013).    
The number of people with CKD who progress to ESKD is estimated from national renal 
registries as the number of people who start renal replacement therapy each year 
(Australia and New Zealand Dialysis and Transplant Registry 2015a; Rao, Casula and 
Castledine 2014; United States Renal Data System 2014b).  The incidence of new patients 
with ESKD starting renal replacement therapy in Australia has been relatively stable over 
the last five years at around 110 patients per million population (pmp) per year (Australia 
and New Zealand Dialysis and Transplant Registry 2015a), but the prevalence of people 
with ESKD in Australia has increased from 608 pmp in 2002 (McDonald 2002) to 928 pmp at 
the end of 2014 (Australia and New Zealand Dialysis and Transplant Registry 2015a).  
Similar increases in prevalence of ESKD have been observed in the United States (United 
States Renal Data System 2002, 2014b)and the United Kingdom (Ansell and Feest 2001; 
Rao, Casula and Castledine 2014).   
At the end of 2014 there were 1123 people in Australia living on dialysis and waiting for a 
kidney transplant from a deceased donor (Australia and New Zealand Dialysis and 
Transplant Registry 2015e).  Despite efforts to increase the transplantation rate, the most 
recent Australian data shows that in 2014 there were around 330 deceased donors 
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resulting in approximately 650 kidney transplants (Australia and New Zealand Dialysis and 
Transplant Registry 2015f, 2015g; Council of Europe 2014).  As around 700 people in 
Australia join the waiting list each year, the number on the waiting list has not reduced 
significantly (Australia and New Zealand Dialysis and Transplant Registry 2015e).  It is 
estimated that worldwide over 170,000 people are waiting for a kidney transplant 
(Australia and New Zealand Dialysis and Transplant Registry 2015e; Council of Europe 2014; 
NHS Blood and Transplant 2015; United States Renal Data System 2014a). 
2.2 Definition and diagnosis of CKD   
The kidneys perform many excretory and regulatory functions.  The primary function of the 
kidney is to maintain fluid and electrolyte balance and excrete metabolic and toxic waste 
products.  The kidneys also manufacture a range of hormones which sustain red blood cell 
production, blood pressure control, acid-base balance and calcium phosphate metabolism 
(Eaton and Pooler 2013; Eckardt et al. 2013).   
The terminology in common use to describe the disease process and failure of normal 
kidney function refers to both the organ (kidney) and the functional system (renal) (Levey 
and Coresh 2002).  Within the literature and around the world the words ‘renal’ and 
‘kidney’ are often used interchangeably.  Similarly the words ‘disease’ and ‘failure’ are also 
exchanged for one another, although ‘failure’ more specifically describes the impact of the 
disease on the functional status of the kidney (Johnson et al. 2013).  As this thesis is being 
written in an Australian setting the terms chronic kidney disease (CKD) and end stage 
kidney disease (ESKD) will be used in line with the terms used in the Kidney Health Australia 
– Caring for Australasians with Renal Impairment (KHA-CARI) guidelines (Johnson et al. 
2013) and which are widely used and understood within the field of renal care.   
Chronic kidney disease is a progressive irreversible disorder defined by declining kidney 
function.  A diagnosis of CKD is based on a measurable reduction in the function of the 
kidneys, and evidence of damage to the structure of the kidneys existing for a period of 
time greater than three months (Johnson et al. 2013).  A single kidney contains 
approximately one to two million nephrons, each containing a glomerulus to filter the 
blood and tubules to reabsorb and balance fluid and electrolytes (Eckardt et al. 2013).  The 
glomerular filtration rate (GFR) is used as a measurement of kidney function and is 
calculated based on the level of creatinine in the blood (Levey and Coresh 2012).  A 
reduced GFR seen along with markers of kidney damage such as protein, albumin or blood 
in the urine, or abnormalities in imaging, indicates the presence of kidney disease (Johnson 
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et al. 2013).  Where these changes last less than three months the disease is classified as 
acute kidney injury (AKI) (Langham et al. 2014), but where they continue for three months 
or more a diagnosis of CKD can be made (Eckardt et al. 2013).  In 2002 the National Kidney 
Foundation’s Kidney Disease Improving Global Outcomes group (KDIGO) developed a five 
stage system to categorise CKD (Levey and Coresh 2002).  The classification system was 
revised in 2012 to include albuminuria and it is currently used to underpin the 
development of renal services and guidelines worldwide (KDIGO 2013).  The KDIGO system 
of categories for the prognosis of CKD by GFR and albuminuria is illustrated in table 1 
below.   
Table 1: Prognosis of CKD by GFR and albuminuria categories KDIGO 2012 
    Persistent albuminuria categories 
Description and range 
    A1 A2 A3 

















































G1 Normal or high > = 90 
 
   
G2 Mildly decreased 60-89 
 
   
G3a Mildly to 
moderately 
decreased 
45-59    
G3b Moderately to 
severely decreased 
30-44    
G4 Severely decreased 15-29 
 
   
G5 Kidney failure <15 or on 
dialysis 
   
Green: low risk (if no other markers of kidney disease, no CKD); Yellow: moderately 
increased risk; Orange: high risk; Red: very high risk 
(KDIGO 2013, p.14) Reproduced with permission from KDIGO 
2.3 The physiological effects of CKD 
The physiological effects of CKD include high blood pressure (hypertension), anaemia, 
oedema, and abnormalities in the composition of the blood such as high potassium levels 
(hyperkalaemia), high phosphate levels (hyperphosphataemia), high levels of the metabolic 
waste product urea (uraemia) and deranged blood lipid levels (hyperlipidaemia) (Eckardt et 
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al. 2013).  The person with CKD may experience symptoms such as altered patterns of 
urination, breathlessness, fatigue, nausea and vomiting, loss of appetite, pruritus, 
headaches and loss of libido (Johnson et al. 2013; O'Callaghan 2009). 
Because CKD often develops slowly without significant signs or symptoms in the early 
stages, it is estimated that up to 90% of cases of CKD in Australia go unrecognised until the 
disease has progressed to stage three of the KDIGO system or beyond (Johnson et al. 2013).  
Some individuals lose 90% of their renal function before they notice any symptoms at all 
(Chadban et al. 2003; John et al. 2004) 
Strategies for the management of the some of the physiological effects (both signs and 
symptoms) of CKD are listed in Table 2. 
Table 2: Treatment of CKD 
Symptom Strategy 
Hypertension Anti-hypertensive medication (Phoon, Richard K. S. and Johnson, D. 
2012) 
Anaemia Erythropoietin supplementation (McMahon and Macginley 2012) 
Oedema Restricted fluid intake (Phillips and Knuchel 2011) 
Hyperkalaemia Restricted dietary potassium intake and medical therapy (Chan and 
Chadban 2013) 
Hyperphosphataemia Restricted dietary phosphate intake and medical therapy (Chan and 
Chadban 2013) 
Uraemia Dialysis and medical therapy for symptom management (Koncicki 
et al. 2015) 
Hyperlipidaemia Lipid lowering medication (Phoon, Richard K. S. and Johnson, D 
2012) 
 
Chronic kidney disease is associated with higher incidence of comorbid disease and poorer 
outcomes than seen in the general population (Eckardt et al. 2013).  Where CKD coexists 
with cardiovascular disease (CVD),the blood vessels, heart valves and soft tissues become 
calcified, contributing to higher than normal rates of death after myocardial infarction 
(Japanese Society of Nephrology 2009; Moe and Chen 2008; Ross and Banerjee 2013).  
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Other comorbidities of CKD include renal bone disease and an increased risk of cancers of 
the kidney and urinary tract (Danovitch 2010b). 
The most severe stage of CKD is stage five, also known as end-stage kidney disease (ESKD).  
End-stage kidney disease is a chronic, life threatening condition said to occur when the GFR 
is <15ml/min/1.73m2 or when renal replacement therapy is required in order to support 
life (Danovitch 2010b; Johnson et al. 2013).  
2.4 Therapeutic options for people with ESKD 
Once CKD progresses to ESKD, the individual will require some form of renal replacement 
therapy unless they have chosen not to pursue active treatment for their disease.  End-
stage kidney disease is a life limiting condition that if left untreated will result in the death 
of the patient.  Broadly speaking there are two choices for people with ESKD: conservative 
care or active management with renal replacement therapy which includes haemodialysis 
(HD), peritoneal dialysis (PD) and kidney transplantation.   
Before commencing any renal replacement therapy option, the risks and benefits of the 
therapy need to be considered.  A table listing the comparable risks and benefits of each 
renal replacement therapy modality can be found in Appendix 1.    
 
2.4.1 Conservative care 
Renal conservative (supportive) care is a valid treatment option for people with high levels 
of comorbid disease or advanced age (Chambers, Brown and Germain 2010).  It focuses on 
relieving symptoms, maximising quality of life and facilitating a good death (Brown et al. 
2013).  No difference has been found in the survival of people with ESKD who are over 75 
years of age and who have a high level of comorbidity and who either have dialysis or do 
not have dialysis (Chandna et al. 2011).  Interest in conservative care as a treatment option 
for individuals with ESKD has increased in recent years and is often offered with the 
support of a multidisciplinary renal supportive care service.  This service comprises medical, 
nursing, social work and dietary expertise to provide a tailored, holistic package of care for 
each individual (Brown et al. 2015; Josland et al. 2012). 
2.4.2 Haemodialysis 
The aim of haemodialysis is to remove toxins and excess fluid through a combined process 
of diffusion and ultrafiltration.  It achieves this by filtering the person’s blood across a 
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semipermeable membrane (Daugirdas 2015; Kallenbach 2012).  The first human 
haemodialysis took place in 1924, and the technology was gradually refined during World 
War II.  The artificial kidney pictured below in figure 1 dates from 1943 and comprises a 
wheel made of wooden paddles wrapped in semipermeable cellulose which rotates 













Figure 1: Kolff's Artficial Kidney 1943 
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Due to the challenges of developing a financially viable dialyser membrane and a reliable 
access to the blood stream, haemodialysis did not become a widely available treatment 
option until the 1960s (Eknoyan 2009; Kallenbach 2012).  Current dialysis technology uses 
disposable dialysers containing thousands of hollow fibres made of semi-permeable 
membrane (Ahmad et al. 2015).  Blood is pumped through the dialyser and waste products 
and excess fluid are removed by diffusion and ultrafiltration (Daugirdas 2015).  A 













The surgical creation of a vascular access is required to allow for large volumes of blood to 
be removed, filtered and returned to the body during haemodialysis sessions (Lopez-
Vargas, P. and Polkinghorne, K 2012).  There are currently three options for haemodialysis 
vascular access; arteriovenous fistula (AVF), arteriovenous graft (AVG) or a central venous 
access device (CVAD) (Polkinghorne et al. 2013).  An AVF is created by joining an artery 
directly to a vein using the person’s own blood vessels.  The AVF is long lasting and has the 
lowest rate of morbidity and mortality of all the vascular access options (Lopez-Vargas, P. 



















Where the creation of an AVF is not possible the second option is to create an AVG by using 
a graft of synthetic material to connect the artery to the vein, illustrated in figure 4 (Konner 
2005).  Grafts do not have the longevity of the AVF and they have been shown to have an 








For people who require haemodialysis urgently or for whom vascular surgery is not 
possible, a double lumen CVAD may be used (Santoro et al. 2014).  Rates of infection with a 
CVAD are the highest of the three vascular access options (Lopez-Vargas, P. and 





Figure 3: Arteriovenous fistula 















People on haemodialysis spend a minimum of 12 hours per week connected to the dialysis 
machine (Caring for Australasians with Renal Impairment 2005b) either at a hospital or 
satellite dialysis centre, or independently at home.  During every dialysis session, access to 
the vascular system is achieved by the insertion of two large cannulas into the AVF/AVG  
(Vale, Lopez-Vargas and Polkinghorne 2011) or by accessing the CVAD.  An aseptic 
technique must be maintained throughout because of the risk of causing bacteraemia 
(Lopez-Vargas, P. and Polkinghorne, K. 2012; Vale, Lopez-Vargas and Polkinghorne 2011).  
Bleeding is a potential complication of haemodialysis, either from a loose connection in the 
circuit, or through a cannula becoming dislodged.  When removing the cannulas at the end 
of the haemodialysis session time must be taken to apply pressure to the site to ensure the 
bleeding has completely stopped (Faratro et al. 2015).  Exsanguination from a 
haemodialysis access is a rare but serious occurrence that most commonly occurs at home 
and which causes death in approximately 40% of cases (Gill, Storck and Kelly 2012).  
2.4.3 Peritoneal dialysis 
Peritoneal dialysis uses the peritoneal membrane to remove toxins and excess fluid in a 
similar way to the dialyser membrane in HD (Blake and Daugirdas 2015; Danovitch 2010a).  
Metabolic waste is removed by diffusion while the addition of glucose to the PD fluid in 
differing concentrations creates an osmotic gradient for the removal of fluid (Blake and 
 
Figure 5: Central venous access device for haemodialysis 
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Daugirdas 2015).  Volumes of fluid are drained in and out of the peritoneal cavity through a 
surgically inserted, permanent PD catheter.  The first PD treatment for a person with 
uraemia was performed in 1924 but it did not become a widely accepted treatment option 
for chronic ESKD until 1968 when the development of the Tenkhoff catheter provided a 
permanent, low irritant, long lasting peritoneal access device (Twardowski 2006).  A 











Peritoneal dialysis is prescribed for each person depending on their specific needs for fluid 
and solute removal.  The PD prescription comprises of the composition and volume of the 
PD fluid to be used, the number of ‘exchanges’ or times that fluid has to be drained in and 
out in a 24 hour period, and the length of the ‘dwell’ which is the length of time the fluid 
sits in the peritoneal cavity before it is drained out (Crabtree and Jain 2015).  Peritoneal 
dialysis is the first treatment option for many people as it can be more easily carried out 
independently at home, but it is not suitable for people who have had prior abdominal 
surgery, or who are unable to maintain meticulous standards of hygiene (Blake and 
Daugirdas 2015).    
2.4.4 Transplantation 
The third option for the active treatment of ESKD is kidney transplantation.  This involves 
surgically grafting a donated organ into the person with ESKD and then preventing rejection 
of the organ by suppressing the immune response with medication (Mahendran and 
Barlow 2014).  The first successful kidney transplant took place between identical twins in 
 
Figure 6: Peritoneal dialysis 
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1954 (Starzl 1990).  By the early 1960’s the development of immunosuppressive 
medications such as prednisolone and azathioprine resulted in the successful 
transplantation of organs from non-related and deceased donors (Mahendran and Barlow 
2014).  Advances in surgical techniques and medical therapies over the last 60 years have 
now made kidney transplantation a viable treatment option for many people with ESKD 
(Garcia et al. 2013).  Modern medications are very successful at controlling the immune 
response and preventing rejection of the transplanted organ, but this does increase the 
likelihood of a person developing a life-threatening infection or cancer in the future 
(Helanterä et al. 2014; Wong, G. et al. 2013). Figure 7 below shows a diagram of the kidney 
transplant surgery, including the anastomosis of the blood vessels and ureter, and the 












Kidney transplantation is recognised as the best RRT option in terms of survival, cost and 
quality of life (QOL) (Australia and New Zealand Dialysis and Transplant Registry 2015b; van 
Holder, van Biesen and Lameire 2014; von der Lippe et al. 2014).  A full summary of the 
comparative risks and benefits of HD, PD and transplantation is presented in Appendix 1.   
With a functioning kidney transplant people can live for many years without the restrictions 
on their lifestyle experienced by those on dialysis.  Despite these benefits two barriers exist 
which prevent people from receiving kidney transplants.  First is the suitability of the 
recipient to undergo transplantation and second is the availability of a donated organ.  In 
 
Figure 7: Kidney transplant 
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the next section the process of transplant suitability assessment is explained, followed by a 
description of organ donation and the process by which kidneys from a deceased donor are 
allocated to people on the waiting list.   
2.5 Assessment for transplant suitability 
Because of risks such as surgical complications and immunosuppression associated with 
transplantation, people wishing to receive a kidney transplant must first be assessed for 
their suitability.  The assessment process includes consideration of the person’s original 
kidney disease, cardiovascular health, history of malignancy and infectious disease, and an 
assessment of surgical suitability (Campbell et al. 2013; Mahendran and Barlow 2014).  In 
Australia there are three criteria for entry to the transplant waiting list.  First, the individual 
must have ESKD requiring dialysis.  Second, they must have an anticipated low peri-
operative mortality rate.  Lastly, there must be an “anticipated 80% likelihood of survival at 
five years post-transplant” (TSANZ 2016, p. 40).  Some countries allow people to join the 
transplant waiting list before they start dialysis, thus increasing their chances of getting a 
pre-emptive transplant and benefitting from the associated improved graft survival and 
quality of life (Davis 2010; Fissell et al. 2012).  Other countries like Australia do not allow 
this as it further disadvantages individuals who are difficult to match by placing more 
people on the waiting list (Transplantation Society of Australia and New Zealand (TSANZ) 
2016).  However, pre-emptive transplantation with a donated organ from a living donor is 
permitted worldwide (Garcia et al. 2013).  
2.6 Kidney donors 
Donated kidneys come from one of two sources.  Either a living person donates one of their 
kidneys to the recipient, or the organ is taken from a deceased person.  Data shows that 
when a kidney is donated by a living donor the kidney transplant functions for a longer 
period of time and the recipient has a longer survival time (Australia and New Zealand 
Dialysis and Transplant Registry 2015f).  The most recent Australian data shows that 95% of 
people and 90% of grafts survive to five years with a kidney from a living donor, compared 
to 89% of people and 81% of grafts from a deceased donor (Australia and New Zealand 
Dialysis and Transplant Registry 2015f).   
2.6.1 Living donors 
A living donor is a family member or a friend of the recipient whose motivation for 
donation is to alleviate the suffering of their loved one.  Potential donors are screened 
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carefully to ensure the quality of the donated organ, and to assess the physical and 
psychological health of the donor in order to prevent problems in the future (Mahendran 
and Barlow 2014).  Because of the lack of deceased donor organs, and because of the 
improved outcomes of living donor transplants, many initiatives have been developed to 
increase the pool of live donors including transplants from non-related donors (Terasaki et 
al. 1995), altruistic strangers (Clarke, Mitchell and Abraham 2014), blood group 
incompatible pairs (Muramatsu et al. 2014; Wyburn et al. 2010), and kidney exchange 
programmes for incompatible donor pairs (Ferrari et al. 2011; Ferrari, Woodroffe and 
Christiansen 2009; Garcia et al. 2013; Warren and Montgomery 2010).   
2.6.2 Deceased donors 
Deceased donors are people who have been declared brain dead but whose breathing and 
circulation are maintained by artificial life support (Escudero et al. 2015).  Brain death is 
defined as, “a complete and irreversible loss of brain function” (Machado 2010, p. 9) and is 
clinically diagnosed on the basis of diagnostic criteria and confirmatory tests (Machado 
2010; Munoz and Fox 2013).  Because of the relatively small number of deceased donor 
organs available compared to the large number of people waiting for a transplant, 
strategies have been adopted to increase the number of deceased donors including 
donation after cardiac or circulatory death (DCD) (Manara, Murphy and O'Callaghan 2012) 
and the use of donors who were previously thought to been unsuitable, known as 
extended or expanded criteria donors (ECD)(Pesavento 2014).   
2.6.3 Allocation of deceased donor organs 
Globally the strategies used to allocate deceased donor kidneys vary according to locally 
agreed priorities.  These include the age of the donor and the recipient, the presence of 
comorbidity in the donor and the length of time the recipient has spent on the waiting list.  
In Australia the allocation of organs from deceased donors is managed by the National 
Organ Matching System (NOMS) run by the Australian Red Cross (Clayton et al. 2013).  
When a kidney from a deceased donor becomes available the selection of a recipient takes 
into account multiple factors and is ultimately calculated by a computer algorithm.  Factors 
which are considered include the person’s blood group, their tissue type or human 
leukocyte antigen (HLA) matching, the level of HLA-antibodies to human tissue the person 
has in their body, and the length of time the person has spent waiting (Transplantation 
Society of Australia and New Zealand (TSANZ) 2016).  In some cases special consideration is 
made for factors like age where the recipient is a child or a previous living donor in need of 
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a kidney transplant (Cecka et al. 2010; O'Connor et al. 2010).  This mathematically 
generated selection process means that if a perfect tissue typing match is made, it is 
possible, although rare, for a person to receive an organ after waiting only a few months.  
However in people with high levels of HLA-antibodies it may be difficult to find an organ 
that does not cause a strong immune reaction.  These people may have to wait for many 
years before receiving an offer (Wright 2011).   
2.7 Waiting time 
People waiting for a kidney transplant from a deceased donor are faced with a paradox.  
They must be ready at any time in case an organ becomes available, while being prepared 
for what will most likely be a long wait.  Renal registry data and quantitative studies 
provide some information about estimated wait times and the effect of waiting on survival.  
The most recent reported data from Australia shows that in 2014 the median waiting time 
for a kidney from a deceased donor was 2.6 years (Australia and New Zealand Dialysis and 
Transplant Registry 2015e).  This is similar to the US where the median wait time in 2013 
was 3.6 years (United States Renal Data System 2014a), and in the UK in 2014 where it was 
2.8 years (NHS Blood and Transplant 2015).    
2.7.1 Impact of waiting time on patient and graft survival 
The physical effects of waiting time for a kidney transplant have been investigated in a 
number of studies.  In 1999 a longitudinal study by Wolfe et al. compared the rates of 
mortality in people who were on dialysis for ESKD over a period of six years from 1991-
1997(Wolfe et al. 1999).  Of the 228,552 people in the study, 46,164 were on the waiting 
list for a kidney transplant and 23,275 received a kidney transplant.  The study found that 
the annual death rates in those three groups were 16.1 per 100 in people on dialysis, 6.3 
per 100 in people on the waiting list, and 3.8 per 100 in people with a kidney transplant.  
People on dialysis, therefore, were 2.6 times more likely to die than those on the waiting 
list for a kidney transplant, while people on the waiting list were 1.7 times more likely to 
die than those with a kidney transplant.  This finding was thought to reflect the selection 
process for transplantation suitability which screens out people who are less healthy.    
An analysis of 73,103 transplants from 1988-1997 by Meier-Kriesche et al. in 2000 found 
that the longer a person spent on dialysis, the greater the risk of graft loss and death after 
transplantation (Meier-Kriesche et al. 2000).  Spending more than four years on dialysis 
was shown to cause a 68% increased risk of graft loss and death than a person who 
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received a kidney pre-emptively before starting dialysis.  Another study by Meier-Kriesche 
and Kaplan (2002) conducted a retrospective data analysis comparing the outcomes of 
2,405 kidney pairs transplanted from 1988-1998 (Meier-Kriesche and Kaplan 2002).  In this 
study kidney pairs were defined as organs from the same deceased donor where one 
kidney had been allocated to a recipient who had been on dialysis less than 6 months and 
the other had been allocated to a recipient who had been on dialysis more than two years.  
Acute rejection and delayed graft function were found to occur more frequently in the 
group who had been on dialysis more than 2 years, and those people also demonstrated 
poorer graft and patient survival outcomes.  The assertion of this study is that “… waiting 
time on dialysis is the strongest modifiable risk factor for renal transplant outcomes” 
(Meier-Kriesche and Kaplan 2002, p. 1377). 
Another retrospective cohort study from the same era compared the outcomes of 9130 
transplants from living donors to recipients who had either been transplanted either pre-
emptively, or who had been on dialysis prior to transplantation (Mange, Joffe and Feldman 
2001).  The study showed an increased risk of rejection in the first six months in people 
who had been on dialysis and overall better graft survival in people who had not received 
dialysis prior to transplantation.  These findings were confirmed in an analysis of 112,249 
transplants from 1999-2008 (Schold et al. 2010).  The length of time spent on dialysis prior 
to transplantation was found to have a negative effect on graft survival outcomes.  
However, by adjusting for factors such as comorbid conditions, social class, income, access 
to health care and health literacy (Schold et al. 2010, p. 2014), the study found that dialysis 
did not have such a great effect as shown previously. 
2.8 Conclusion 
This chapter has described how the incidence of CKD and ESKD is increasing worldwide, 
with an estimated 170,000 people worldwide living on dialysis while waiting for a kidney 
transplant (Australia and New Zealand Dialysis and Transplant Registry 2015e; Council of 
Europe 2014; NHS Blood and Transplant 2015; United States Renal Data System 2014a).  
Treatment options for ESKD include haemodialysis, PD and kidney transplantation with a 
fourth option of conservative care for those who do not wish to pursue active therapy 
(Blake and Daugirdas 2015; Chandna et al. 2011; Danovitch 2010b; Daugirdas 2015).  Each 
of the renal replacement therapy options has its own set of risks and benefits.  Dialysis is 
effective for maintaining life in people with ESKD, but both haemodialysis and PD require 
large amounts of time to be invested in the treatment, with a dependence on a machine 
 
18 
that impacts many other areas of daily life (Hakim and Saha 2014).  Kidney transplantation 
has been shown to offer the best physical health and QOL as well as being the cheapest 
long term option (Australia and New Zealand Dialysis and Transplant Registry 2015f).  
People who want a kidney transplant who do not have a living donor have no choice but to 
go onto the waiting list for a kidney from a deceased donor (Transplantation Society of 
Australia and New Zealand (TSANZ) 2016).  People wait around three years on average for a 
kidney transplant from a deceased donor because the number of people waiting for a 
kidney far exceeds the number of organs that are available (Australia and New Zealand 
Dialysis and Transplant Registry 2015e; NHS Blood and Transplant 2015; United States 
Renal Data System 2014a).  However because deceased donor organ allocation is based on 
tissue type matching it is possible, although very rare, that a person may receive a 
deceased donor organ after only waiting for a short time (Transplantation Society of 
Australia and New Zealand (TSANZ) 2016).  Studies have shown that the length of time 
spent living on dialysis while waiting for a kidney transplant affects the rates of rejection 
and graft survival (Schold et al. 2010).  The longer a person spends living on dialysis waiting 
for a kidney transplant, the poorer their post-transplant outcomes (Meier-Kriesche and 
Kaplan 2002; Wolfe et al. 1999).  While this is helpful information, this quantitative data 
does not describe what the experience of waiting for a kidney transplant is like.  In order to 
gain a fuller understanding of this paradoxical experience, the next two chapters will 
explore the literature, and particularly the qualitative data, in more detail to establish what 




 BACKGROUND LITERATURE  CHAPTER 3
This chapter presents the literature that describes and informs the experience of waiting 
for a kidney transplant.  Based on the background information an initial search of the 
Embase, Medline and PsychINFO databases was made.  The initial search terms used were 
“wait*”, “kidney”, “renal” and “transplant*”.  Examination of the papers found in this 
preliminary search led to a series of themes and concepts being developed: living with 
chronic disease; the experience of waiting and strategies for managing a period of waiting; 
the passage of time; and uncertainty.  The Embase, Medline and PsychINFO databases 
were searched again using these themes as search terms up to the current date in 2014.  
Decisions about whether to include the studies were based on whether or not they 
addressed the themes that had been identified.  Reference lists were scrutinised for further 
relevant studies, and as the writing process went on newer studies were published which 
had cited one of the original papers found in the search.  A total of 120 papers were 
included.  The resulting summary of the literature provides a comprehensive overview of 
the experience of waiting for a kidney transplant from a deceased donor.  The themes that 
emerged are used as headings and sub-headings in this chapter.   
This chapter does not include literature concerned with post-transplant outcomes because 
the focus of this study is the pre-transplant waiting period.  It also does not include studies 
about the experiences of people waiting for a transplant from a living kidney donor.  Living 
kidney donation can be achieved by direct action on the part of both the donor and the 
recipient, and it often includes an emotional connection between the pair (Pradel et al. 
2009; Udayaraj et al. 2012).  Qualitative studies published from 1985 – 2013 about the 
experience of waiting for a kidney transplant from a deceased donor are presented as a 
systematic review in the following chapter. 
3.1 The burden of living with chronic disease 
Waiting for a transplant is an experience that occurs in the context of living with a chronic 
disease.  The hope of a transplant is the hope for life without the chronic illness.  Chronic 
conditions such as CKD are defined by their ongoing nature and irreversibility (Stewart and 
Sullivan 1982) and cause both a burden of illness and a burden of treatment (Sheilds et al. 
2015; Tong et al. 2009).  People living with chronic disease face the reality of their own 
mortality each day (Brown et al. 2006) as well as the erosion of their ‘normal’ lives that 
results in altered relationships and a poorer quality of life (Alshraifeen, McCreaddie and 
Evans 2014; Pierce 2014). 
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3.1.1 Burden of illness 
Living with a chronic disease creates physical and psychological challenges, and many 
people live with multiple coexisting chronic diseases which impact their lives (Sheilds et al. 
2015).  In a study of people with chronic illness, Öhman et al. (2003) described how people 
viewed their bodies as a hindrance to the life they wanted to live (Öhman, Söderberg and 
Lundman 2003).  Symptoms of pain and lethargy stopped them from achieving the most 
basic daily activities such as personal hygiene, sleeping and eating.  Fatigue is a commonly 
reported symptom of chronic disease (Moens, Higginson and Harding 2014; Polaschek 
2003b).  Bonner et al. (2010) reported on the relationship between biochemical markers, 
fatigue and activity in people with CKD (Bonner, Wellard and Caltabiano 2010).  Worsening 
renal failure, as indicated by the serum haemoglobin, albumin, phosphate and urea levels, 
was an indicator for greater fatigue and less activity.   
The physical limitations of chronic disease mean that people are no longer able to invest 
time in the activities that had previously defined their sense of self, such as independent 
living, employment, education and social relationships (Bennett et al. 2013; Kuluski et al. 
2014; Pierce 2014; Tong et al. 2013; Tong et al. 2009).  As their strength and energy 
decrease, the increasing anxiety and depression can cause people to dwell on the meaning 
of their lives and develop a new image of themselves (Bjork and Naden 2008).  Living with 
chronic illness has been described as a “loss of self” (Charmaz 1983, p. 168)or a “lost life” 
(Monaro, Stewart and Gullick 2014, p. 3262).  Rather than expecting a return to health, 
people become immersed in the chronic disease experience.  With no prospect of recovery 
they develop a new self-image that includes the disease (Charmaz 1983; Williams 1984).  
Bury described living with a chronic condition as biographical disruption  that “involves a 
recognition of the worlds of pain and suffering, possibly even death, which are normally 
only seen as distant possibilities or the plight of others” (Bury 1982, p. 169).  The concept of 
biographical disruption suggests that chronic conditions alter the normal course of life 
which would otherwise be expected to follow a series of culturally accepted milestones 
(Bury 1982) such as becoming independent and caring for others.  Many people with 
chronic disease lose the expectation to get better and resume normal duties.  Instead of 
focussing on recovery, they restructure their life to include the diagnosis and treatment of 
the disease as part of a new self-identity (Bury and Wood 1979; Charmaz 1983, 1994; 
Moore 2013; Stephens, McKenzie and Jordens 2014; Williams 1984).  
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In people waiting for a transplant the hope of returning to a normal life is not given up 
completely, but while they wait the restrictions of living with a chronic illness causes them 
to feel that that their lives are ‘on hold’ (Bjork and Naden 2008; Brown et al. 2006; Moran, 
Scott and Darbyshire 2011; Pierce 2014; Yngman-Uhlin, Fogelberg and Uhlin 2015).  They 
live in a state of constant readiness understanding that an offer could come at any time, 
but they are repeatedly disappointed as weeks, months and years on dialysis go by (Pierce 
2014).  Rather than relinquishing the expectation of recovery, they experience feelings of 
powerlessness and acceptance as they continue to wait (Jonsén, Athlin and Suhr 2000; 
Pierce 2014; Yngman-Uhlin, Fogelberg and Uhlin 2015). 
3.1.2 Burden of treatment 
As well as the impact of the disease itself, the task of managing treatment regimen 
associated with chronic illness has also been described as burdensome.  In a study of 97 
people with various chronic conditions Sav et al. identified four themes regarding the 
burden of treatment (Sav et al. 2013).  Firstly, the financial burden of paying for 
medications and treatment and the impact of that expense on the social, recreational and, 
in some cases, the basic daily living of the rest of the family.  Second, the relentless time 
and travel burden of undergoing therapy and travelling to appointments.  Third were the 
side effects, the inconvenience and the stigma of taking medication, in addition to the 
financial burden of buying the medicine.  Finally was the healthcare access burden relating 
to problems people experience when accessing the healthcare system such as long waiting 
periods and the lack of continuity (Sav et al. 2013, p. 668-672).  Sheilds et al. (2015) found 
that the experience of living with CKD was defined by, “the day-to-day intensity of 
managing symptoms and technologies” (Sheilds et al. 2015, p. 212).  Once CKD progresses 
to ESKD, the technological requirements of dialysis therapy become all-consuming.  The 
experience of living on dialysis has been called a “lost life” (Monaro, Stewart and Gullick 
2014, p. 3262) or a “restricted life” (Clarkson and Robinson 2010, p. 31), while for those 
waiting for a kidney transplant it has been described as “being on hold” (Moran, Scott and 
Darbyshire 2011, p.505) and “life in standby” (Yngman-Uhlin, Fogelburg and Uhlin 2015, p. 
1).  These comments reflect those already mentioned relating to living with a chronic 
condition (Bjork and Naden 2008; Brown et al. 2006; Pierce 2014) and they show how hard 
it is for people to differentiate between the experience of the disease and the experience 
of the therapy itself (Tong et al. 2009).  People on dialysis invest considerable effort in 
maintaining health, continuing in employment, carrying out family responsibilities and 
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paying for treatment (Bennett et al. 2013; Bonner, Wellard and Caltabiano 2010; Kuluski et 
al. 2014; Sav et al. 2013) as their dependence on dialysis encroaches upon everyday life 
(Herlin and Wann-Hansson 2010; Kaba et al. 2007).   
3.1.3 Facing mortality 
People who are living with a chronic condition while waiting for a transplant have been 
found to have a heightened sense of their own mortality (Brown et al. 2006; Jonsén, Athlin 
and Suhr 2000; Yngman-Uhlin, Fogelberg and Uhlin 2015).  The effect of facing death was 
reported in one study as transformative (Brown et al. 2006), although participants also 
worried that they would not survive long enough to receive a transplant and were very 
aware of the effects of their chronic disease continually eroding their health while they 
waited (Brown et al. 2006; Jonsén, Athlin and Suhr 2000; Yngman-Uhlin, Fogelberg and 
Uhlin 2015).   
Fear of death has been linked to increased anxiety in people with ESKD (Li et al. 2012; Silva 
et al. 2014).  Not thinking about death (Calvey and Mee 2011; Öhman, Söderberg and 
Lundman 2003), or talking about death may be viewed as a strategy to avoid facing one’s 
own mortality (Baines and Jindal 2003). It has been suggested that there is a culture of not 
speaking about death within the community of people on dialysis, perhaps because 
admitting to someone else’s mortality means that people have to face the possibility that 
the same thing could one day happen to them. (Baines and Jindal 2003; Sheilds et al. 2015).   
In a narrative enquiry by Sheilds et al. (2015) a group of participants with CKD showed an 
awareness that their illness was life-limiting and that without dialysis they would die.  
However, there was felt to be an expectation in the dialysis setting that talking about death 
was inappropriate and that they should rather focus on the life-saving technology (Sheilds 
et al. 2015).  In this study people with CKD rarely discussed death with their family or 
treating doctors although they were well aware of it, having seen people in the dialysis unit 
decline in health and die (Baines and Jindal 2003) and having experienced times when they 
were been close to death themselves (Sheilds et al. 2015). 
As well as facing the reality of their own mortality, people waiting for a transplant also have 
to manage their feelings towards the deceased donor.  People struggle with the moral guilt 
of waiting for someone to die and they question their own merit to receive something that 
has come at such a great cost (Tong et al. 2015). In a qualitative study of 35 heart and 
kidney transplant recipients, participants admitted that during their wait they sometimes 
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wished that a suitable donor would die (Sanner 2003).  Feelings towards the donor 
included sorrow for the family’s loss, gratitude, indebtedness and guilt which were 
managed by avoidance, denial and suppression (Sanner 2003). 
3.1.4 Altered relationships 
The experience of living with a chronic disease has been found to cause people to feel 
socially isolated and lonely (Monaro, Stewart and Gullick 2014; Öhman, Söderberg and 
Lundman 2003; Tong et al. 2009).  In part this may be because the physical limitations of 
the disease mean that people are no longer able to invest time and energy in maintaining 
social relationships (Bonner, Wellard and Caltabiano 2010; Herlin and Wann-Hansson 2010; 
Kuluski et al. 2014; Pierce 2014).  Also by limiting what people are able to achieve, chronic 
illness may change the way they are perceived by others (Brown et al. 2006).  Long-term 
chronic conditions have been shown to cause intolerance among friends and family when 
the person fails to get well (Bury 1982) and may lead to people living restricted and socially 
isolated lives, feeling discredited and burdensome to others (Charmaz 1983, P. 168).  
People with a chronic condition may feel they are viewed as hypochondriacs because they 
continue to have the same symptoms and problems (Stewart and Sullivan 1982).  Michael 
(1996) reported that people felt a “loss of connectedness” and found it difficult to relate to 
others as they had done prior to their diagnosis (Michael 1996, p. 256).  In some cases 
these feelings of isolation are exacerbated by people living with a chronic condition 
choosing to withhold information from their loved ones in order not to burden them 
(Monaro, Stewart and Gullick 2014; Öhman, Söderberg and Lundman 2003; Tong et al. 
2009).    
3.2 Waiting for a transplant gives hope 
A kidney transplant offers the hope of life without restriction and with the freedom to 
follow any path (Charmaz 1991; Tong et al. 2015).  Hoping for a transplant (Dekkers, Uerz 
and Wils 2005; Hagren et al. 2001; Herlin and Wann-Hansson 2010; Polaschek 2000; 
Polaschek 2003b; Rittman et al. 1993) allows people to believe that one day they will re-
gain something approaching the normal life they had before they were sick (Calvey and 
Mee 2011; Moran, Scott and Darbyshire 2011; Yngman-Uhlin, Fogelberg and Uhlin 2015), 
free from the constraints of dialysis (Sadala et al. 2012).   
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“The young revealed hope in soon having a kidney transplant: dreaming of 
a future free from catheters, from bags and from the dialysis machine the 
hope of freedom, the hope to live a normal life” Sadala 2012, p.72. 
Yngman-Uhlin et al. (2015) interviewed eight people who were waiting for a kidney 
transplant while living on haemodialysis in Sweden (Yngman-Uhlin, Fogelberg and Uhlin 
2015).  They found that the thought of a getting a kidney transplant gave people hope of 
relief in the future while feeling ‘tied up’ by the dialysis treatment.  In  a qualitative, 
phenomenological study of the experiences of 16 people living on haemodialysis in the 
Republic of Ireland, Moran et al. (2011) found that a transplant was viewed as a “light at 
the end of the tunnel”, enabling people to endure the dialysis therapy (Moran, Scott and 
Darbyshire 2011, p.504).  The same phrase, “a light at the end of the tunnel” was used in 
Pierce’s phenomenological study of people waiting for a liver transplant (Pierce 2014, p. 89) 
and Calestani et al.’s (2014) qualitative study of people’s attitudes to being listed for a 
kidney transplant (Calestani et al. 2014, p. 2146).  Transplant was viewed as a means of 
returning to ‘happiness and health’ (Pierce 2014, p. 89), holding the promise of a return to 
normal life (Calestani et al. 2014).  In another study of 14 people waiting for a liver 
transplant in Sweden, the experience of being activated on the waiting list elicited feelings 
of relief because it gave people the hope of getting a transplant one day (Jonsén, Athlin and 
Suhr 2000).  Likewise Bjork and Naden’s (2008) report of the experience of 21 people 
waiting for a liver transplant in Norway found that the thought of a transplant gave them 
hope for the future tempered with concern about the operation (Bjork and Naden 2008).   
3.3 Waiting for a transplant and health related quality of life  
Health related quality of life (HRQOL) is a concept that aims to quantify a person’s 
wellbeing.   Individuals score their personal sense of wellbeing across number of ‘domains’ 
such as physical, emotional and social health, work life, sexual function, family adaptation 
and social support.  Scores are then compared between different subsections of the 
population to evaluate HRQOL.  Various tools have been developed to measure HRQOL 
including the Kidney Disease Quality of Life short form (KDQOL-SF) (Hays et al. 1994), the 
Medical Outcomes Study Short Form 36-item health survey (SF-36)(Ware Jr and 
Sherbourne 1992), the Karnofsky performance index, the General Health Questionnaire 
(GHQ-28), the Multidimensional Scale of Perceived Social Support, the Herth Hope Index 
(HHI) and the Sickness Impact Profile (Alshraifeen, McCreaddie and Evans 2014; Gomez-
Besteiro et al. 2004; Landreneau, Lee and Landreneau 2010).  Use of these quality of life 
 
25 
(QOL) measurement tools in the population of people with ESKD has been reviewed (Butt 
et al. 2008; Cagney et al. 2000) and many have been validated for use in this patient 
population (Barotfi et al. 2006; Gomez-Besteiro et al. 2004).   
In a study comparing the HRQOL scores of people on dialysis with those of the general 
population, people on dialysis report lower scores, and therefore a poorer quality of life 
(Alshraifeen, McCreaddie and Evans 2014).  The physical domains are affected the most, 
reflecting the effect of the chronic condition on a person’s physical health.  The more 
severe the person’s symptoms, the poorer their perceived HRQOL (Carr et al. 2009).  When 
comparing the HRQOL scores of people on haemodialysis, people on PD and those with a 
functioning kidney transplant, people with a transplant report higher scores than those on 
either dialysis modality (Bohlke et al. 2008; Landreneau, Lee and Landreneau 2010; Liem et 
al. 2007; Overbeck et al. 2005).  In terms of HRQOL, kidney transplantation is the best renal 
replacement therapy option. 
The effect of waiting for a kidney transplant has been evaluated by comparing the HRQOL 
scores of people who are on dialysis and either listed or not listed for transplant.  Østhus et 
al. (2012) conducted a study into the relationship between acceptance on the transplant 
waiting list, HRQOL and depression (Osthus et al. 2012).  Health related quality of life was 
measured in 215 people in Norway using the KDQOL-SF version 1.3 (Hays et al. 1994) and 
depression was assessed using the Beck Depression Inventory (Beck et al. 1996).  The study 
found less depression and better HRQOL scores in the 122 people who had been accepted 
onto the transplant waiting list, compared to the 93 who had been rejected.  Likewise, 
Santos (2011) in a study of 161 people undergoing haemodialysis therapy in Brazil found 
that people who were not waiting for a transplant had poorer HRQOL scores in both the 
physical and the emotional domains (Santos 2011).  Being on the waiting list for a kidney 
transplant is associated with less depressive symptoms and better HRQOL scores than 
those who are not wait listed (Szeifert et al. 2012).  These findings may reflect the 
transplant selection criteria (Transplantation Society of Australia and New Zealand (TSANZ) 
2016) which pick out healthier people with less physical co-morbidities.   
In contrast, a study by Lin et al. (2010) of 335 people in Taiwan who were either waiting or 
not waiting for a kidney transplant, found that the group waiting for a transplant had lower 
overall life satisfaction scores than those who were not waiting (Lin et al. 2010).  This was 
felt to be because of the long waiting times and uncertainty about the impending surgery 
and long-term outcome.  Despite being healthy enough to be listed for a kidney transplant, 
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anxiety about the future weighed people down and was evident in their life satisfaction 
scores.  Low HRQOL scores have been linked to depression and anxiety (Franke et al. 2003).   
Anxiety and depression are commonly reported symptoms in people who are waiting for a 
transplant.  Anxiety is due to an awareness people have that they might die before the 
transplant comes up, or that their disease might progress too much for them to continue 
waiting (Jonsén, Athlin and Suhr 2000).  People are mindful of time running out and they 
experience anxiety about the future success of their transplant (Yngman-Uhlin, Fogelberg 
and Uhlin 2015).  Also the restrictions of living with a chronic disease while waiting for a 
transplant gives rise to feelings of sadness, depression and anxiety (Bjork and Naden 2008; 
Brown et al. 2006; Jonsén, Athlin and Suhr 2000; Moran, Scott and Darbyshire 2011; Pierce 
2014; Yngman-Uhlin, Fogelberg and Uhlin 2015).  Participants express fluctuating feelings, 
from “elation to despair” (Brown 2006, p. 127) as they wait day by day.  The initial hope 
and excitement of being on the list to get a transplant is overcome by feelings of 
depression and discouragement as the waiting time continues (Brown et al. 2006).  Where 
there is a lack of communication, frustration and anxiety increase as people feel forgotten 
(Brown et al. 2006; Jonsén, Athlin and Suhr 2000; Yngman-Uhlin, Fogelberg and Uhlin 2015; 
Yorke and Cameron-Traub 2008).  
People waiting for a kidney transplant experience depression and anxiety at similar rates to 
other people on dialysis.  A study by Chilcot et al. (2014) found that approximately 25% of 
people with ESKD experience symptoms of depression, including  people on dialysis, 
transplant recipients and those waiting for a transplant (Chilcot et al. 2014).  Li et al. (2012) 
conducted a study of 442 people waiting for a transplant in Hong Kong and found that 
23.5% of participants reported a low or very low level of happiness (Li et al. 2012).  The 
lower a person’s expectation of getting a transplant, the lower their happiness score.  
Depression was related to concerns about their illness, the dialysis therapy, social isolation, 
fears of burdening their family and ideas of impending death.   
Spending a longer time on dialysis and on the waiting list is associated with higher levels of 
stress and anxiety (Silva et al. 2014).  In a study of 50 people in Brazil who were on the 
waiting list for a kidney transplant 56% of the group showed signs of stress and 60% 
showed anxiety with 30% having scores that indicated severe anxiety (Silva et al. 2014).  
These findings are similar to a study by Corruble et al. (2010)of 390 people in France who 
were assessed for anxiety and depression at the time of going onto the waiting list and 
then again at 12 months of waiting, 24 months of waiting and 3 months after 
 
27 
transplantation (Corruble et al. 2010).  The study found that anxiety and depression 
increases during the waiting period and drops markedly after the transplant takes place.   
3.4 The experience of waiting 
It has been suggested that “waiting puts people at the mercy of another’s schedule” 
(Mulcahy, Parry and Glover 2010, p. 1063).  People waiting for a kidney transplant are at 
the mercy of a computer algorithm and an unknown donor.  They are waiting for 
something specific that will occur at an unknown time.  The literature about waiting 
encompasses waiting for events with a definite end point and waiting for indefinite events 
that may never happen.  All of this is relevant to the experience of waiting for a kidney 
transplant. 
3.4.1 Definite waiting 
Some forms of waiting have an expected definite end point and the person entering into 
the wait knows from the start how long they will be waiting.  Definite waiting includes 
waiting for news such as the results of exams or medical tests (Sweeny 2012; Sweeny and 
Andrews 2014; Sweeny and Cavanaugh 2012; Sweeny and Krizan 2013) or waiting for 
scheduled surgery (Carr et al. 2009; Carr, Teucher and Casson 2014; Johnson, Horwood and 
Gooberman-Hill 2014 {Sjöling, 2005 #812).  None of these experiences are exactly like the 
experience of waiting for a kidney, because they do not include the emotional level of 
waiting for a donor to die.  However the findings can be applied to the situation of waiting 
for a kidney transplant because they provide information about how people respond when 
they are waiting and when there are delays to the expected outcome. 
Research in the workplace found that unexpected delays in a situation where there was a 
predicted end point caused people to lose the sense of being in control, leading to negative 
feelings (Guenter, Hetty van Emmerik and Schreurs 2014).  The negative feelings were 
found to be greater if someone or something was identified as the reason for the hold-up, 
whereas if it was perceived as just ‘bad luck’ the delay was tolerated more easily.  It was 
also shown that providing information about the prospective length of the delay and the 
cause of the delay gave a better sense of control and an improved experience of waiting.  
This finding was confirmed in a study of train passengers by Cheng and Tsai who also found 
that negative emotions were reduced by providing information and by apologising about 
the length of the wait (Cheng and Tsai 2014).   
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In a systematic review of studies looking at the patient perspective of waiting for scheduled 
surgery, Carr et al. found a relationship between quality of life (QOL) while waiting and the 
severity of the person’s symptoms.  They found that the greater the degree of impairment, 
the poorer the QOL with waiting described as stressful and causing anxiety among 
participants (Carr et al. 2009).  In one of the included studies (Sjöling et al. 2005), waiting 
for surgery was described as like living “in ‘no man’s land’ – waiting to return to a more 
normal life”, and as being “… on hold – a continuous struggle against a faceless system” 
(Sjöling et al. 2005, p. 541-542).  A study by Carr et al. (2014) found that people waiting for 
surgery reported that time seemed to go slowly when they experienced pain or distress, or 
could not carry out their day to day routines as normal or when they felt out of control.  
However where people had greater autonomy and more ability to carry out normal 
activities, the time of waiting seemed to speed up and the date for the surgery came 
around quicker than expected (Carr, Teucher and Casson 2014). 
These examples show that even waiting for something with a definite endpoint causes 
people to feel out of control, stressed and anxious (Carr, Teucher and Casson 2014).  The 
negative feelings caused by waiting can be reduced when people understand how long they 
are likely to wait and what is the reason for the delay (Cheng and Tsai 2014).  When people 
are able to continue with their normal routines they have a better QOL (Carr, Teucher and 
Casson 2014).  Waiting for a kidney transplant is not an example of a wait with a definite 
endpoint, but these insights are nevertheless helpful as they show what it is that people 
experience while they wait. 
3.4.2 Indefinite waiting   
Some types of waiting do not have a definite endpoint, but are unpredictable and 
indefinite.  This includes not only waiting for transplants (Naef and Bournes 2009) but other 
surgeries where the date is not certain (Johnson, Horwood and Gooberman-Hill 2014), as 
well as living with cancer (Bailey, Wallace and Mishel 2007; Jowsey, Ward and Gardner 
2013; Lovgren, Hamberg and Tishelman 2010; Mulcahy, Parry and Glover 2010) or another 
terminal diagnosis (Ellingsen et al. 2013; Lovgren, Hamberg and Tishelman 2010; Zhou 
2010) and waiting for attention by people in long term care facilities (Mitchell et al. 2005).   
In a study of people waiting for a lung transplant Naef and Bournes (2009) made three 
findings.  Firstly, waiting is frustrating and difficult.  Individuals are constrained and 
restricted while they wait, weighed down with lives ‘on hold’.  The second finding 
concerned the hope of the transplant that people waited for.  Keeping a firm image in their 
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minds of what the transplant would do for them when they got it was part of the 
experience of waiting.  Thirdly, ‘fortifying engagement’ described the activities and 
relationships people undertook while they waited.  These helped participants to endure 
while they waited and included keeping busy, faith in God and relationships with family, 
friends and other people who were waiting {Naef, 2009 #693}. 
Transplantation is not the only type of surgery where the wait is for an indefinite length of 
time.  Johnson, Horwood and Gooberman-Hill (2014) conducted a study of people waiting 
for hip replacement surgery in the UK where the constraints of the health care system 
meant that the date was often rescheduled.  In this study the participants felt that the time 
they spent waiting for surgery was lost time.  They “… spoke of inability to make plans and 
of impatience and eagerness to have the operation as soon as possible” (Johnson, Horwood 
and Gooberman-Hill 2014, p. 130).  The authors found that participants, “… ‘put off making 
decisions’ and faced an uncertain future, over which they lacked control” (Johnson, 
Horwood and Gooberman-Hill 2014, p. 130). 
People with cancer endure a cycle of “waiting for diagnosis … for treatment … for remission 
… for relapse” (Mulcahy, Parry and Glover 2010, p. 1065-6) which is outside of anyone’s 
control and cannot be predicted.  Waiting was described as the “worst part of the cancer 
experience”, and felt like living “… on someone else’s schedule” (Mulcahy, Parry and Glover 
2010, p. 1065-6).  Hajdarevic, Rasmussen and Hörnsten (2014) found that in the initial 
stage of the cancer experience people felt uncertain and “groundless”, followed by 
“searching for solid ground”, going on with normal routines and re-evaluating priorities 
(Hajdarevic, Rasmussen and Hörnsten 2014).  The impact of the disease upon the time and 
energy available caused people to re-evaluate their priorities and invest in the relationships 
and activities that were most important to them while they waited (Zhou 2010). 
In a study of the lived experience of waiting among people in long-term care, Mitchell et al. 
(2005) found that waiting made people feel angry and upset, afraid of being forgotten and 
robbed of their self-worth (Mitchell et al. 2005).  Activities that filled their time and 
occupied their minds made waiting easier to endure, as did the attitude they chose to 
adopt while they waited.  Participants learned to live with the experience of waiting and 
accept it as inevitable, not as a personal punishment.   
Waiting for a kidney transplant is a wait of unknown length combined with an uncertain 
outcome of either successful surgery, or graft failure and return to dialysis, or even death.  
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As waiting is an experience of the passing of time, the next section of the chapter will 
explore the different ways that the concept of time is described in the literature. 
3.5 The experience of the passage of time  
Waiting is an experience of time, and therefore an examination of the literature describing 
the different ways people experience the passing of time is relevant to appreciate the 
experience of waiting for a transplant.  The concept of time has been examined over many 
centuries and researchers have developed different perceptions of what time is and how it 
passes (Jowsey 2015).  Some of the ideas and concepts about time that are particularly 
relevant to the experience of waiting for a kidney transplant are those of; linear time 
(Barbour 2009), embodied time (Davies 1994), and liminality (Turner 1977).  Each of these 
concepts is described below.   
3.5.1 Linear time / clock time 
Isaac Newton in Mathematical Principles of Natural Philosophy (1687) describes time as 
linear, something that passes from one moment to another and that is measurable by 
means of the movement of the planets, or of a man-made clock (cited in Barbour 2009, p. 
2).  Commonly measured in hours and minutes, it is also referred to as ‘clock time’ (Davies 
1994).  Two studies reported that people waiting for a transplant understood the 
information that they were given about the average waiting time to mean the actual length 
of time they would have to individually wait (Moran, Scott and Darbyshire 2011; Yngman-
Uhlin, Fogelberg and Uhlin 2015).  This is an example of using clock time to measure an 
event that is not easily defined in days and hours.  The disappointment that people feel 
when they wait longer than the average indicates that there are different ways of 
describing the passage of time that may be more appropriate in the experience of waiting 
for a transplant. 
3.5.2 Embodied time 
While clock time is a convenient way to measure time, life events happen within a certain 
context and in relationship with other people (Valtteri and Dan 2014).  Within these 
situations time may be described as ‘embodied’ as it is defined by the activities and people 
involved, rather than by the number of minutes that pass (Davies 1994).  The embodied 
experience of the duration of an event depends upon an awareness of the flow of time and 
also of the present moment (Valtteri and Dan 2014), consciously living in the present and 
appreciating every opportunity of daily life (Lovgren, Hamberg and Tishelman 2010).  
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Pemberton and Cox (2014) showed that people with chronic disease perceived time to go 
past quickly when they felt well, but when they felt ill they perceived time slowing down, 
prolonging the feelings of confinement and restriction (Pemberton and Cox 2014). Davies 
called this phenomenon “process time” which she described as “an enmeshing of time in 
social relations” (Davies 1996, p. 583).  The length of time an activity takes is not predicted 
by hours and minutes but by the nature of the task and the ability of the people involved.   
Chronic illness changes a person’s perspective on the experience of time.  A study by Zhou, 
2010 into the experiences of people with HIV/AIDS in China showed that the constraints of 
the disease caused participants to gain a new perspective on their remaining days of life 
(Zhou 2010).  Rasmussen and Elverdam’s 2007 study of people who had survived cancer 
showed that a diagnosis of cancer resulted in a heightened awareness of the passing of 
time passing and a re-ordering of priorities based on valued relationships and activities 
(Rasmussen and Elverdam 2007).  Bennett et al. (2013) found that people re-evaluated 
their use of time after receiving a diagnosis of ESKD (Bennett et al. 2013).  People valued 
their relationships with others more highly than before, and had a greater appreciation for 
time spent together.  In Kieran’s (2005) narrative account of people living with kidney 
disease in Ireland she says, “Dialysis magnifies time.  Time simply stands still as the patient, 
attached to a machine, unable to concentrate, read or work, simply endures” (Kierans 
2005, p. 351)(Kierans 2005).  People waiting for a kidney transplant develop an “awareness 
that time is running out” (Yngman et al. 2015, p. 4).  Time that was not spent on dialysis 
was precious and the use of it was budgeted carefully.  People waiting for a transplant 
experience an altered awareness of time, with months and years appearing to slow down 
while they wait, and which becomes harder as time goes by (Brown et al. 2006; Yngman-
Uhlin, Fogelberg and Uhlin 2015).   
3.5.3 Liminality 
Liminality has been described as “the space betwixt and between” (Sabo 2014, p.184), a 
dynamic transitional phase in between the moment when an experience has begun and the 
end point when the experience is complete (Sabo 2014; Turner 1977).  Liminality has also 
been described as a process, starting with a sense of uncertainty and moving into a lasting 
phase of creating and recreating meaning within the experience of illness (Little et al. 
1998).  Kelly (2008) suggested that people in the in-between liminal states are also 
“between social roles, cultural expectations and status” (Kelly 2008, p. 336).  She offers the 
concept of “living loss” as a theory to describe the active experience of living in a state of 
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liminality (Kelly 2008).  In a study of 100 people with CKD, Molzahn et al. reported the 
liminal spaces in this group as: “Living/Not Living”, “(In)Dependence”, 
“Restrictions/Freedom”, “Not Normal/Normal”, “Worse Off/Better Off” and 
“Alone/Connected” (Molzahn et al. 2008, p. 16-18).  The experience of living with CKD 
exists in a liminal space – not fully identifying with the sick role, but neither being really 
well (Molzahn, Bruce and Sheilds 2008).  Bruce et al. reported the experiences of liminality 
of people with HIV/AIDS, CKD and cancer.  Participants experienced opposing feelings: 
being ill but not being ill; fearful but fearless; alive but not living; existing in the overlapping 
space.  They hid their illness from others, living with uncertainty and finding it hard to make 
plans (Bruce et al. 2014).  Waiting for a transplant has been described as “until transplant … 
and after transplant” (Brown 2006, p. 130) and a liminal space “between the roles of sick 
and healthy” (Crowley-Matoka 2005, p. 821) that becomes a way of life for people while 
they wait (Crowley-Matoka 2005).  People understand there is nothing they can do that 
would affect when the call will come and yet they have to remain on high alert in the 
present moment (Pierce 2014) living in both a constant state of preparedness with phone 
charged and bag packed, while taking one day at a time and trying not to think about the 
long wait ahead (Yngman-Uhlin, Fogelberg and Uhlin 2015). 
These concepts of time are all relevant to the experience of waiting for a kidney transplant.  
Renal registries calculate maximum, minimum and median waiting times and present them 
in clock time (Barbour 2009).  However the actual experience of living on dialysis while 
waiting on the list is a liminal experience; ready and prepared for a transplant, but not 
transplanted yet (Brown et al. 2006).  The length of the wait in embodied time involves 
dialysis and all the physical effects of ESKD, and cannot be predicted by the clock (Moran, 
Scott and Darbyshire 2011; Yngman-Uhlin, Fogelberg and Uhlin 2015).  The experience of 
time is reconstructed, focussing on day to day life and re-evaluating the importance of 
relationships and activities (Bennett et al. 2013). 
3.6 Uncertainty 
Uncertainty occurs when a person cannot make sense of the situation they find themselves 
in due to lack of familiarity with what is happening or because the inability to predict what 
will happen in the end (Weitz 1989).  The concept of uncertainty has been studied over 
many years and various definitions have been suggested (Mast 1995).  Uncertainty has 
been defined as a perceptual state that changes over time (Hilton 1992); as a “complex 
cognitive stressor” (Mast 1995, p. 4) ; as “… the inability to determine the meaning of 
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illness-related events … [or] … to accurately predict outcomes because sufficient cues are 
lacking” (Mishel 1990, p. 256); and as “... a perception of being unable to assign 
probabilities for outcomes that prompts a discomforting, uneasy sensation…” (Penrod 
2001, p. 241).  Uncertain situations may be ambiguous, inconsistent, vague, unpredictable, 
unfamiliar and lacking in information (McCormick 2002).  The level of uncertainty is 
affected by the perceived levels of confidence and control a person has, with greater 
confidence and control being associated with reduced levels of uncertainty (Penrod 2007).  
By adopting appropriate coping strategies people may learn to adapt to the uncertain 
situation (Mishel 1988) and where uncertainty continues over a long period of time, the 
position of uncertainty itself becomes the new baseline from which the person moves 
forward and adapts (Mishel 1990).   
The experience of waiting for a transplant is uncertain, based as it is on the death of a 
compatible donor at a point in the future which is unknown and unpredictable (Tong et al. 
2015).  While the thought of getting a transplant gives people hope (Bjork and Naden 2008; 
Brown et al. 2006; Jonsén, Athlin and Suhr 2000; Moran, Scott and Darbyshire 2011; Pierce 
2014; Yngman-Uhlin, Fogelberg and Uhlin 2015), as time goes by hope changes to 
uncertainty (Moran, Scott and Darbyshire 2011; Pierce 2014).  Waiting for a transplant has 
been described as described as an “emotional rollercoaster” with uncertainty the “only 
constant in this state of flux” (Pierce 2014, p. 104).  Martin et al. (2010) looked at the 
causes of uncertainty both before and after transplantation.  They found that medical 
sources of uncertainty for people included trying to make complicated decisions with 
inadequate information, including the problem of not knowing when an organ would 
become available.  Personal and social uncertainty were caused by a lack of clarity 
surrounding their role and identity (Martin et al. 2010).  Pelletier investigated whether 
people waiting for a kidney transplant do indeed ‘grow through uncertainty’ as Mishel 
proposes (Pelletier 2012).  Her quantitative study used numeric scales to measure 
uncertainty and growth through uncertainty in 103 people who were waiting for a kidney 
transplant in the US.  The results showed a clear relationship between the length of time 
spent waiting and the amount of growth through uncertainty, thus supporting Mishel’s 
theory (Mishel 1990).  The study also showed that uncertainty increases as waiting time 
goes on (Pelletier 2012). 
Waiting for a transplant includes the experience of living with a chronic illness which itself 
is a source of uncertainty.  The study by Bjork and Naden (2008) into the experience of 
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waiting for a liver transplant found that people experienced uncertainty related to both the 
fear of dying before they received a transplant and the effect of their disease on everyday 
life while they waited (Bjork and Naden 2008).  Lasker et al. (2010) found that uncertainty 
in people waiting for a liver transplant was related in part to the fatigue of living with end 
stage liver disease, as well as depression, fear and anxiety (Lasker et al. 2010).  In her auto-
ethnographic account of living with ulcerative colitis Moore (2013) concludes that “… 
chronic illnesses are unpredictable; living with them fills the mind with uncertainty” (Moore 
2013, p. 206-7).  The uncertainty of chronic illness can be related to finding a diagnosis or 
an effective treatment option (Stewart and Sullivan 1982).  The person may experience 
doubts about their future prospects for recovery or for ongoing life with a chronic illness 
(Bjork and Naden 2008; Bury and Wood 1979).   
Uncertainty also features as a theme in the literature regarding the experience of waiting.  
People living with cancer or waiting for surgery at an unspecified time live with an 
uncertain future (Hajdarevic, Rasmussen and Hörnsten 2014; Johnson, Horwood and 
Gooberman-Hill 2014).  Stating that “waiting is often more anxiety-provoking than even 
dire medical procedures and diagnoses” (Sweeny 2012, p.259), Sweeny points out the link 
between waiting, uncertainty and anxiety, a phenomenon called rumination, where people 
faced with waiting for an uncertain outcome have repetitive and unrelenting thoughts 
(Sweeny 2012).  Turning over the possible outcomes in their minds, rumination can result 
in increased anxiety.  Uncertainty is a source of impatience and agony to people while they 
wait for a transplant (Jonsén, Athlin and Suhr 2000). 
People waiting for a kidney transplant live with uncertainty that may be related to living 
with a chronic illness, to waiting itself or to the uncertain outcome of the transplant.  As 
the symptoms and situations of illness that once caused uncertainty become familiar, they 
eventually become part of the normal routine and people adjust to living with uncertainty 
(Pelletier 2012). 
3.7 Strategies for managing the waiting period  
People have inherently different levels of tolerance for waiting (Sweeny and Andrews 2014) 
with those who are more naturally optimistic describing less anxiety than people with a 
more pessimistic outlook.  While a coping style is a characteristic within a person (Sweeny 
and Andrews 2014), other factors have been identified that affect the way people manage 
the waiting period for a transplant.  These are emotional regulation; the provision of 
information about transplantation; and social support provided by family, friends and other 
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non-medical people.  These factors have been found to be effective in reducing uncertainty 
while people wait for a transplant (Cupples et al. 1998; Kimmel 2001; King, Dan and 
Johnstone 2006; Naef and Bournes 2009; Rodrigue and Baz 2007; Stone et al. 2013; Weems 
and Patterson 1989).   
3.7.1 Emotional regulation 
“Emotional regulation” (Sweeny and Cavanaugh 2012, p.153), involves dealing with 
uncertainty by not thinking about it – denying that the problem exists or using distraction 
to lessen the impact of the uncertainty(Brown et al. 2006).  People prepare themselves for 
a bad outcome by moderating their hopes for the future or by re-evaluating the 
significance of the outcome so that bad news is received as less important (Brown et al. 
2006).  They may also prepare themselves practically and emotionally for a negative 
outcome, thereby reducing the disruption of bad news and giving the feeling of being in 
control while they wait (Sweeny and Cavanaugh 2012).  Distraction is another form of 
emotional regulation that has been found to be helpful in the context of waiting for a 
transplant (Naef and Bournes 2009).  Keeping busy with activity occupies the mind and 
diverts attention from the outcome of the wait. 
3.7.2 Providing information 
Communication and information are essential to resilience for individuals waiting for organ 
transplant (Pierce 2014; Yorke and Cameron-Traub 2008).  Facts communicated by the 
healthcare providers and found on the internet serve to relieve anxiety, while lack of 
information increases the frustration of waiting for a transplant (Yngman-Uhlin, Fogelberg 
and Uhlin 2015) and causes people to feel forgotten, afraid and insecure (Jonsén, Athlin 
and Suhr 2000).  Where unforeseen delays unexpectedly extend the length of a wait, 
negative feelings of anxiety can be eased by providing people with information (Cheng and 
Tsai 2014; Guenter, Hetty van Emmerik and Schreurs 2014).  Information reduces the level 
of uncertainty in the situation and gives people a greater sense of being in control (Sweeny 
2012).   
People living with a chronic disease seek to validate and understand their experience by 
learning about their condition (Bury 1991; Stewart and Sullivan 1982).  The communication 
of information results in people on the transplant waiting list feeling better cared for and 
supported (Rodrigue, Mandelbrot and Pavlakis 2011; Yngman-Uhlin, Fogelberg and Uhlin 
2015).  People combine medical information with personal stories to create their own 
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narrative of the experience.  Bury suggested that part of the purpose for creating these 
narratives is legitimation of their chronic condition; to understand how their sense of self 
has been altered by the disease and to gain perspective (Brown et al. 2006; Bury 1991).  As 
the everyday life is disrupted by chronic illness, so the individual seeks knowledge from 
new sources, both informal and professional, in order to contextualise (Stephens, McKenzie 
and Jordens 2014) and to make sense of their experience (Bury and Wood 1979; Michael 
1996).  Studies have repeatedly found that people who are waiting for a transplant require 
the communication of regular information to help them cope with the uncertainty of 
waiting while living with a chronic illness (Jonsén, Athlin and Suhr 2000; Yngman-Uhlin, 
Fogelberg and Uhlin 2015; Yorke and Cameron-Traub 2008). 
In a study investigating the use of information to manage uncertainty in people awaiting 
organ transplantation, Stone et al. (2013) listed a range of sources that people used to 
increase their knowledge.  These included the internet, books, conferences and seminars, 
their medical team and other people who were either waiting for a transplant or had 
experienced a transplant.  The study found that people preferred to receive information 
from other people rather that printed material or the internet and they valued information 
from peers more highly than their doctors as they had been through the experience 
themselves (Stone et al. 2013).  In a study of people with cancer, participants found the 
greatest encouragement in other people with cancer who they met at a support group 
(Mulcahy, Parry and Glover 2010).  The support group provided an alternative source of 
information that was both comforting and empowering and which delivered education and 
practical evidence of how to live with a disease far better than a doctor or a description on 
the internet. 
Although many participants cited information as a useful way of managing uncertainty, a 
number recognised that certain types of information actually increased their anxiety (Stone 
et al. 2013).  Some participants chose to avoid information about negative outcomes as an 
active way of dealing with their uncertainty. 
A number of studies have documented the use of formal educational support for people 
awaiting kidney transplant.  Weems, Taylor and Davidson (1983) developed a programme 
that involved sending six monthly letters to people who were on the waiting list for a 
kidney transplant.  The letters covered topics relating to the post-transplant period such as 
medications, diet and exercise, emotional challenges and potential complications (Weems 
and Patterson 1989).  Participants in the study reported that as well as giving helpful 
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information to them and their families, the letters also made them feel cared for by the 
medical team.  A study by King, Dan and Johnstone (2006) used a series of four weekly 
classes for people on the transplant waiting list run by the nephrology social workers (King, 
Dan and Johnstone 2006).  At the third class in the series transplant recipients came to 
share their first hand experiences and the study reports that it was at this point that 
participants developed a deeper understanding of the benefits and pitfalls of the transplant 
process.  A study by Rodrigue, Mandelbrot and Pavlakis (2011) tested whether support in 
the form of either; one to one therapy individually tailored to the participant’s QOL needs; 
structured emotional and educational support; or standard care of clinic visits alone had 
any measureable effect in improving QOL and reducing psychological distress in people 
waiting for a kidney transplant (Rodrigue, Mandelbrot and Pavlakis 2011).  The one to one 
therapy showed the greatest effect in improving QOL, but there was no difference between 
the one to one therapy and the supportive therapy in reducing psychological distress.  Both 
interventions were better than standard clinic visits alone. 
These studies show that the communication of information is helpful to people who are 
waiting for a transplant, although certain types of negative information may add to a 
person’s anxiety (Stone et al. 2013).  Information should be provided in a format that 
meets people’s individual needs, but it seems that it is most powerful when it comes from 
others who have been through the experience themselves (Calestani et al. 2014; King, Dan 
and Johnstone 2006; Stone et al. 2013).   
3.7.3 Support from others 
Social support has been acknowledged as a factor in a person’s adjustment to a diagnosis 
of chronic illness (Kimmel 2001) and comes from sources such as family members, friends, 
workmates, other people with the same condition, spiritual leaders, medical teams and 
online support groups (Bury and Wood 1979; Godbold 2013; Kimmel 2001).  Chronic 
disease gives people a fresh appreciation of the support they receive from those around 
them (Sheilds et al. 2015).  Bennett et al. (2013) found that that living on dialysis with ESKD 
made people more aware of the importance of relationships, with some participants citing 
seeing  their children or grandchildren grow up as the reason for carrying on with dialysis 
(Bennett et al. 2013).  People described the gratitude they feel towards family members 
who support them (Monaro, Stewart and Gullick 2014; Polaschek 2000; Tong et al. 2009).  
As ‘care givers’ adapt to becoming ‘cared for’, the success of such reframed relationships 
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rests upon the dynamics that existed prior to the chronic disease diagnosis (Monaro, 
Stewart and Gullick 2014).   
In the context of waiting for a transplant, good social support has been shown to 
contribute towards better coping effectiveness (Jalowiec, Grady and White-Williams 2007; 
Tong et al. 2015).  Study participants appreciate being listened to and consistently report 
their need for supportive relationships and information about the transplant process 
(Brown et al. 2006; Jonsén, Athlin and Suhr 2000; Pierce 2014; Yngman-Uhlin, Fogelberg 
and Uhlin 2015; Yorke and Cameron-Traub 2008).  Scott et al. (2011) recommended the use 
of social relationships as a means of helping people to manage their feelings of uncertainty 
before and after transplantation (Scott et al. 2011).  By observing how others live with 
dialysis and transplantation, a sense of normality is created around an experience that is 
not common in the general population.   
Relationships with the healthcare team have been found to be an important source of 
support for people waiting for a transplant (Brown et al. 2006; Yngman-Uhlin, Fogelberg 
and Uhlin 2015; Yorke and Cameron-Traub 2008).  Regular communication with the 
medical team helped people to feel less anxious while they waited (Yngman-Uhlin, 
Fogelberg and Uhlin 2015), while contact with the nurses was described as an essential 
care need and provided reassurance that participants had not been forgotten while they 
waited (Yorke and Cameron-Traub 2008).  Some people felt isolated and wished for better 
support from the healthcare team while they waited (Brown et al. 2006; Jonsén, Athlin and 
Suhr 2000).  In a study from 1996 of 16 people with various types of chronic conditions, 
people reported feeling unseen by their doctors and viewed only as a disease, without 
being given time to make a proper human connection (Michael 1996).  Where information 
from the medical team was felt to be lacking people tended to feel forgotten and 
frustrated (Brown et al. 2006; Jonsén, Athlin and Suhr 2000; Yngman-Uhlin, Fogelberg and 
Uhlin 2015; Yorke and Cameron-Traub 2008).  Lack of information from healthcare 
providers caused people to seek out information for themselves from sources such as the 
internet, other patients and their own observations (Godbold 2013; Wehrens 2014).  
Relationships with doctors and other healthcare providers changed as the person became 
the expert based on their experiential knowledge of their own chronic condition (Wehrens 
2014). 
As well as needing and receiving support from others while waiting for a transplant, people 
fear that they are being a burden to their loved ones (Cupples et al. 1998; Yngman-Uhlin, 
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Fogelberg and Uhlin 2015).  A study into the experience of people whose spouses were 
waiting for a lung transplant found that spouses demonstrated clinically low QOL scores 
and caregiver strain (Rodrigue and Baz 2007).  Despite being thankful for the support they 
received, people with CKD worried that they were being a burden to their loved ones by 
being dependent upon their help and assistance while they waited for a kidney transplant 
(Monaro, Stewart and Gullick 2014; Polaschek 2003a).  In order to protect their support 
network from being burdened, people sometimes chose to hold back information about 
their illness and how they were feeling (Öhman, Söderberg and Lundman 2003; Tong et al. 
2009).    
The importance of feeling supported by a community of people is a commonly recurring 
finding in the literature abut chronic illness (Kimmel 2001), uncertainty (Scott et al. 2011) 
and waiting for a transplant (Naef and Bournes 2009).  People need interaction with others 
and the opportunity to give and receive information (King, Dan and Johnstone 2006; 
Yngman-Uhlin, Fogelberg and Uhlin 2015; Yorke and Cameron-Traub 2008).  Effective social 
support helps people to endure the wait for a transplant (Jalowiec, Grady and White-
Williams 2007). 
3.8 Conclusion  
This literature review has described a wide range of literature that is relevant to help 
understand the experience of waiting for a kidney transplant from a deceased donor.  
People move from an initial perception of their CKD as a temporary interruption (Charmaz 
1991), to waiting many years with a chronic illness (Pierce 2014).  Uncertainty is a common 
feature of living with a chronic illness (Sheilds et al. 2015), waiting (Johnson, Horwood and 
Gooberman-Hill 2014) and waiting for a transplant (Moran, Scott and Darbyshire 2011), 
and it increases as the wait for the transplant goes on (Corruble et al. 2010; Silva et al. 
2014), resulting in greater anxiety and a poorer QOL (Lin et al. 2010).  The uncertainty of 
waiting for a transplant results in people feeling that their lives are on hold (Bjork and 
Naden 2008; Brown et al. 2006; Moran, Scott and Darbyshire 2011; Pierce 2014).  Time 
becomes embodied with the wait for a transplant not measured in minutes and hours but 
taking as long as it takes (Kierans 2005).  Living in a liminal state, ready for transplant but 
not yet receiving it (Brown et al. 2006), causes people to reconstruct their use of time, 
prioritising the relationships and activities that are the most meaningful to them (Bennett 
et al. 2013; Yngman-Uhlin, Fogelberg and Uhlin 2015).  Relationships are highly valued as a 
source of emotional support while people wait (Rodrigue, Mandelbrot and Pavlakis 2011; 
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Yngman-Uhlin, Fogelberg and Uhlin 2015) as is the acquisition of knowledge (Stone et al. 
2013). 
The next chapter will present a systematic review of the literature relating specifically to 
the experience of waiting for a kidney transplant. 
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  SYSTEMATIC REVIEW OF QUALITATIVE DATA CHAPTER 4
4.1 Introduction  
This chapter reports a systematic review of the qualitative literature related to the 
experience of waiting for a kidney transplant from a deceased donor.  It describes the 
process of conducting a systematic review including the design of a protocol; the 
development of a search strategy; critical appraisal and data extraction.  Findings of all 
included studies were be synthesised to provide a meta-synthesis of the evidence.  The 
systematic review has been published in the JBI Database of Systematic Reviews and 
Implementation Reports (Burns, Fernandez and Stephens 2015) 
4.2 Why a systematic review? 
Systematic review methodology has been described as “… a protocol driven and quality 
focused approach to summarising healthcare evidence” (Bearman et al. 2012, p. 625).  The 
concept of systematically evaluating care through controlled trials was first advocated by 
Archie Cochrane in his 1972 seminar, and later book of the same name, ‘Effectiveness and 
efficiency: Random reflections on health services’ (Cochrane 1972).  He proposed 
combining the evidence of multiple controlled trials to form a critical summary (Starr et al. 
2009) and expounded the importance of calibrating survey instruments, and of identifying 
and measuring any sort of bias in a study (White 1997).  Based on his proposition, the 
Cochrane Collaboration was established in Britain in 1993 and is now an international 
organisation with contributors from over 100 countries.  The Cochrane Collaboration 
provides evidence for health care practice  through an online repository of systematic 
reviews of randomised controlled trials that is accessible worldwide known as the Cochrane 
Library (The Cochrane Collaboration History  2013).  While the Cochrane Collaboration is 
concerned with processing quantitative evidence from randomised controlled trials, other 
forms of evidence are equally useful for informing care and methods for the critical 
appraisal and synthesis of qualitative research, economic analysis and expert opinion have 
been developed (Joanna Briggs Institute, Systematic Review  2013).  The Joanna Briggs 
Institute (JBI) was established in 1997 and provides another online source of systematic 
reviews including research from the fields of nursing, allied health, and management as 
well as medicine in the Joanna Briggs Institute Database of Systematic Reviews and 
Implementation Reports (Joanna Briggs Institute - About Us  2012).   
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The process of writing a systematic review begins with the development of a detailed 
protocol to review the evidence on a given topic (Bearman et al. 2012).  Systematic reviews 
are considered to be the highest level of evidence because of the rigorous process involved 
for their development.  The first step of the process involves developing the review 
question, including inclusion and exclusion criteria to clearly define parameters around the 
question under investigation.  A search strategy is constructed and a comprehensive search 
of published and unpublished data is made.  Once appropriate literature is identified, each 
article is appraised for its relevance to the question and for the quality of its data by two 
independent reviewers using standardised appraisal tools.  The use of two reviewers using 
the same appraisal tools is a strength of the systematic review methodology as it is 
effective in limiting bias.  The final step is for the appraised data to be combined and 
summarised into a meta-synthesis of all the findings (Joanna Briggs Institute, Systematic 
Review  2013). 
The systematic review described in this chapter has been carried out using the Joanna 
Briggs Institute Qualitative Assessment and Review Instruments (JBI-QARI) for appraisal and 
data extraction and has been published in the JBI Database of Systematic Reviews and 
Implementation Reports (Burns, Fernandez and Stephens 2015).  Prior to commencement 
of this review a search was performed through the JBI Database of Systematic Reviews and 
Implementation Reports, the Cochrane Library, Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), Medical Literature Analysis and Retrieval System Online 
(MEDLINE) and the database of the American Psychological Association (PsycINFO) to 
ensure that no similar systematic reviews had previously been published. 
The reason for including a systematic review in this master’s thesis is to provide a detailed 
appraisal of the evidence relating specifically to the experience of waiting for a kidney 
transplant from a deceased donor.  In the previous chapter literature relating to a wide 
range of topics was presented, to provide a comprehensive foundation for the forthcoming 
study.  This is complemented by the systematic review in which a narrowly defined section 
of the literature will be closely examined.  The combination of the general literature review 
and the systematic review gives an extensive insight into the experience on which to base 
the study data collection and analysis. 
4.3 Objectives of this systematic review 
Preliminary searches revealed that while some primary qualitative research had been 
conducted, these studies had not been systematically reviewed.  The purpose of this review 
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was to synthesise qualitative evidence relating to the experiences of people who were 
living on dialysis while waiting for a kidney transplant from a deceased donor,  
4.4 Inclusion criteria for studies in the systematic review 
4.4.1 Types of participants 
This review considered studies that included adult patients who were aged 18 years and 
over when they started dialysis, in order to examine the experiences of adults rather than 
children or adolescents.  It only considered studies including people who were waiting for a 
kidney transplant from a deceased donor and who had been on dialysis (either 
haemodialysis or peritoneal dialysis) for up to 15 years.  The advent of erythropoietin in the 
mid-1980s combatted the effects of anaemia associated with ESKD and considerably 
improved the QOL of people on dialysis (Cotton and Holechek 1989; Rutherford 1991).  
Around the same time advances in immunosuppressive medication meant that 
transplantation became a feasible option with good outcomes for more people (Danovitch 
2010a).  Therefore this systematic review only includes studies of people who had been on 
dialysis for up to 15 years, because people who were on dialysis for longer may have had 
experiences that are not typical today.  This review did not consider people receiving 
dialysis for acute kidney failure, people who were waiting for a transplant from a living 
donor or people waiting for a pre-emptive transplant from a deceased donor. 
4.4.2 Phenomena of interest   
This review considered studies that investigated the experiences of adults who are waiting 
for a kidney transplant from a deceased donor including the impact that waiting for a 
transplant had on lifestyle and day-to-day living. 
4.4.3 Context 
This systematic review considered studies involving adults with ESKD who were on either 
haemodialysis in a hospital or a satellite unit or at home, or on peritoneal dialysis, and who 
were waiting for a kidney transplant from a deceased donor.  
4.4.4 Types of studies 
This review considered studies that focused on qualitative data including, but not limited 
to, designs such as phenomenology, grounded theory, ethnography, action research and 
feminist research.  Qualitative research is employed to investigate questions relating to a 
person’s experiences (Denzin and Lincoln 2011).  As this review is concerned with the 
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person’s experience of waiting for a kidney transplant it is appropriate to make a review of 
qualitative studies. 
4.4.5 Search strategy 
The search strategy aimed to find both published and unpublished studies.  A three-step 
search strategy was employed in this review.  An initial limited search of MEDLINE and the 
Excerpta Medica Database (Embase) was undertaken followed by an analysis of the text 
words contained in the title and abstract, and of the index terms used to describe articles.  
A second search using all identified keywords and index terms was undertaken across all 
included databases.  The titles and abstracts of studies identified in this search were 
scrutinised and full text obtained to ascertain whether they met the inclusion criteria.  
Thirdly, the reference lists of all identified reports and articles were searched for additional 
studies.  Only studies published in English were considered for inclusion in this review.  
Studies published from 1985 to 2013 were considered for inclusion, which reflected the 
advances in dialysis and transplantation previously mentioned.   
The databases searched included: 
CINAHL (1985 – 2013)  
MEDLINE (1985 – 2013)  
Embase (1985 – 2013)  
Cochrane Database of Systematic Reviews  
PsycINFO (Ovid)  
The search for unpublished studies included: 
ProQuest Dissertations and Theses  
OpenGrey  
Virginia Henderson International Nursing Library  
New York Academy of Medicine  
The initial keywords used were: kidney/renal failure, kidney/renal transplant, quality of life, 
experiences, not living donors, waiting, qualitative, dialysis.  The literature search was 
carried out in consultation with a librarian at the University of Wollongong.  Separate 
search strategies were carried out for each database and references were entered into 
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Endnote.  All duplicate references were removed.  A detailed search strategy has been 
reported in Appendix 2. 
4.5 Method of the review  
Papers identified in the searches were selected for inclusion in the study if they met the 
inclusion criteria.  That is, they included adult patients aged 18 years and over when they 
started dialysis, who were waiting for a kidney transplant from a deceased donor and who 
had been on dialysis for up to 15 years.   
4.5.1 Assessment of methodological quality 
Papers were read in full and assessed for methodological validity by two independent 
reviewers using the JBI-QARI appraisal instrument (Appendix 3) prior to their inclusion in 
the review.  No disagreements between the reviewers occurred and therefore the 
involvement of a third reviewer was not required.  In order to include only high quality 
studies, a cut off value of Mean minus one Standard Deviation was used (Jakobsen et al. 
2014). 
4.5.2 Data collection  
Data was extracted from papers by two independent reviewers using the JBI-QARI 
standardised data extraction tool (Appendix 4).  The use of two reviewers and standardised 
data extraction tools minimises error and creates a consistent data set that can then be 
used for subsequent synthesis (Munn, Tufanaru and Aromataris 2014).  The data extracted 
included specific details about the phenomena of interest, populations, study methods and 
outcomes relating to waiting for a kidney transplant.  If participants in the study included 
both those waiting and those not waiting for a transplant, only findings that specifically 
related to waiting for a transplant were extracted.  The level of credibility of the findings 
was deemed to be ‘unequivocal’ where the finding was supported either by reference to 
comments made by the participants of by the use of direct quotations of the participant’s 
words.  Where the finding was made without reference to words spoken by the 
participants, but with logical progression from other findings and comments the finding 
was deemed ‘credible’. 
4.5.3 Data synthesis 
Qualitative research findings were pooled using JBI-QARI software.  Findings were 
aggregated to generate a set of statements by assembling the findings according to their 
quality, and categorising them on the basis of similarity in meaning.  These categories were 
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then subjected to a meta-synthesis in order to produce a single comprehensive set of 
synthesised findings that can be used as a basis for evidence-based practice.  
4.6 Systematic review results 
4.6.1 Search results 
Eight hundred and eighty seven studies were identified from the search strategy and 17 
from other sources.  Following removal of 33 duplicates the majority of the remaining 
papers were excluded based on a review of the title and abstract against the inclusion 
criteria.  A total of 16 studies were deemed potentially eligible for the review and full text 
of these studies was obtained.  The 16 studies were critically appraised for methodological 
quality using the JBI QARI critical appraisal checklist for interpretive and critical research 
(Appendix 3).  Based on the JBI-QARI assessment of methodological quality, the calculated 
mean quality score was 16.88 (SD 2.28) (Table 3), therefore the quality threshold score was 
calculated to be 14.6.  Two studies with scores below the quality threshold were excluded 
(Murray, Conrad and Zarifian 1999; Wells 2009).  A further two papers were excluded as 
two of the studies resulted in the publication of two papers each, (Moran, Scott and 
Darbyshire 2011; Polaschek 2003b) therefore only one paper for each study was included.  
This left a total of 12 studies included in the review.  The search process for the review is 
included below in Figure 8 and the critical appraisal scores are recorded in Table 3. 
In the two studies where all the participants were waiting for a transplant (Calvey and Mee 
2011; Polaschek 2000) there was a total of 18 findings of which 14 were ‘unequivocal’ and 
four were ‘credible’.  In the other ten studies where the participants included both people 
waiting and not waiting for a kidney transplant (Dekkers, Uerz and Wils 2005; Hagren et al. 
2001; Herlin and Wann-Hansson 2010; Kaba et al. 2007; Landreneau and Ward-Smith 2007; 
Moran 2008; Rittman et al. 1993; Sadala et al. 2012; Shih and Honey 2011; Yu and Petrini 
2010) a total of 15 findings were found relating to waiting for a transplant.  One of these 
was a ‘credible’ finding while the other 14 were ‘unequivocal’.  This gave a total of 33 study 









Table 3: Critical appraisal scores 
  
JBI critical appraisal checklist for interpretive and critical research 





Calvey D, Mee L., 
2011 
2 2 2 2 2 0 1 2 2 2 17 
Dekkers W, Uerz I, 
Wils J-P., 2005 
2 2 2 2 2 2 1 2 1 2 18 
Hagren B, Pettersen I, 
Severinsson E, Lützén 
K, Clyne N., 2001 
2 2 2 2 2 1 1 2 2 2 18 
Herlin C, Wann-
Hansson C., 2010 
2 2 2 2 2 1 2 2 2 2 19 
Kaba E, Bellou P, 
Iordanou P, Andrea S, 
Kyritsi E, Gerogianni 
G, et al., 2007 
2 2 2 2 2 0 0 2 2 2 16 
Landreneau KJ, Ward-
Smith P., 2007 
2 2 2 2 2 0 2 2 2 2 18 
Moran A.,2008 2 2 2 2 2 2 2 2 2 2 20 
Polaschek N., 2000 2 2 2 2 2 2 2 2 2 2 20 
Rittman M, Northsea 
C, Hausauer N, Green 
C.,1993 
2 2 2 2 2 0 1 2 1 2 16 
Sadala MLA, Bruzos 
GAdS, Pereira ER, 
Bucuvic EM., 2012 
2 2 2 2 2 0 0 2 2 2 16 
Shih LC, Honey M., 
2011 
1 2 2 2 2 0 0 2 2 2 15 
Yu H, Petrini MA., 
2010 
1 2 2 2 2 2 0 2 2 2 17 
Excluded studies 
Murray LR, Conrad 
NE, Zarifian A., 1999 
0 2 2 2 2 0 0 2 1 2 13 
Wells SA., 2009 1 2 2 1 1 0 0 2 2 1 12 
Moran A, Scott A, 
Darbyshire P., 2011 
2 2 2 2 2 1 2 2 2 2 19 
Polaschek N., 2003 2 2 2 2 2 0 0 2 2 2 16 
 Where “Yes” = 2, “No” = 0 and “Unclear” = 1 
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4.6.2 Description of included studies  
The 12 studies included in this review used varying qualitative designs.  Seven studies 
adopted a phenomenological methodology (Calvey and Mee 2011; Herlin and Wann-
Hansson 2010; Landreneau and Ward-Smith 2007; Moran 2008; Rittman et al. 1993; Sadala 
et al. 2012; Yu and Petrini 2010), three were described as interpretive without specifying a 
methodology (Hagren et al. 2001; Polaschek 2000; Shih and Honey 2011), one used 
grounded theory (Kaba et al. 2007) and one virtue ethics (Dekkers, Uerz and Wils 2005).  
Two of the studies were theses (Moran 2008; Polaschek 2000)and 10 were published 
papers (Calvey and Mee 2011; Dekkers, Uerz and Wils 2005; Hagren et al. 2001; Herlin and 
Wann-Hansson 2010; Kaba et al. 2007; Landreneau, Lee and Landreneau 2010; Rittman et 
al. 1993; Sadala et al. 2012; Shih and Honey 2011; Yu and Petrini 2010).   
All the studies used interviews as the method of data collection.  Data collection took place 
in the dialysis unit in seven studies (Calvey and Mee 2011; Hagren et al. 2001; Herlin and 
Wann-Hansson 2010; Kaba et al. 2007; Moran 2008; Rittman et al. 1993; Yu and Petrini 
2010), and in the participant’s home in three (Dekkers, Uerz and Wils 2005; Polaschek 
2000; Sadala et al. 2012).  Two of the studies (Landreneau and Ward-Smith 2007; Shih and 
Honey 2011) did not report where data collection took place.  Data analysis methods 
included Colaizzi’s (Colaizzi 1978) seven step framework for phenomenological analysis 
(Calvey and Mee 2011; Landreneau and Ward-Smith 2007; Yu and Petrini 2010), 
Diekelmann, Allen and Tanner’s (Diekelmann, Allen and Tanner 1989) seven stage 
hermeneutical analysis process (Moran 2008; Rittman et al. 1993; Shih and Honey 2011), 
interpretative phenomenological analysis (Dekkers, Uerz and Wils 2005), interpretive 
content analysis (Hagren et al. 2001), Ricour’s (Ricoeur 1984) three stage hermeneutic 
method (Sadala et al. 2012), McKracken’s (McCracken 1988) analytic categorization 
(Polaschek 2000), Giorgi’s (Giorgi 1997) descriptive phenomenological method (Herlin and 
Wann-Hansson 2010) and theoretical sampling (Kaba et al. 2007). 
The number of participants ranged from six (Polaschek 2000) to 23 (Kaba et al. 2007) with a 
total of 151 participants in all 12 studies.  Participant ages ranged between 20 to 82 years 
(Calvey and Mee 2011; Dekkers, Uerz and Wils 2005; Hagren et al. 2001; Herlin and Wann-
Hansson 2010; Kaba et al. 2007; Landreneau and Ward-Smith 2007; Moran 2008; Polaschek 
2000; Rittman et al. 1993; Sadala et al. 2012; Shih and Honey 2011; Yu and Petrini 2010).  
Of the 12 studies included in the review, two specifically stated that all the participants 
were waiting for a transplant. In the remaining 10 papers the participants included both 
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those waiting and those not waiting for a transplant. Therefore only findings that 
specifically related to waiting for a transplant were extracted from these 10 papers and 
included in the review.  The characteristics of each study are described in Table 4. 
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Table 4: Summary of included studies 
Study Methodology Methods Participants Phenomena of interest 
Calvey and Mee, 2011 
 




7 HD patients who were waiting for a 
transplant chosen through purposive 
sampling (age 29-60).  All participants were 
waiting for a kidney transplant 
To step into the lives of HD patients once they 
step outside the dialysis unit 
Dekkers, Uerz and 
Wils, 2005 
 




7 people with end stage renal disease and on 
dialysis (ages 55-82). An unknown number of 
participants were waiting for a kidney 
transplant 
 
What are the moral challenges faced by 
patients with an ESKD? 
Do patients with an ESKD implicitly or explicitly 
speak in terms of virtue, when they are invited 
to tell the story of their illness and asked how 
they cope with the challenges of their 
illnesses? 
Are there elements in the patient’s stories that 
can be interpreted in terms of Aristotelian 
virtue ethics? 





15 patients, at least 3 months on 
maintenance HD (<1year - >3 years), age 
range 50-79years. An unknown number of 
participants were waiting for a kidney 
transplant  





Phenomenology Interviews 9 HD patients aged 30-44 years.  Eight 
participants were waiting for a kidney 
transplant. 
How HD patients between 30 and 45 years of 
age experienced their dependence on HD 
treatment 
Kaba, et al. 2007 Grounded theory Interviews 23 HD patients, average age 62, average 
length of treatment 5.7years. An unknown 
number of participants were waiting for a 
kidney transplant 
To explore how Greek patients receiving long-
term HD perceive their problems and to 








Interviews 20 randomly selected HD patients, age range 
21-77, on dialysis from 1-5 years. An 
unknown number of participants were 
waiting for a kidney transplant 
To explore what patients on HD perceive 
concerning choice among renal replacement 
therapies: transplantation, HD and PD 
Moran, 2008 Hermeneutical 
phenomenology 
Interviews 16 participants aged 31-66 years and on HD 
10 months-5 years. At least 10 participants 
were waiting for a transplant. 
Accurate, detailed and in-depth description of 
the person’s experience of ESKD and HD 
therapy 
Polaschek, 2000 Critical, 
interpretive 
Interviews Six Pakeha men living on home HD for more 
than one year and no longer than ten years 
aged from their late 20s-60s. All participants 
were waiting for a kidney transplant. 
The concerns of Pakeha men living on home 
HD 
Rittman et al. 1993 Heideggerian 
phenomenology 
Interviews 6 dialysis patients aged 39-58 years, on 
dialysis 3-14 years (5 male, 1 female, 5 
The meanings of living with chronic renal 
failure as described by patients and the related 
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white, 1 black). An unknown number of 
participants were waiting for a kidney 
transplant. 
nursing implications 
Sadala et al. 2012 Phenomenology Narrative 
interviews 
19 participants aged 20-77, on PD for at least 
6 months. An unknown number of 
participants were waiting for a kidney 
transplant. 
The meaning of PD as experienced by patients 
with chronic renal failure 





Seven participants aged 46-77 years, on HD 
for 4-10 years. An unknown number of 
participants were waiting for a kidney 
transplant. 
To explore the impact that dialysis has on 
Maori and their whanau/families 




16 HD patients selected by purposive 
sampling, age 49-74 years, on dialysis for 3 
months to 7 years.  6 participants were 
waiting for a kidney transplant. 
To provide basic information concerning life 
experience and perceptions of ESKD in 
patients undergoing HD 
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4.7 Categorization and synthesis of qualitative research findings 
From the 12 studies included in the review a total of 33 findings were extracted (Appendix 
6) and aggregated to form 11 categories.  From the 11 categories three synthesised findings 
(meta-syntheses) were derived as illustrated in Table 5 – QARI graph.  
Table 5: QARI graph 
Findings Categories Synthesised findings 
Facing the world of renal failure 
and dialysis treatment (U) 
Dependence and 
loss of control 
Physical health and normal 
activities of living 
People who are waiting for a 
kidney transplant from a deceased 
donor are affected by the 
experience of living on dialysis 
with ESKD and its impact on their 
physical health and normal 
activities of living 
The altered interrelationship of 
autonomy and dependence 
involved in living on dialysis: 
Dependence on the dialysis 
machine (U) 
The altered interrelationship of 
autonomy and dependence 
involved in living on dialysis: Their 
new healthcare relationships (U) 
The mortal, fragile self: facing their 
own mortality (C) 
Mortality 
The mortal, fragile self: the issue of 
transplantation (U) 
Bodily self. Participants’ 
descriptions of how they perceived 
themselves and the physical 
changes they had gone through (U) 
Physical health 
Negotiating the requirements of 
dialysis to fit their lifestyle and the 
limitations involved (U) 
 Restricted life 
Total lack of freedom (U) 
 




Findings Categories Synthesised findings 
Mental self. Participant’s 
perceptions of themselves leading 
to feelings of powerlessness, 
worthlessness and low self-
confidence. (C) 
Character and 
state of mind 
Psychological health 
The experience of waiting for a 
kidney transplant from a deceased 




























Being on the waiting list for a 
kidney transplantation (C) 
Hope 
Facing the world of renal failure 
and dialysis treatment (U) 
Future hopes (U) 
Gaining a sense of existential 
optimism (C) 
Gratitude – hope (U) 
Maintaining hope (U) 
The ongoingness and uncertainty 
of life on dialysis and the hope of a 
transplant: The expectation of a 
transplant (U) 
Waiting for a kidney: Living in hope 
(U) 
Choice (U) 
Knowledge Knowledge (U) 
The growing/learning self (U) 
Functional self. The impact on 
what participants perceived to be 
their normal routines and their 









Lost dreams. The loss of dreams 
introduced elements of sadness 
leading to anger and bitterness in 
the descriptions of perceived loss 
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Psychological health (continued) 
The ongoingness and uncertainty 
of life on dialysis and the hope of a 
transplant: Experiencing life on 
dialysis as ongoing (U) 
Psycho-social aspect: Anxiety (U) 
Stress and anxiety 
Stress from HD (U) 
An Uncertain Future (U) 
Uncertainty 
Being on the waiting list for a 
kidney transplantation (U) 
Gaining a sense of existential 
optimism (C) 
The ongoingness and uncertainty 
of life on dialysis and the hope of a 
transplant: Uncertainty about the 
future (U) 
Uncertainty (U) 
Waiting for a kidney: Uncertainty 
(U) 
Findings Categories Synthesised findings 
Feelings of loneliness (U) 
Relationships and 
community 
Relationships and community 
People who are waiting for a 
kidney transplant place value on 
relationships and being part of a 
community. The experience of 
waiting for a kidney transplant 
from a deceased donor while living 
on dialysis with ESKD changes a 
person’s relationships 
Social self. The impact of HD on 
family and friends and the impact 
of family and friends on the lives of 
participants (U) 
The altered interrelationship The 
altered interrelationship of 
autonomy and dependence 
involved in living on dialysis: 
Changing personal relationships 
(U) 
The altered interrelationship of 
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autonomy and dependence 
involved in living on dialysis: Their 
new healthcare relationships (U) 
4.7.1 Synthesised findings of the systematic review 
Three synthesised findings were derived from the meta-synthesis of the study findings.  
Each synthesised finding is described below along with supporting illustrations from the 
literature and a full list of study findings is presented in Appendix 6.  The approach adopted 
for meta-synthesis and presentation of the data is that of the Joanna Briggs Institute 
(Burns, Fernandez and Stephens 2015; Munn, Tufanaru and Aromataris 2014) 
4.7.1.1 Synthesised finding 1: The physical experience of living on dialysis while waiting 
for a kidney transplant 
People who are waiting for a kidney transplant from a deceased donor are affected by the 
experience of living on dialysis with ESKD and its impact on their physical health and normal 
activities of living.  All of the studies referred to the impact that living on dialysis had on the 
participants’ physical wellbeing including their normal lifestyle and activities of living.  This 
meta-synthesis was created from four categories: ‘physical health’, ‘mortality’, 
‘dependence and loss of control’, and ‘restricted life’ with a total of 10 findings.   
Findings relating to physical health were reported in two studies (Calvey and Mee 2011; 
Polaschek 2000).  The physical symptoms of ESKD and the effects of dialysis included 
general lack of energy, fatigue, an altered sleep pattern, itching and restless legs syndrome, 
hypotension, dizziness, loss of appetite, nausea, vomiting, anaemia, weakness, 
breathlessness and general malaise (Calvey and Mee 2011).  Participants reported changes 
to their body image, particularly relating to the placement of the dialysis access and the 
symptoms of uraemia (Calvey and Mee 2011)   
Following on from the theme of physical health was the concept of mortality.  Two findings 
from one of the studies showed that participants comprehended their own mortality and 
their dependence on renal replacement therapy to maintain their lives (Calvey and Mee 
2011).  They were also aware that transplantation could only be achieved by the death of a 
donor and so what they were waiting and hoping for could only be brought about by the 
death of another (Calvey and Mee 2011).  
Two of the studies contained three findings related to dependence and loss of control 
(Polaschek 2000; Sadala et al. 2012).  Participants voiced their feelings of dependence upon 
people such as family, friends and hospital staff to cope with the dialysis regimen, and also 
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dependence on the dialysis machine in order to stay alive while they were waiting for a 
kidney transplant (Polaschek 2000).  Loss of control is a concept that is similar to 
dependence. Participants reported experiencing loss of control in being unable to influence 
when a donor organ would become available for them (Sadala et al. 2012).   
Three studies reported findings related to life on dialysis while waiting for a kidney 
transplant being a restricted life (Herlin and Wann-Hansson 2010; Moran 2008; Polaschek 
2000).  People felt that while they were waiting for a transplant that their life was ‘on hold’ 
(Moran 2008).  They were unable to travel freely as they were restricted by the dialysis 
therapy (Herlin and Wann-Hansson 2010; Polaschek 2000) and they guarded the days in 
between dialysis sessions in order to have a ‘normal’ life (Polaschek 2000). 
4.7.1.2 Synthesised finding 2: The psychological impact of waiting for a kidney transplant 
The experience of waiting for a kidney transplant from a deceased donor impacts a person’s 
psychological wellbeing.  This meta-synthesis was created from six categories containing a 
total of 23 findings: hope, uncertainty, knowledge, life losses, stress and anxiety, and 
character and state of mind.  Findings showed that the experience of waiting for a kidney 
transplant from a deceased donor had both a positive and negative effect on a person’s 
psychological wellbeing.  
The most commonly reported finding was that waiting for a kidney transplant gave people 
hope.  Eight studies reported findings relating to hope (Calvey and Mee 2011; Dekkers, Uerz 
and Wils 2005; Hagren et al. 2001; Herlin and Wann-Hansson 2010; Moran 2008; Polaschek 
2000; Rittman et al. 1993; Sadala et al. 2012).  The expectation of getting a transplant one 
day helped people to cope better with the experience of living on dialysis while they 
waited.  Findings showed that people believed their lives would return to normal after a 
transplant and that they would be able to resume all the normal activities that they could 
not do while they were waiting on dialysis. 
Six studies reported findings about uncertainty (Calvey and Mee 2011; Hagren et al. 2001; 
Herlin and Wann-Hansson 2010; Kaba et al. 2007; Moran 2008; Polaschek 2000).  It is not 
possible to predict when a donor kidney will become available, so people who were waiting 
for a kidney transplant experienced feelings of insecurity and doubt about whether the 
transplant would ever happen and whether everything would go well when it did occur.   
Because the thought of getting a kidney transplant gives people hope, the uncertainty 
surrounding when it will happen causes people to experience stress and anxiety while they 
 
59 
wait.  The two concepts are interrelated.  Two studies reported findings about stress and 
anxiety (Shih and Honey 2011; Yu and Petrini 2010).  If a kidney transplant was not valued 
so much, the ambiguity about timing would not have had such an impact on the people 
concerned.   
Two studies reported three findings relating to knowledge (Calvey and Mee 2011; 
Landreneau and Ward-Smith 2007).  When the person learned more about kidney disease, 
particularly the dialysis routine and kidney transplantation, they were able to cope better 
with the experience of waiting for a kidney transplant.  Sources of knowledge mentioned 
were nephrologists, dialysis nurses and other dialysis patients (Landreneau and Ward-Smith 
2007), although it was noted that information gained from other dialysis patients was often 
out of date and inaccurate.   
Two studies reported three findings related to the concept of loss (Calvey and Mee 2011; 
Polaschek 2000).  These were lost time (Polaschek 2000), lost dreams (Calvey and Mee 
2011), and loss of income and financial independence (Calvey and Mee 2011).  All these 
contributed towards an overall sense of loss in the participants.   
One study found that certain character traits helped some people cope better with living on 
dialysis and waiting for a transplant (Calvey and Mee 2011).  The ability to maintain a 
positive outlook was felt to be important in preventing depression while waiting for a 
kidney transplant.   
4.7.1.3 Synthesised finding 3: The impact of waiting for a kidney transplant on a person’s 
relationships with others 
People who are waiting for a kidney transplant from a deceased donor place value on 
relationships and being part of a community.  The experience of waiting for a kidney 
transplant from a deceased donor while living on dialysis with ESKD changes a person’s 
relationships.  The third meta-synthesis is derived from just one category with four findings 
(Calvey and Mee 2011; Herlin and Wann-Hansson 2010; Polaschek 2000).  Families and 
relationships were a source of strength and encouragement (Polaschek 2000) but ESKD and 
living on dialysis while waiting for a kidney transplant could have a negative impact on 
family relationships with some participants describing feelings of being a burden to their 
loved ones (Calvey and Mee 2011).  Waiting for a transplant caused people to feel isolated 
by the unusual situation they lived with.  This made it difficult to form new friendships and 
led to feelings of loneliness (Herlin and Wann-Hansson 2010) 
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4.8 Systematic review discussion 
The aim of this review was to gain insight into the experiences of people who were waiting 
for a kidney transplant from a deceased donor with the objective of providing a foundation 
to inform the subsequent qualitative study.  The 12 studies included in the review 
generated 37 findings which were then developed into 11 categories and three synthesised 
findings. 
The first synthesised finding showed that people who were waiting for a kidney transplant 
from a deceased donor were profoundly affected by the experience of living on dialysis 
with ESKD.  The disease and resulting dialysis therapy both had a great impact on their 
health and normal activities of living.  End stage kidney disease is a chronic medical 
condition characterised by a decline in kidney function to a point where renal replacement 
therapy, in the form of either dialysis or transplantation, is necessary in order to maintain 
life (Caring for Australasians with Renal Impairment 2005a; Levey and Coresh 2002).  The 
symptoms of ESKD include anaemia, itch, bone pain, hypertension, fatigue, decreased urine 
output, loss of appetite, oedema and breathlessness (Pendse and Singh 2001).  As well as 
symptoms of the disease, the effects of the dialysis therapy itself are also intense, including 
hypotension (Bregman, Daugirdas and Ing 2001), infection (McDonald 2012) and fatigue 
(Bonner, Wellard and Caltabiano 2010).  End stage kidney disease is a chronic, life-limiting 
illness.  The findings showed that people with ESKD have had to consider their own 
mortality and accept the fact that without dialysis their own kidney function is insufficient 
to support life.  Linked with the experience of facing their own mortality, people waiting for 
a kidney transplant had an awareness that their transplant would only occur if somebody 
else died. “Somebody is dead and I’m alive with their kidney … that doesn’t seem right to 
me” (Calvey and Mee 2011, p. 205).   
In addition to the bodily effects of ESKD and dialysis, the findings also showed that dialysis 
therapy led to a restricted life with people feeling out of control and dependent on carers, 
medical staff and machines.  The home-based dialysis therapies PD and home 
haemodialysis had been proven to provide the best outcomes in terms of patient quality of 
life (Alvares et al. 2012), however they are still time-consuming treatments that require a 
level of commitment and skill on the part of the patient. When transport and time spent 
waiting were added onto the treatment time for hospital-based therapies, all dialysis 
therapies could have a negative impact on normal activities of living.  The length of time 
required to be spent in treatment affected a person’s ability to maintain gainful 
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employment.  The ability to work was further restricted when medical appointments, 
emergencies and malaise were considered, as was the ability to go away on holidays (Herlin 
and Wann-Hansson 2010; Polaschek 2000).  For some people the restrictions on travel 
mean a separation from loved ones who live overseas or a long distance away (Moran 
2008; Shih and Honey 2011).  
The second synthesised finding showed that the experience of waiting for a kidney 
transplant from a deceased donor had a psychological effect on a person’s wellbeing.  
Often this was a positive effect with many of the studies reporting that waiting for a renal 
transplant gave people hope that dialysis would not be forever (Calvey and Mee 2011; 
Dekkers, Uerz and Wils 2005; Hagren et al. 2001; Herlin and Wann-Hansson 2010; 
Polaschek 2000; Rittman et al. 1993; Sadala et al. 2012).  People believed that when they 
got a transplant they could return to something like the freedom they had before they 
became unwell.  “The hope of a kidney transplant provided the participants with the 
possibility of returning to a normal life in the future.  In addition, it provided them with the 
strength to endure the experience of being a renal patient” (Moran 2008, p. 173). 
People waiting for a kidney transplant from a deceased donor experience high levels of 
uncertainty.  This includes uncertainty about both the timing and the outcome of the 
transplant.  Uncertainty can result in people experiencing increased stress and anxiety, 
waiting and hoping for the transplant to happen but having no assurance.  The median 
waiting time for a kidney transplant from a deceased donor ranges from 3.1 to four years 
(United States Renal Data System 2011; Wright 2011).  Study findings showed that 
providing people with information about average waiting times might contribute to 
increased psychological pressure.  People learned from observation of others that waiting 
the average length of time did not always mean that it was their turn next.  “I tried hard to 
keep up on the waiting list for many years; I feel aggravated sometimes. I have been on the 
transplant list for many years and nothing happened. I hope the next one may be me but I 
am always disheartened” (Shih and Honey 2011, p. 7). 
Study findings showed that people who were waiting for a kidney transplant gained a 
psychological benefit from the acquisition of knowledge.  Knowledge helped them regain 
some level of control in their lives.  Well informed patients were better able to make 
choices regarding their care while lack of knowledge was a source of anxiety and stress.  In 
some senses the uncertainty experienced by people waiting for a kidney transplant resulted 
from a lack of knowledge.  While it was not possible to provide all the facts and figures to 
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alleviate these patients’ fears, it was evident that people benefitted from having 
information made available to them.  Health practitioners who cared for people waiting for 
a kidney transplant should recognise that being on the transplant list brought about both 
positive and negative feelings.  The effect of waiting for a kidney transplant provided hope 
as well as uncertainty, stress and anxiety. 
The third synthesised finding was that people who were waiting for a kidney transplant 
were part of a community and placed value on relationships with family and friends.  The 
experience of waiting for a kidney transplant changed those relationships.  Study findings 
referred to the participant’s social networks of family, friends and the staff and other 
patients at the dialysis unit (Calvey and Mee 2011; Herlin and Wann-Hansson 2010; 
Polaschek 2000).  These communities were a source of strength and support for 
participants.  Just as the participant had to adapt to the effect of living with ESKD and 
dialysis, the family members and friends also had to adapt, often taking on the role of carer 
for the person waiting for a kidney transplant. Some people accept and value these changes 
in the dynamics of their relationships.  “[It’s a] terrific amount of teamwork, it's so much 
easier with some helping, much more pleasurable, quicker if you work as a team" 
(Polaschek 2000, p. 169).  For others this increased reliance on others was a source of 
anxiety and guilt.  “Why did she marry me, if she married someone else she’d get out … she 
wouldn’t be living this kind of life … how unfortunate she was” (Calvey and Mee 2011, p. 
204).  The unusual situation of waiting for a kidney transplant meant that participants who 
were single found it difficult to establish relationships with new acquaintances, reporting 
feelings of loneliness and isolation (Herlin and Wann-Hansson 2010; Polaschek 2000).  
Medical communities were another important source of support.  People waiting for a 
kidney transplant from a deceased donor drew inspiration from positive relationships with 
friends, family members, other dialysis patients and healthcare workers.  
4.9 Limitations of the review 
Of the 12 studies included in this review, only two included data that was entirely from 
people who were waiting for a kidney transplant.  In the other 10 studies the participants 
included some people who were waiting along with some who were not.  These studies 
were included in the review because some of the findings illuminated the experience of 
waiting for a transplant, but in order to exclude evidence from people who were not 
waiting for a transplant, only findings that specifically mentioned waiting for a kidney 
transplant were included in the review.  This means that there may be more findings that 
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provide evidence into the experience of waiting for a kidney transplant but which were 
omitted from the review because it was not possible to tell which category of participant 
the evidence came from.  
4.10 Systematic review conclusion 
There is little high quality evidence to describe the experiences of people waiting for a 
kidney transplant from a deceased donor.  There are, however a number of high quality 
studies describing the experience of living on dialysis and many of these provide insights 
into the experience of waiting for a transplant (Calvey and Mee 2011; Dekkers, Uerz and 
Wils 2005; Hagren et al. 2001; Herlin and Wann-Hansson 2010; Kaba et al. 2007; 
Landreneau and Ward-Smith 2007; Moran 2008; Polaschek 2000; Rittman et al. 1993; 
Sadala et al. 2012; Shih and Honey 2011; Yu and Petrini 2010).   
Synthesised findings of the review conclude that people who are waiting for a kidney 
transplant from a deceased donor live with the physical effects of a life limiting chronic 
illness.  Dialysis therapy also causes physical side effects and restricts a person’s normal life.  
Waiting for a kidney transplant is psychologically challenging.  The transplant is hoped for 
as it is perceived as providing an escape from dialysis and a return to normal life, but the 
uncertainty surrounding the timing and outcome of the transplant causes people to feel 
anxiety and stress.  People waiting for a kidney transplant value knowledge, although the 
information they require to alleviate the uncertainty they feel is not available.  They exist in 
communities and value their relationships with others.  The dynamics of these relationships 
are affected by the experience of waiting for a kidney transplant.  People can feel isolated 
from others leading a ‘normal’ life, while new relationships are developed within the 
medical team and community of dialysis patients. 
4.11 Implications for practice from the systematic review 
There is limited evidence from the review to support the development of recommendations 
for clinical practice.  Healthcare workers caring for people who are waiting for a kidney 
transplant from a deceased donor should be mindful of the physical and lifestyle effects of 
living on dialysis with ESKD.  Wherever possible, information should be provided to alleviate 
the stress and anxiety related to the uncertainty of waiting.  Staff should consider that the 
experience of waiting is stressful and that people waiting for a kidney transplant may 
require support and reassurance.  It is also important to recognise that people exist within 
communities who may also benefit from receiving information and encouragement.  By 
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acknowledging the importance of relationships to people who are waiting for a kidney 
transplant, healthcare workers should aim to include the patient’s family and friends in 
their care and provide the best source of role modelling behaviour.  Significant community 
members should be included in invitations to appointments and education session with the 
consent of the person being treated (Level 1 evidence(Joanna Briggs Institute, JBI Levels of 
Evidence  2013)). 
4.12 Implications for research from the systematic review 
Given the limited evidence obtained from the review, further research to describe the lived 
experiences of people who are waiting for a kidney transplant from a deceased donor is 
warranted.  Qualitative research designs such as phenomenology and grounded theory 
could investigate the psychological experience of waiting, and the relationship between 
hope, uncertainty and knowledge.  Quantitative studies using validated tools could also be 
conducted.  By producing more evidence relating to this significant specific patient 
population, interventions to improve the experience of waiting could be developed and 
trialled.   
4.13 Conclusion  
The systematic review presented in this chapter has investigated the question, ‘What is it 
like for people to wait for a kidney transplant from a deceased donor?’  The majority of 
studies included in this review reported the experience of living on dialysis with the 
experience of waiting for a kidney transplant largely described incidentally.  A gap in the 
literature was noted for a study that specifically investigated the experience of waiting for a 




 QUALITATIVE DESCRIPTIVE STUDY: METHODOLOGY AND METHODS CHAPTER 5
5.1 Introduction  
The preceding chapters have described the clinical features of ESKD, renal replacement 
therapy options including kidney transplantation and the effect that waiting for a kidney 
transplant has on a person’s daily life.  Through a thorough review of the literature 
including a systematic review, a gap in the literature has been identified for a study that 
specifically seeks to answer the question, ‘What is it like to wait for a kidney transplant 
from a deceased donor?’  This chapter will describe the methodological approach and the 
theoretical framework adopted to conduct this study.  Methods of participant selection and 
recruitment will be explained along with the methods of data collection.  The process of 
ensuring that the study was conducted ethically with the approval of the facilities’ ethics 
approval boards will be shown, along with the approach to data analysis and the steps 
taken to ensure that the findings of the study are trustworthy.  A summary of the reporting 
methods used in this qualitative study has been made using the COREQ (Consolidated 
criteria for Reporting Qualitative research) checklist (Tong, Sainsbury and Craig 2007) and is 
included in Appendix 12. 
5.2 Theoretical perspective 
A qualitative exploratory descriptive research design was used for this study.  Exploratory 
descriptive research involves both ‘finding out what is there’ and ‘describing what has been 
found’(Sandelowski 2000).  In the case of a question such as this one where there is 
minimal data and no studies relating to the specific experience and patient population, 
exploratory descriptive research is an appropriate choice of methodology, conducted for 
the purpose of finding out and exploring unknown phenomena relating to a single topic or 
population (Huttlinger 2006; Polit and Beck 2012).  The participants’ recollections and 
anecdotes represent a moment that may not necessarily reflect the way they view life the 
next day, nor represent the way another person living with the same realities views the 
situation (Lincoln and Guba 1985; Lincoln, Lynham and Guba 2011).  Each unique viewpoint 
contributes to the total knowledge about the experience under investigation (Bazeley 
2013).  What can be known about waiting for a kidney transplant may be revealed by 
talking to people who are waiting for a kidney transplant and living with on dialysis with 
ESKD, with each person’s experience contributing towards the whole understanding. 
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5.3 The position of the researcher within the study 
Every researcher brings to their research their own formed observations and experiences 
which have the potential to influence their findings (Doyle 2013).  The relationship between 
the knower and what is known cannot be separated, meaning that it is impossible for the 
researcher not to interact with the participant in the process of finding out what it is they 
want to know, or for their biases not to inform the way they interpret what they see 
(Thorne 2008).  The position of the researcher in this study is stated to demonstrate 
reflexivity – that is the process the researcher has undertaken to identify their own 
standpoint towards the subject under investigation and to consider the impact their views 
might have on the conducting of the study and the analysis of the data (Altheide and 
Johnson 2011).  By analytical scrutiny of the researcher’s established perceptions, 
reflexivity enhances the transparency of the study (Denzin 2011).   
As the principal researcher in this study, I am a woman who brings 13 years of renal nursing 
experience to the study along with an awareness of the individual participants’ life 
situations and medical histories.  I am also acquainted with the details of the donation 
process and the medical circumstances leading up to donors giving their organs after death.  
To a certain extent I share the hopes and fears of the people who are waiting for a 
transplant, but I have also been saddened by the medical information about the donors, 
able to piece together details of lives shockingly cut short and generous families left behind 
grieving.  While prior knowledge such as this may be a source of coercion and bias in the 
data collection and data analysis processes, it is also the case that such an ongoing 
relationship may contribute to reciprocity and encourage participants to share their stories 
(Doyle 2013; Harrison, MacGibbon and Morton 2001).  It can be difficult for people to 
articulate their experiences and so an existing relationship with the researcher may provide 
recognition and support.  In this case the researcher’s clinical experience gave the 
inspiration for the study through observation of the wide variety of responses by people 
who were waiting for a kidney transplant from a deceased donor.  Observing some people 
to endure impatience and anxiety, while others seemed unconcerned and unmotivated, the 
question of what it is like to live while waiting for a kidney transplant from a deceased 
donor became a clinically relevant research question. 
5.4 Research design 
A qualitative descriptive research design was adopted for this study.  Qualitative research 
seeks to describe, “… what people do in their everyday lives and what their actions mean to 
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them” (Erickson 2011, p. 43).  It is concerned with the kinds of things that give meaning and 
purpose to a person’s life and it creates knowledge that provides detailed explanation 
framed within the context of the individual human experience (Erickson 2011).  Qualitative 
research provides information that would be inappropriate to assess quantitatively, 
investigating questions that cannot be answered numerically by measurement or statistics 
(Thorne 2008) but rather producing a rich description of the situation under investigation 
(Denzin and Lincoln 2011).   
Description has been defined as, “… itemizing or documenting something that requires it – 
telling what it is that one observed” (Sandelowski, 2000 in Thorne 2008, p, 47).  It involves 
finding out what is there and describing what has been found (Sandelowski 2000) and it 
provides a report of observable facts relating to a question.  Descriptive research is used to 
generate new observations by taking a different approach, moving on from information 
that is already established and exploring the context (Thorne 2008).  In this study the 
research question asks about the experiences of people, therefore it is appropriate to 
adopt a qualitative approach.  As there is currently little literature relating to waiting for a 
transplant, the descriptive design will document the characteristics of the experience in 
broad terms to provide a baseline for further studies. 
5.5 Participants and setting 
5.5.1 Sampling 
A combination of convenience and purposive sampling was adopted to recruit participants 
for this study.  The group may be described as a convenience sample as all of the 
participants were patients of the renal department at one metropolitan hospital in 
Southern Sydney, New South Wales (NSW) where the principal researcher was also 
employed as a transplant coordinator.  As the aim of this study is to describe a 
phenomenon about which relatively little has been documented, it is appropriate to use a 
convenience sample, but it is acknowledged that the results may be specific to the care 
provided at the particular unit (Polit and Beck 2014; Thorne 2008).  The group may also be 
described as a purposive sample.  Specific criteria were applied when selecting people to 
participate to ensure that those who took part had personal experience of living with the 
situation under investigation (Bazeley 2013; Polit and Beck 2014).  A purposive sampling 
method selects participants based on pre-determined criteria and is commonly used in 
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qualitative research where a specific experience is under investigation (Burns and Grove 
2011). 
Sample size was initially determined by the number of people who attended the focus 
groups.  The potential participants of this study were a time-poor group of people, 
maintaining dialysis therapy as well as work and family commitments.  In order not to add 
to the burden of appointments, only those who responded to the letter and follow up 
phone call were included and no further attempts were made to recruit more participants 
at that time.  In qualitative research it is important to show the adequacy of the sample by 
achieving data saturation, where the existing findings are consistently repeated and where 
no new findings appear (Morse 2015).  In this study the data from both focus groups was 
remarkably consistent, with participants voicing the same concerns in both groups.  Data 
saturation was reached with the six participants who took part.   
5.5.2 Eligibility criteria 
To be eligible for this study people had to be undergoing dialysis therapy for ESKD and be 
active on the National Organ Matching System (NOMS) waiting list for a kidney transplant 
from a deceased donor.  People who could not communicate in English were excluded from 
the study because focus groups were the chosen method for data collection and it was felt 
to be impractical to use an interpreter in a focus group environment (Burns and Grove 
2011).  As the study was seeking to explore the experience of adults, people under the age 
of 18 were excluded.   
5.6 Recruitment 
Initially permission was sought from all the nephrologists in the department to approach 
those people under their care who were on the waiting list for a kidney transplant from a 
deceased donor to take part in the study.  The letter of invitation was signed by the Head of 
the Renal Department who was instrumental in promoting the research (Appendix 7).  
People meeting the eligibility criteria were sent the letter of invitation and a participant 
information sheet (Appendix 8) explaining the nature of the research.  The contact 
information for the principal researcher was included in the letter.  People were asked to 
respond by phone to indicate their willingness to take part in the study and the letters of 
invitation were followed up by a phone call from the principal researcher two weeks later 
to confirm whether or not they would be able to attend.  As the principal researcher was 
involved in the clinical care of the invitees, steps were taken to ensure that they 
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understood that their participation or non-participation would have no effect on their 
treatment.  The participant information sheet (Appendix 8), consent form (Appendix 9) and 
revocation of consent form (Appendix 10) stated that participation was voluntary and 
would not influence their clinical care.  Potential participants were also advised verbally by 
the principle researcher that taking part in the study would make no difference to their day 
to day care.  The information sheet explained that the participant’s written consent to take 
part would be required and consent forms (Appendix 9) were signed on arrival at the venue 
before the focus groups started.   
5.7 Ethical considerations 
5.7.1 Ethical process 
Ethical approval to conduct this study was obtained from the Human Research Ethics 
Committee (HREC) of South Eastern Sydney Local Health District (SESLHD) and the 
University of Wollongong with Site Specific Approval (SSA) from the hospital at which the 
research was conducted.  The research was deemed to be of low/negligible risk according 
to the Australian national ethical standards.   
The involvement of the Head of the Renal Department in signing the letter of invitation and 
the transplant coordinator as the principle researcher could be viewed as coercive, but the 
participant information sheet clearly stated that participation or non-participation would 
have no effect on their ongoing clinical care.  This information was repeated verbally in the 
follow up phone calls and the focus groups.  
5.7.2 Privacy and confidentiality 
The focus groups took place in a meeting room which was undisturbed and private.  
Participants were informed that the information they shared in the focus groups would only 
be used for the purposes of the research and would not be reported to anyone outside of 
the group.  Participants were also asked to respect the confidentiality of the other 
members of the group in not repeating what was shared to other parties.  The verbatim 
transcripts of the focus group discussions were de-identified and pseudonyms were created 
for the participants to be used in all publications (Morse and Coulehan 2015).  The digital 
documents and sound files were saved on a password protected computer for the duration 
of the study to be deleted after five years as per the National Health and Medical Research 
Council (NHMRC) requirements.    
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5.7.3 Risks and benefits 
It was acknowledged that there was a risk of causing distress to the participants by 
encouraging them to reflect on the experience of waiting for a transplant.  This was made 
clear to people on the participant information sheet (Appendix 8).  A second facilitator was 
present in each of the focus groups in order to provide comfort and assistance to people at 
the time if they became upset during the discussion.  An arrangement was made for the 
renal social worker to offer counselling to those for whom the discussion raised deeper 
psychological discomfort.  Literature has shown that people can benefit from being given 
the opportunity to tell their story (Nel, Romm and Tlale 2015).  The focus group 
environment provided participants with an opportunity to air their point of view and form 
relationships with other people in a similar situation to themselves. 
5.8 Data collection 
Focus groups were used as the method of data collection.  Focus groups are designed to 
foster a sense of collaboration between group members in order to explore a topic and 
achieve a deeper level of discussion than would be possible with individual interviews alone 
(Kamberelis and Dimitriadis 2011, p.546).  The use of focus groups as a method of data 
collection originally has its roots in the discipline of social science and was later adopted by 
market researchers as a means of gathering consumer information (Halcomb et al. 2007; 
Kamberelis and Dimitriadis 2011).  An important feature of focus groups is the social 
interaction between participants which enables them to co-construct an interpretation of 
the experience that represents their own view (Lehoux, Poland and Daudelin 2006).  It has 
been suggested that focus groups may be more effective than interviews as they create a 
social dynamic in which it is easier for people to form opinions and create a shared 
perspective (Hildebrandt 1999; Thorne 2008).  They encourage people to take part who 
may not be confident on their own or who may feel they have nothing worthwhile to 
contribute (Greenwood, Ellmers and Holley 2014; Kitzinger 1995).  Criticisms of focus 
groups would be that that social dynamic can make it harder for people to express more 
diverse opinions and that they have the potential to be dominated by the most articulate 
participants (Cleary, Horsfall and Hayter 2014; Thorne 2008).  Skilful facilitation is required 
to ensure that all participants are given the opportunity to speak, and interact with one 
another (Thorne 2008).  Focus groups were used in this study to capitalise on the networks 
that exist within communities of dialysis patients.  It was hoped that as the participants 
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shared many experiences in common the focus groups would stimulate conversation and 
provide a rich source of data for analysis. 
Two focus groups were scheduled to take place at a meeting room on the hospital campus.  
The place and space used for data collection have been found to play an active role in the 
interactions between the participants, the facilitator and the data, and have an effect on 
the sense of authority, security and confidentiality within the group (Gagnon et al., 2014).  
By locating the focus groups on the hospital campus it was hoped that participants would 
find it easy to attend as they would already be familiar with transport arrangements such as 
travel time and parking availability.  However a meeting room was used in an area of the 
hospital that was not normally visited by renal patients in order to provide a relatively 
private environment away from the usual clinical setting and to emphasise that the focus 
group was not part of their clinical care (Polit and Beck, 2014, Halcomb et al., 2007). 
The first focus group was scheduled for a Monday at 10.00am and the second focus group 
was scheduled for a Tuesday at 2.00pm.  As in-centre haemodialysis operates Monday, 
Wednesday, Friday morning and afternoon shifts, and Tuesday, Thursday, Saturday 
morning and afternoon shifts, these days of the week and the times were chosen to 
maximise the number of patients who could participate in the focus groups.   
In qualitative research it is more important to show the adequacy and appropriateness of 
the sample rather than a large number of participants.  Adequacy refers to the 
phenomenon where data is repeated by different participants in different groups, and 
appropriateness indicates that the focus group participants met the necessary criteria to be 
able to speak with authority about the situation being studied (Morse 2015).  
The focus group questions followed a semi-structured format.  A semi-structured question 
guide was developed with initial questions informed by the literature and the principal 
researcher’s experience as a clinician as follows: 
What are your experiences of being on dialysis? 
What are your thoughts about getting a kidney transplant? 
What was your experience of first being activated on the waiting list for a kidney 
transplant? 
What is your experience of being on the waiting list for a kidney transplant now? 
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What difference has being on the waiting list for a kidney transplant made to your 
day to day life? 
Can you think of anything that would improve the experience of waiting for a 
kidney transplant? 
Where areas of common interest developed in the conversation the facilitator asked 
unscripted questions to explore these topics more deeply.  Each focus group was conducted 
by two facilitators.  In the first group the primary researcher of the study watched and 
listened as the group was led by an expert with extensive experience in leading focus 
groups.  The primary researcher then led the second focus group with the support of one of 
her university supervisors.  In this way a novice researcher was able to learn and practise a 
new skill with support and supervision.  The second facilitator was also available to provide 
support should any of the participants become upset, document field notes about any non-
verbal communication they observed and pick up lines of discussion that had not been fully 
discussed.  The benefits of dual moderated focus groups have been documented (Hudson 
2003; Kamberelis and Dimitriadis 2011).  Only group participants and researchers were 
present in the focus groups.  The focus group discussions were recorded with a digital 
sound recording device.  The audio files were uploaded and transcribed verbatim by a 
commercial transcription service.  Audio recording and verbatim transcription have been 
recommended as techniques to enhance the credibility and authenticity of the data (Polit 
and Beck 2014) and are commonly used in qualitative data collection.  Pseudonyms for the 
participants were created and the transcripts were reviewed by the principal researcher to 
remove any identifying information. 
5.9 Data analysis 
The purpose of data analysis is to transform and organise the raw data in, “…a new, rich, or 
expanded way” (Thorne 2008, p. 175) that gives meaning to the issue under investigation.  
It aims to provide a theoretical summary or a reconceptualization that presents the data in 
a fresh way that is recognisable to participants and clinicians.     
The first part of the data analysis was immersion in the data.  Although the audio 
recordings were transcribed by a professional transcription company, the researcher 
listened to the recordings while concurrently reading the transcripts many times.  Field 
notes taken during the focus groups were added to the transcription documents to add 
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more detail about participant interactions and other non-verbal information.  By repeated 
listening and reading of the transcripts the content of the data became very familiar.   
The second part of the data analysis process was coding; identifying and labelling all the 
different elements contained within the data while looking for commonalities and 
differences.  In this study interview transcripts were coded using Nvivo software, a 
commercial product developed to assist with the management of qualitative data during 
analysis (Bazeley 2013).  No pre-conceived coding system was used, but instead the codes 
and the categories were derived directly from the data (Brewer et al. 2014).  By breaking 
the data apart into its component pieces the researcher was then able to consider how the 
different elements relate to each other (Hsieh and Shannon 2005). 
The next stage of analysis scrutinised the data for patterns and variations.  Initial codes 
were intentionally broad to allow the data to be interrogated repeatedly in order to find 
out in what different ways the concepts within the data were related to each other (Thorne 
2008).  The development of sub-categories and categories through reflection sought to 
convey the underlying meanings, concepts and interpretation of the data (Sandelowski and 
Barroso 2003).  During this analytical process the researcher remained critical and reflective 
towards their own pre-knowledge, while attempting to hear what the participants were 
communicating at that moment (Thorne 2008).  The process of data analysis went through 
many stages as the researcher considered what concepts were being revealed.  The 
researcher’s prior knowledge provided a practice context from which the data was 
interpreted (Thorne, Kirkham and MacDonald-Emes 1997).  Links and relationships 
between sub-categories were established and the data was organised into the final 
conceptualisation to provide an account of what it is like and how it feels to wait for a 
kidney transplant from the participants’ point of view.   
5.10 Trustworthiness 
The trustworthiness of a qualitative study lies in the transparency of the data collection and 
analysis processes, and in establishing that the findings are credible (Polit and Beck 2014).  
Although participants may report completely different experiences to each other this 
diversity contributes to the breadth of knowledge of the experience.  The reported findings 
should reflect the experiences and viewpoints of the participants rather than that of the 




Transparency refers to the clear documentation of the chosen study methods and the 
findings that resulted (Altman and Moher 2013).  In the method of data analysis adopted 
for this study, the findings came directly from the experiences of the participants as 
reported in the focus group transcripts and not from pre-conceived criteria dictated by the 
researcher (Shenton 2004).  As the primary researcher was a novice, analysis of the data 
was carried out with the support of the supervisors for her post graduate degree, and by 
peer debriefing.  Preliminary findings of the study were presented to a group of specialist 
transplant nurses at a national conference.  This feedback provided consensual validation 
that these were sound conclusions.  Peer debriefing helps to provide transparency to the 
data analysis process (Bazeley 2013).   
5.10.2 Credibility 
Credibility is a measure of whether the study methods and findings accurately answered 
the chosen research question (Oliver 2012).  In this study the chosen methodology, data 
collection and data analysis methods are established as effective in answering qualitative 
questions and have been used in similar studies relating to the experiences of a group of 
people with a shared clinical experience (Brewer et al. 2014; Gibson et al. 2013; Ravenscroft 
2005).  Adopting methods that have been used in other similar studies strengthens 
credibility (Shenton 2004). 
The authenticity of the findings compared to what else is known about the topic is another 
method of establishing credibility (Thorne 2011), sometimes referred to as triangulation 
(Bazeley 2013).  A systematic review of qualitative literature was conducted to inform this 
study, although the primary focus of the studies included in the review was the experience 
of living on dialysis.  The focus group data showed congruence with the three meta-
syntheses found in the systematic review which suggests that the study has credibility in 
relation to what else is known.  The use of an alternative method of inquiry, such as 
systematically reviewing the literature, to research the same question is another strategy 
for establishing the credibility of a study (Shenton 2004). 
5.11 Conclusion 
This chapter has described the methodology and methods used to conduct this study into 
the experiences of people who are waiting for a kidney transplant from a deceased donor.  
It has listed the data collection and data analysis methods that were adopted.  As a piece of 
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qualitative research, transparency in all these details enhances the trustworthiness of the 




 QUALITATIVE DESCRIPTIVE STUDY: FINDINGS CHAPTER 6
6.1 Introduction  
This chapter reports the results of the data analysis presented as the findings of the study.  
Four main themes were identified in the data: living on dialysis is physically and mentally 
restricting; living with uncertainty; altered relationship dynamics; and feelings towards the 
deceased donor.  Within these four themes were nine subthemes.  A summary of themes 
and subthemes is shown in Table 6 below.  
Table 6: Themes and subthemes 
 
Theme Subtheme 
Living on dialysis is physically and mentally 
restricting 
Transplant means freedom from dialysis 
Acceptance of the wait as a normal part of life  
Living with uncertainty An ongoing wait 
Fear of losing hope 
Altered relationship dynamics Valuing family support 
Protecting loved ones 
Supported from within the dialysis community 
Feelings towards the deceased donor Pragmatic appreciation 
Identifying with another’s loss 
 
In this chapter a brief biographical description of the focus group participants is followed by 
a detailed description of the themes and subthemes including data that illustrates each 
finding.   
6.2 Demographic information – an introduction to the participants 
Six people took part in the focus groups, with one group having four participants and the 
other two.  Each participant is described below including information about their age, 
marital and employment status, family or social support networks, ethnic background and 
length of time on dialysis.  A summary of the demographic information is given in Table 6. 
 
77 
Three of the participants did not speak English as their first language but transcript quotes 
have been left unadjusted in order to preserve the original meaning of their words. 
Table 7: Demographic information 
Focus 
group 




Type of dialysis therapy Time on 
dialysis 
2 April 47 Single Chinese Home HD (initially PD) 3 years 
1 Barry 50 Married English Home HD (initially hospital 
HD) 
10 months 
2 Cathy 63 Married Greek Home HD (initially hospital 
HD) 
4 ½ years 
1 Mary 29 Single English PD (initially hospital HD) 6 years 
1 Vincent 52 Single Filipino PD 2 years 
1 William 52 Married English PD (initially hospital HD) 3 years 
 
April was a Chinese lady in her late forties.  She was single and lived with her adult son 
while most of her relatives including her aging parents, lived overseas.  She had been on 
dialysis for three years, initially on PD, but had recently transitioned to haemodialysis and 
was dialysing independently at home.  April worked in corporate business on short term 
contracts.   
Barry had been on dialysis less than one year at the time of the focus group.  He was an 
Australian-born married man in his fifties, with three teenaged children.  Barry managed his 
haemodialysis independently at home and in this way was able to combine renal 
replacement therapy with a demanding job for an international company, plus extensive 
volunteering commitments with his children’s activities.   
Cathy was a Greek lady in her sixties, married with grown up children, grandchildren and a 
network of friends and relatives both in Australia and in Greece.  She had been on dialysis 
for four and a half years, starting in the hospital, but eventually mastering haemodialysis at 
home.  Her adult son had recently had a stroke and returned to live at the family home so 
that Cathy could help him with his care. 
Mary was a single woman in her late twenties.  Australian-born, she came from a large 
caring family of South American background.  She had been on dialysis for six years, initially 
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on hospital haemodialysis, but had switched to PD after a few months.  She completed 
university while on dialysis, but once she graduated had found it impossible to find work 
that she could fit around her medical appointments and dialysis regimen.    
Vincent was a single man in his fifties who had migrated to Australia from the Philippines 
many years ago.  Many of his family members still lived overseas, including his elderly 
mother.  Vincent had been on PD for two years, and was the only participant who had not 
had any experience of haemodialysis.  He had a part time job in the retail industry. 
William was a married, Australian born man in his fifties who worked in his own business.  
His renal disease was hereditary and so he had also observed the experiences of his two 
brothers.  One brother had received a kidney transplant several years earlier, and the other 
was not yet on dialysis.  William had been on dialysis for three years, initially on hospital 
haemodialysis but switched to PD after a few months.  
6.3 Living on dialysis is physically and mentally restricting 
The data show that the experience of waiting for transplant is contextualised within the 
experience of living on dialysis.  The greatest challenge for people who are waiting for a 
kidney transplant is not specifically the waiting, but living on dialysis while they wait.  
Dialysis impacts life in many ways as it limits peoples’ ability to work, travel and use their 
time freely.  Within this theme of restriction are two subthemes: the thought of getting a 
transplant gives people hope; and the wait becomes accepted as a normal part of life. 
Mary commented, 
Yeah, the waiting list pretty much doesn't - the dialysis is the one that 
affects you physically and mentally, but being on the waiting list?  Not 
really. 
Mary found the effects of dialysis to be both physical and psychological.  She described how 
the relentless cycle of being on dialysis impacted her life, often all day and every day.  
I would have haemodialysis and then the day that I had off was pretty much 
in bed all day and then by night I was feeling a bit okay to get out of bed 
then to go back to the haemodialysis [the next day].  
Participants talked about how living on dialysis not only affected them physically, but also 
restricted their everyday activities of life.  The hours set aside for dialysis therapy limited 
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the amount of time available for other pursuits while the amount of activity they could 
attempt in between dialysis sessions was restricted by the side effects of the therapy.  
I'm functioning - on the day that I do it you're a little bit flat in the morning. 
To be honest, you're not lively … I can still function, a little bit slower. 
(Barry) 
Participants felt that time spent on dialysis restricted their lives by taking up hours of time 
that could otherwise be spent in fruitful activity.  Cathy and April both expressed frustration 
that time on dialysis dragged by slowly:  
… you have so much spare time you have attach the machine, you can't 
really do anything.  For three hours I'm perfect.  After three hours, the hours 
never go. (Cathy) 
I feel like I have to watch something, watching some movies or something 
otherwise the time like never finish. (April) 
The hours of time spent attending to the requirements of dialysis therapy affected other 
areas of the participants’ lives.  The impact of dialysis on employment was a commonly 
reported restriction.  Mary’s experience illustrates how difficult it is for a person to 
continue in employment while coping with ESKD and dialysis: 
I finished university, wanted to get back into the workforce and my health 
has been such a roller coaster ride that I can't actually do full time work.  So 
went down to part time and then was in hospital for like a month so then 
had to drop work completely.  So now I'm trying to get back into the 
workforce again. 
William described the effect of dialysis on his work life: 
You can't say to your friends, geez I saw a job in the paper I'd really love - 
oh no that's right, I can't go for that.  But I'm just doing what I can … I just 
still keep on working every now and again, casual.  
April, William and Vincent had all reduced their work hours to part time as they found the 
demands of full time work to be unsustainable.  William also referred to effect this had had 
on his finances.  His reduced working hours had meant a significant impact on some 
financial investments he had taken out shortly before he became unwell. 
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So the day-to-day things, not only come from the physical aspects of 
dialysis but the fact it can have a financial - I was just unlucky that I made 
huge money investments that were based over a long period of time to 
return, right, and I had to sell them virtually three to six months after 
buying them and that just doesn't work. So financially there was that big 
change. 
By restricting their ability to work, dialysis affected the participants’ economic 
wellbeing, not just because of the cost of medical treatment, but also by reducing 
the amount of money they were able to earn. 
People reported how dialysis restricted their freedom to travel overseas.  Four out of the 
six focus group participants had significant family links to countries overseas including April 
and Vincent who both had elderly parents living outside Australia.  For them dialysis meant 
not being able to see their parents. 
You know after this PD and the home dialysis I think we just attach [to] the 
machine now … you can't do a lot of things.  I want to travel.  I want to back 
to China to visit my parents. (April) 
Mary was the only participant who had managed to travel overseas while on dialysis.  
Although she was glad to have made the trip, the additional planning and uncertainty about 
whether she could get dialysis while she was away added to the overall stress of the 
journey 
Planning several months ahead and you're worried is my machine going to 
arrive and is everything going to be okay?  Are the products going to arrive?  
It’s extra stress. (Mary) 
Barry had three adolescent children and overseas family holidays had been a normal part of 
life up until his diagnosis with ESKD.  He spoke about how he was trying to minimise the 
impact of dialysis on this family tradition: 
I said don’t stay because of me. So I'm trying to pack them off to Disneyland 
or something at the moment. That's a hard one, because the youngest one 
is only 12, nearly 13. He wants you there, whereas the others, older 
teenagers, well we’ll see you when we get back. But deep down they want 
you there as well. 
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Overseas travel had been a regular activity of life for many of the participants prior to 
dialysis and the resulting restrictions on travel were keenly felt. 
The experience of living on dialysis was described as socially isolating with friends from 
outside the dialysis world.  Although physically able to take part in activities, participants 
felt disconnected from their friends, nor fully able to relate to them their own experiences.  
Mary commented: 
…  all my friends when we go out for dinner or something, they're all talking 
about work and stuff and I'm just like, oh I can't talk about work.  I can't 
participate in the conversation.  Just little things like that. 
Although Mary had completed her university course while on dialysis, the symptoms of her 
ESKD had meant that she had been unable to find work after she graduated.  Being the only 
unemployed member in her group of friends meant that she felt disconnected from the 
general conversation about work while her own experience of life on dialysis was foreign to 
her friends. 
William had a similar experience, relating how he and his friends used to go away for 
golfing weekends.  Once he started on dialysis he felt it wasn’t the same: 
Apart from the fact that I go away with the golf club every now and again, 
but they're always on the turps... What a waste of time, you know.  Like 
you're there, you're just used as a driver. 
Like many people who are on dialysis, William was on a strict fluid restriction limiting the 
amount of liquid he can drink in one day to 1.5-2litres.  Even though he could still attend 
the golfing weekends with his friends, the fact that he could not drink with them in the 
evenings meant that he felt excluded.  His experience of life was so different to that of his 
acquaintances that they could not relate as they had done before dialysis. 
Waiting for transplant from a deceased donor in Australia means having to be on dialysis 
and the data show that it is dialysis that takes priority over everything else in life.  Living on 
dialysis while waiting for a kidney transplant confines normal activity in many ways.  It 
restricts a person’s ability to pursue the activities they would normally hope to achieve if 
they were well such as have a career, travel overseas and be financially independent and it 
can lead to feelings of social isolation..   
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6.3.1 Transplant means freedom from dialysis 
When asked to reflect on how they felt about getting a kidney transplant the participants’ 
responses showed that they viewed it as something necessary if their life was ever to 
return to normal.  A future that included a transplant gave them hope that the physical and 
mental restrictions of life on dialysis would not continue for ever.  April described what 
getting a kidney transplant would mean to her: 
Kidney transplant I think is very good.  I warm to it because I think first 
bring me the freedom.  That's I really want.  I want the freedom … I want 
lots of freedom - because this one [dialysis] definitely does affect my life. 
Her emphatic repetition of the word ‘freedom’ illustrated April’s underlying sense of 
confinement while living on dialysis.  She stated that living on dialysis had made a big 
difference to her life and she believed that a kidney transplant would bring her the freedom 
she had lost.   
In a similar vein Mary talked about transplant as a necessity to regain a normal life: 
… something that has to be done for me to get better and get my life back 
on track.  So I really hope it’s soon, because I've been waiting for so long. 
The phrase “something that has to be done” showed the inevitability that Mary felt of a 
kidney transplant being the only way to get her life on track.  On dialysis her life she felt her 
life was off track, out of control and heading in a direction she did not want to go.  The 
burden of waiting “so long” was clearly heavy on her.  She hoped a transplant would allow 
her the freedom to direct her own life and make her own choices and decisions 
unrestrained by dialysis.  
For Cathy the restrictions of dialysis affected not only her but her whole family.   
I’m waiting for kidney for myself, for my family.  I like to do other things.  
That's why I'm waiting for a kidney.  I want to have normal life. 
While living on dialysis Cathy could not choose to live exactly as she pleased.  There were 
other things she would like to do, not just for herself, but also for her family.  The only way 
for her to have the freedom to choose was for her to get a kidney transplant.  
Participants accepted that dialysis was necessary to maintain life, but because of dialysis 
they lacked the liberty to make their own choices and freely live the way they wanted to.  A 
kidney transplant was seen as a way of escape from their dialysis imprisonment.  Being 
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active on the transplant waiting list gave hope that life on dialysis would not have to be 
endured for ever.   
6.3.2 Acceptance of the wait as a normal part of life  
Over time the experience of waiting for a kidney transplant became an accepted part of the 
participants’ daily life.  The data show that while the restrictions of dialysis loomed large in 
life, the transplant waiting list did not feature highly.  The wait for a transplant had been 
normalised, making it hard for participants to articulate any actual effect of waiting on their 
day to day lives.   
April’s comments illustrate how her feelings towards getting a kidney transplant had 
changed from the time she was first put on the waiting list.  She said: 
Yeah, initially I'm really worried about all the phones, especially when I'm 
working; phone always attach me, but after a while I don't care.  I feel like 
it's not coming; don't worry, I just leave it …  
Her relationship with the phone is indicative of her feelings about a kidney transplant, as 
people on the transplant list have to be contactable at all times in case a kidney becomes 
available.  Her words showed that the initial state of readiness diminished as time went by.  
After a while she stopped taking all her calls and just accepted that she was on the list. 
Barry explained it in this way: 
I don’t wake up every day thinking hopefully today ... I'm on the list.  It will 
happen when it happens. 
The possibility of getting a transplant did not feature highly in Barry’s day to day thoughts.  
Although Barry hoped to get a transplant one day, this comment demonstrates that he did 
not feel it was likely to happen and therefore he did not think about it very much.  Waiting 
for a transplant had been accepted as a part of his normal life. 
Vincent agreed: 
I am actually not thinking about it over and over again.  If it will happen it 
will happen. … Because I still work part-time, so I never think about the 
waiting list. Because I normally just do the same, more or less the same 
thing what I did before. So I didn't really think about it. 
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Vincent attributes not thinking about the transplant list to the fact that his life is “more or 
less” the same as before.  However his comment, “If it will happen it will happen” is similar 
to Barry’s and shows that Vincent had accepted the wait as a normal part of life.   
This sense of acceptance is captured by the participants’ use of idioms to describe their 
situation.  Barry and Vincent’s use of the phrase, “It will happen when it happens”, has 
already been documented, but other participants used similar expressions to describe their 
feelings of powerlessness. 
 Mary said: 
… this has to be done, what can you do?  I just have to go with the flow see 
what happens 
The expression “Go with the flow” conjures an image of being swept along by a strong 
flowing current, unable to pull free or change direction. 
William said: 
No one would ever wish this on anyone. But at the same time, it is just what 
it is. 
Cathy said: 
… I'm looking forward for a kidney and whatever is coming is coming. 
Another metaphor that William used was to describe the wait as a game.  All that a person 
could do was play by the rules and wait for their number to come up.  He said: 
… [They said] you're a common garden type variety person. You’ll have a 
good chance of getting a transplant.  To me that's a funny comment 
because if you're common that means that there's going to be a lot more 
common people on the list. It’s just a percentage game. 
William described waiting for a kidney as a game of chance, “a percentage game”.  A person 
won when their number came up and nothing they did made any difference to the 
outcome.   
Cathy referred to luck when she said: 
I continue to wait if I'm lucky. If I'm not lucky, you can't do nothing else. 
Chance and luck cannot be affected by any action.  Like the phrases “It will happen when it 
happens”, “Go with the flow”, “It just is what it is” and “Whatever is coming is coming” they 
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reflect the immutable nature of the experience of waiting for a kidney transplant.  The 
participants’ use of these metaphors and idioms captured a sense of acceptance towards 
the situation they found themselves in.  No matter what they did, they could not change 
the experience or make it end, so they accepted whatever would happen to them.  The 
desired transplant would occur at some unpredictable time in the future and until that time 
the wait would continue, unaffected by anything they did.  
6.4 Living with uncertainty 
The data showed that people waiting for a kidney transplant live with uncertainty.  Within 
the data about uncertainty were two distinct subthemes.  Firstly was uncertainty about the 
timing of the transplant and how long they would have to wait.  Secondly was uncertainty 
about the outcome of the transplant and whether or not it really would bring them the 
freedom that they hoped for.  This uncertainty about the outcome of the transplant led to 
the participants expressing fear, not just of something going wrong, but of   having to live 
on dialysis indefinitely without any hope for escape.   
6.4.1 The uncertainty of an ongoing wait 
A major difficulty with waiting for a kidney transplant is that there is no way of predicting 
how long the wait will be.  Uncertainty about the timing of the transplant was described by 
participants in both focus groups and caused considerable discussion.  Suggestions were 
made for giving people more facts about when the kidney transplant would come and 
participants were anxious to be given any information at all that could tell them when they 
were going to be called.   
When asked if there were any ways of making the experience of waiting for a kidney 
transplant better William said: 
Could I just - I know that there's a list, but do you ever find out where on the 
list you are and is this something that you guys question of whether it’s 
worthwhile telling people or - I suppose it depends if you're two and you're 
220. 
As the discussion continued William himself then argued against his idea, acknowledging 
that if a person was told they would get a kidney in the next two weeks and then did not, 
that would be worse than not knowing at all.  He also noted the difference between a 
person being encouraged by being number two on the list or being demoralised by being 
told they were number 220.  However his question and his comment, “I’ve always 
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wondered you know”, display a deep desire for more information to reduce the uncertainty 
in his life and allow him to plan for the future.  
The identical question was raised in the second focus group by April who said: 
I don't know the system can inform you to say you are very close; just 
something ready; you're hoping will you.  I don't know is that how it works 
or not? 
Why you not inform how many people in front of us?  You shouldn't tell 
that?  No, that's a secret. 
April and Cathy discussed the subject and, as in the first focus group, determined that it 
might be more stressful for a person to know where they were on the list.  April’s 
comments also showed how much she wanted to know how long she would have to wait.  
Despite understanding on one level that it really was not possible, and maybe not 
beneficial, for her to know when she would get a kidney transplant, her language revealed 
doubt and even hinted at thoughts of a conspiracy.   
People on the transplant waiting list live with uncertainty.  While being constrained by the 
dialysis regimen, they have no way of knowing how long it will continue.  ‘How long will I 
have to wait?’ is the question they want answered.  As it is impossible to say, they continue 
to live with uncertainty.      
6.4.2 Fear of losing hope 
Despite wanting and needing a kidney transplant, participants expressed fear about what 
might happen when the transplant came.  Participants described concerns about the 
uncertain outcome of the transplant and whether it would really give them everything they 
hoped for.  Part of the process of joining the waiting list for a kidney transplant was that all 
the participants received education about the risks and benefits of transplantation.  In the 
focus groups participants showed that they had heard and understood this information.  
While they focussed on the benefit of regaining the freedom to live a normal life, they were 
also very aware that a kidney transplant was not a guarantee of a problem-free future.   
Despite a transplant giving the hope of freedom, ambiguity about the final result and the 
risks of adverse effects also caused fear: 
To be honest it's still a little bit scary in the transplant, but that's one way to 
get you back to normal life … so I like transplant, but only little bit scare me 
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is things because some people tell me the story about you might be easy to 
get cancer or might be - but that's little bit scary things (April) 
April once again acknowledged that getting a kidney transplant was the only way she was 
going to return to a normal life, but this time she said the prospect was scary.  Her 
comment about getting cancer related to information she heard in the education sessions.  
Immunosuppressive medication must be taken life-long after a transplant and does 
increase a person’s risk of developing cancer. 
Mary also used the word “scary” and described the ambivalent feeling of wanting 
something and yet not wanting it.  She said: 
Well for me it was more, it was scary at the same time. Like I thought, okay 
I want to get the call, but at the same time, the day I do get the call I don’t 
know - because straight away you have to go into hospital and stuff …  
Mary’s words showed that she wanted to get a kidney transplant, but that she knew it 
would completely disrupt her life.  She gave the specific example of “go into hospital” and 
then summarised the rest as “stuff” followed by a pause.  The word “stuff” referred to the 
surgery, follow up and the unknown outcome.  Mary wanted to get a transplant, but she 
also feared facing the new set of problems that it might bring. 
Cathy also described the complex emotional mix of hope and fear: 
Sometimes when the phone ring I say oh no is it hospital? My heart is 
[beating] like this. I'm thinking the operation; scared me, the tablets after 
the operation. 
Despite being something that she wanted, the thought of the actual day of the kidney 
transplant scared Cathy.  She was scared of having an operation and scared of the 
medication she would have to take afterwards.  Again this may reflect what she had been 
told as part of her education about the benefits and risks of transplant.  As long as the 
transplant was an event at some abstract time in the future it was something that she 
welcomed, but when she thought about it happening in reality at that moment, then the 
risks stood out more clearly to her and she was fearful.   
 Despite fearing the surgery and its ambiguous outcome, participants also feared a future 
where transplantation was not a possibility: 
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(April) …if you're not on the transplant list you feel, oh my god!  You think 
about your rest of life; feel bad like this until you… 
(Cathy) …die. 
(April) …the day you're gone.   
Despite never having met before, the two women seem to understand each other so well 
on this matter that Cathy finishes April’s sentence.  The thought of life without the 
possibility of a transplant left them with only dialysis until the day they died.  Without the 
hope of a transplant they feared the rest of their lives would be spent feeling bad “like this” 
on dialysis.  They feared losing the hope of an escape from dialysis. 
As well as giving the hope of freedom from dialysis, waiting for a kidney transplant also 
brought fear.  Participants hoped to be released from dialysis, but they were aware that the 
outcome of the transplant was not certain and that many things could go wrong.  Although 
dialysis held them back from living a normal life, its familiar routine felt safe when 
compared with the unknown prospect of leaving and starting a new chapter with a kidney 
transplant.  People waiting for a kidney transplant live with the uncertainty of wanting 
something and yet not knowing when it will happen or what the outcome will be.   
6.5 Altered relationship dynamics 
The focus group discussions showed that living on dialysis while waiting for a kidney 
transplant altered a person’s relationships.  Within this theme, three subthemes were 
evident.  Some relationships were strengthened by the experience of facing difficulty 
together and led to the participants placed greater value on their family’s support.   As a 
result of this increased appreciation, participants were observed to protect the people they 
loved from distress by downplaying the negative effects of their disease and the dialysis 
therapy. Thirdly, participants developed new connections were formed within the dialysis 
community that became another important source of support. 
6.5.1 Valuing family support 
The data showed that people had a heightened appreciation of the help and 
encouragement they received from their family members while they waited.  There were 
many comments like Mary’s who credited her family as her primary source of support: 
Like myself as well, my family has been my driving force I guess.  They're 
always there, yeah, so for me, like my family’s just been so important. 
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Barry credited his wife as a great source of strength and recognised the importance of 
having someone to provide assistance through the experience. 
My wife’s very supportive with me with it. Honestly, they're the ones that 
get the hard part … I think you need that support mechanism.  I don’t know 
how you'd cope. Having someone there to support, I think is a really 
important thing to - just sometimes to talk it out with. 
Cathy’s family provided her with the motivation to continue on dialysis. 
See I got four grandchildren and when I am doing dialysis sometimes when 
I'm too stressing I said you do it for yourself or you do it for your grandkids.   
With the diagnosis of ESKD and the need for dialysis these significant relationships had 
become more valued by the participants.  Their family members gave practical support and 
emotional inspiration to continue on with dialysis as they waited each day.   
6.5.2 Protecting loved ones 
Whilst appreciating the help and support of family members, participants explained how 
they tried to shield their loved ones from the full impact of their illness and the burden of 
the dialysis therapy.  Mary’s comments illustrate how she chose to withhold information 
from her family to prevent them from worrying about her.  She describes how she lied to 
her father rather than upset him when she was feeling unwell.   
With my dad, it’s more if I'm sick I’ll call him … and he’ll be like, how are 
you?  I'm like, I'm good, I'm good.  I could be really bad but I will tell him I'm 
perfect and he’ll be like … are you sure?  I'm like yeah dad of course, I’ll tell 
you if I'm sick, but I never do.  I do tell my mum though.  I’ll be like, mum I 
feel so bad, but don’t tell dad because you know how dad is. 
Vincent described a similar experience of keeping information to himself when he was 
starting on dialysis: 
I knew that I got a problem with my kidneys since 1996. … and no, I didn't - 
even my family, my sisters I never tell them about that I have a problem. 
Just really no one knew actually.  Then I got my tube [PD catheter] so I 
didn't tell anyone that I got a problem because I didn't want them to worry, 




All but one of the participants described how they chose to withhold information about 
how sick they were in order to spare their loved ones from worry.   
Another example of participants hiding their feelings was seen in people who had 
experienced a family member come forward as a potential living kidney donor.  Participants 
reported feeling a burden of gratitude and guilt at the prospect of a family member 
undergoing unnecessary and possibly harmful surgery to benefit them.  When the potential 
donors could not proceed the participants reported mixed feelings of disappointment at 
not getting a transplant, but also relief because of the responsibility they felt towards the 
donor’s wellbeing.  Vincent told of his experience of a potential live donor who came 
forward but who eventually changed his mind: 
… after four months when he decided not to so I actually don’t feel bad 
because I was thinking also about his family, you know, his kids.  Because 
he got young kids so I said, it’s okay; because you know … he worried that I 
won't be friends with him anymore.  No, no it’s okay, I said, I told him, it’s 
okay, you know, because you got your family, young family and he married, 
five kids, you know.  If ever something happen to him, it would be on my 
conscience.  So it’s okay. 
Although he wanted the kidney transplant, when the donor changed his mind Vincent 
rationalised his disappointment by thinking of the man’s family.  He suspended his own 
happiness about escaping from dialysis by the thought of how indebted he would have 
been to them if there had been any ill consequences for the donor. 
Several of Mary’s family members had been tested as potential donors but none of them 
were found to be medically suitable, including her father who had been very upset that he 
could not help his daughter in this way.  Mary described her feelings of relief: 
I got family members tested, so both my parents and my younger sister got 
tested, but neither one could donate.  So in a way I was relieved, because I 
had the fear that something might happen to them.  So in the back of my 
mind and I secretly didn't tell them, but I was really relieved. 
Although each potential live donor had come forward voluntarily without any coercion, 
Mary felt responsible and expressed relief that they could not donate.  However she kept 
her feelings of relief a secret, disconnecting herself again to protect her family members 
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from further hurt.  While the would-be donors acted out of an altruistic desire to help, 
Mary felt both indebted and guilty. 
6.5.3 Supported from within the dialysis community 
While people reported feeling isolated from people in their non-dialysis social circle, they 
formed new connections within the medical system and the dialysis community.  The 
stories of these fellow dialysis patients provided the participants with knowledge and 
information that they could compare with their own experiences.   
Barry reflected on the time he spent dialysing at the hospital and the people that he met 
there.  He was struck by how hard life was for some of them and was thankful that in 
comparison his experience was relatively easy: 
There were some great people up there.  I met some really nice people, 
elderly and everything and they've all got different stories, different ways of 
looking at it.  …there is a gentleman there with no legs from diabetes and 
he gets in there in the morning 7 o'clock for his session.  He doesn't get to 
go out of there until sometimes 8 o'clock at night.  I was in the afternoon 
session and he'd be in there all day … That's why I say there are people 
worse off … 
William also acknowledged that by listening to others it was possible to gain a new 
perspective on his own experience.   
 You finally realise, well I never thought about it that way.  You hear other 
people’s versions of things and it opens up your mind to that aspect of it as 
well. 
As well as gaining perspective on their own experiences, stories from within the dialysis 
community also helped people maintain hope while waiting for a transplant.  Cathy happily 
recounted the time she heard that a person she knew from the dialysis unit had received a 
transplant: 
… Maria told me … she say George has got a kidney.  I'm like my cross and I 
was crying and I say, “Good on you George”, because you can say to 




These data illustrate the peer support that exists between dialysis patients.  Two dialysis 
patients are talking joyfully about a third who had got a transplant and Cathy is recognising 
that when she too receives her kidney, other patients will hear about her and be given 
hope. 
Living on dialysis while waiting for a kidney transplant places new pressures and 
expectations upon existing relationships and leads to the development of new friendships.  
Connections made through the dialysis experience can provide perspective and hope, while 
a renewed appreciation of significant relationships can lead to deceit and disconnection as 
loved ones are shielded from the true impact of the disease burden and the deep desire for 
a transplant.   
6.6 Feelings towards the deceased donor  
The final theme from the data is the deceased donor who provides the kidney and thus 
facilitates the hoped-for return to normal life.  Although there was no specific question 
about donors in the focus group question guide, the topic came up in both focus groups as 
people recalled their experiences with loved ones coming forward as potential donors.  For 
various reasons these living donors were unable to go ahead, leaving the participants with 
no option but to wait for a deceased donor.  Focus group participants were reluctant to 
dwell on the concept of someone having to die in order for them to receive their 
transplant.  Although there was only a small amount of data, two subthemes were 
apparent. Firstly there is a sense of the practical logic of using organs from people who are 
deceased.  Along with this practicality, the second subtheme is an appreciation of the 
human cost of the donation and the pain that the donor’s family would experience in order 
for them to receive the transplant they desire.   
6.6.1 Pragmatic appreciation 
Participants rationalised their need for a deceased donor as a practical use of an organ that 
was no longer required.  April said that in her Asian culture it was unacceptable to ask a 
living person to donate an organ, but for a deceased person she said: 
That's why donation I think is good, because I believe that when the people 
pass away, it's not useful anymore.  What's that one used for?  So, if not 
used for things you can reuse it, help other people live. That's good. 




But a donor, someone that's passed away, I can live with that, no issue at 
all. 
This comment came during a discussion about living donors.  Barry was expressing his 
preference to get a kidney from a deceased donor, rather than put a loved one at risk.  Both 
April’s and Barry’s comments show that they believe the use of good organs from people 
who are deceased is a sensible alternative to taking them from healthy living people.  
6.6.2 Identifying with another’s loss 
Mary’s remarks in the same discussion shared Barry’s lack of concern toward the donor but 
showed more insight regarding the circumstances and the other people who might be 
affected. 
Like you say if it is a donor kidney, I'm happy to - I won't feel the guilts in a 
way.  In the back of my mind I think I will feel bad for the family, they've lost 
a family member.  But I don’t think I will have such a big issue. 
Mary said she would be happy to receive a kidney from a deceased donor without the same 
“guilts” she would have felt if her own family member had donated an organ.  The person 
would have died anyway, whether or not they donated their organs, therefore Mary did not 
feel personally responsible for causing them harm.  However her comment shows a deeper 
recognition of the grief of loss that the donor’s family would experience.  She identified 
with them as people who would be suffering the loss of a loved one. 
Some of the participants showed they appreciated the human loss involved by not wanting 
any information about the donor.  Cathy and April agreed that neither of them wanted to 
know anything about their donor. 
(Cathy) … Myself, I don't want to find out somebody died. If they got a 
kidney for me I don't want to know who gave it to me. 
(April) … No one - no I don't want too … No it's better don't see people. 
Cathy struggled with the idea that when her kidney came it meant that someone 
somewhere had passed away: 
Myself, sometimes my husband tell me don't worry you know, you're going 
to be lucky.  I said … I'm not make my cross to God somebody to die and I 
get the kidney.  It's not good.  If I'm lucky one will just come nicely, 
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Cathy said that she could not pray to God for a transplant as it would be like praying for 
someone to die.  She understood that there would not be a transplant unless someone 
died.  She told her husband off when he said she would be lucky one day because she knew 
that her lucky day would be a very bad day for the donor.  Instead she chose to ignore this 
fact and hope for a kidney to “come nicely”.   
Some participants struggled with emotions surrounding the death of the donor.  Although 
using the donor’s organs to help others made no difference to the outcome for the donor, 
participants realised that when their transplant kidney becomes available the donor’s 
family would be grieving and suffering the loss of their loved one.  Participants did not 
express any feelings of personal guilt for the donor’s death, but wishing for the transplant 
to happen caused mixed emotions because it meant the death of another.  They lived with 
the knowledge that when their longed-for transplant and escape from dialysis took place, it 
would be as a result of someone’s death.  When they finally received the call they had been 
waiting for, there would be a family of grieving relatives mourning the death of the donor. 
6.7 Conclusion   
This chapter has reported on the experience of waiting for a kidney transplant as shown in 
the data.    The data show that living on dialysis is physically and mentally challenging, while 
the wait for a transplant is accepted as part of everyday life.  A kidney transplant is seen as 
the event that will give freedom to live a normal life again.  The experience of waiting is 
fraught with feelings of uncertainty regarding the timing and the outcome of the 
transplant.  The dynamics of existing relationships are altered with people experiencing a 
fresh appreciation of the support they receive from family members, while at the same 
time distancing themselves in order to protect their loved ones from further worry.  New 
supportive relationships develop within the dialysis community.  Key to getting a transplant 
was a deceased donor with the data revealing gratitude towards the donor and an 
understanding of the human loss involved.  In the next chapter these findings will be 




 QUALITATIVE DESCRIPTIVE STUDY: DISCUSSION CHAPTER 7
7.1 Introduction 
The aim of this qualitative descriptive study was to describe the experience of waiting for a 
kidney transplant from a deceased donor from the perspective of the people waiting.  The 
data showed that participants were so immersed in the experience of living on dialysis that 
it was hard for them to separate their feelings about dialysis from their feelings about 
waiting for a transplant.  Living on dialysis was an integral component of waiting for 
transplant that loomed large in the participant’s lived experiences.  Living on dialysis was 
the context from which all their answers came, as if they were trapped in dialysis and the 
kidney transplant was the means of escape.  Participants did not know how long they would 
have to wait and they experienced both hopes and fears for life with a kidney transplant.  
People lived each day in a liminal state: prepared to stay, but ready to leave; enduring yet 
accepting; connecting and disconnecting with the people in their lives.  Key to the escape 
was the deceased donor who would release them at a time that was unknown and outside 
of their control.  
7.2 The all-encompassing and overwhelming nature of living with ESKD 
People waiting for a kidney transplant from a deceased donor have often lived with CKD for 
many years prior to starting dialysis.  During this time they gradually add more and more 
restrictions to their lives.  To combat feeling short of breath when fluid overloaded, fluid 
intake is restricted.  Faced with lethargy caused by anaemia, daily activity is reduced.  As 
normal renal function decreases, the diet is regulated and a complex regimen of 
medications introduced.  On commencement of dialysis, another set of restrictions is 
applied to an already restricted life.  Surgeries take place to establish and maintain dialysis 
access.  Large chunks of time are spent attached to the dialysis machine; three or four times 
a week for haemodialysis or every night for PD.  Even people who dialyse independently at 
home invest weeks of time learning the necessary skills.  On top of all this is the 
requirement to be available for multiple doctors’ appointments and the inevitable hospital 
admissions during periods of crisis (Ahmad et al. 2015; Burns, Fernandez and Stephens 
2015; Calvey and Mee 2011; Crabtree and Jain 2015; Daugirdas 2015).   
This study has found that people who are living on dialysis with ESKD while waiting for a 
kidney transplant from a deceased donor are burdened by their disease and by the dialysis 
treatment.  Although the focus of the study was about waiting for a kidney transplant, 
participants spoke at length about how dialysis affected their lives.  They accepted that 
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dialysis was necessary to continue living, but they demonstrated a sense of lives lived 
within boundaries that had been forced upon them, with limited opportunities for travel, 
employment, financial independence, and normal social interaction.   
This finding is consistent with the literature about living with chronic illness.  Chronic 
conditions such as ESKD are continuous and never-ending (Stewart and Sullivan 1982), 
disrupting peoples’ lives (Bury 1982) as they adapt to the limitations of the illness and the 
demands of therapy (Sheilds et al. 2015).  People who are on dialysis and waiting for a 
kidney transplant describe a poorer quality of life than before they became ill (Alshraifeen, 
McCreaddie and Evans 2014; Gomez-Besteiro et al. 2004; Landreneau, Lee and Landreneau 
2010).  The surrender of time and autonomy to dialysis therapy results in a sense of loss 
and bereavement as people reflect on all the activities and pursuits they cannot continue 
(Calvey and Mee 2011; Monaro, Stewart and Gullick 2014; Polaschek 2000; Polaschek 
2003b).  Even self-identity is affected (Charmaz 1983) as people fail to maintain the kind of 
normal life they had always hoped to live (Bury 1982; Monaro, Stewart and Gullick 2014).  
The first synthesised finding of the systematic review (Burns, Fernandez and Stephens 
2015) showed that people waiting for a kidney transplant from a deceased donor are 
deeply affected by the experience of living on dialysis, and the data from this study 
provides further confirmation of this view. 
7.2.1 Hoping to escape dialysis with a transplant 
From the perspective of a person living with ESKD, the possibility of a kidney transplant 
allows them to view their ongoing and irreversible chronic disease (Sav et al. 2013) more 
like an acute disorder, as something temporary that can be escaped from (Moran, Scott and 
Darbyshire 2011; Yngman-Uhlin, Fogelberg and Uhlin 2015).  The hope of getting a kidney 
transplant one day helps people to endure and gives them a more positive outlook on life 
while they wait (Pierce 2014).  The effect of this hope has been measured in quantitative 
research looking at the HRQOL scores of people with ESKD (Lin et al. 2010; Osthus et al. 
2012; Santos 2011).  In general HRQOL scores among people with ESKD have been found to 
be poorer than the general population (Alshraifeen, McCreaddie and Evans 2014).  
However, when comparing different groups within the ESKD population, people who are on 
the transplant waiting list report better HRQOL scores and less depression than those who 
are just on dialysis and not waiting for a transplant (Lin et al. 2010; Osthus et al. 2012; 
Santos 2011).   
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The findings of the study also confirmed that waiting for a kidney transplant gave people 
hope that they would not have to live on dialysis for ever.  Study participants clearly 
articulated the hope they held that a kidney transplant would bring them freedom from 
dialysis.  While living with the overwhelming physical and psychological burdens of dialysis, 
the thought of getting a kidney transplant gave them hope that one day they would live a 
normal life again.  Even being on the waiting list was viewed as a positive, and the prospect 
of their name being removed from the list was mentioned with horror.  The thought of 
dialysis as their only option was described as depressing and frightening. 
7.2.2 Waiting becomes a normal part of life  
Waiting for a kidney transplant has been described as a liminal experience, in-between 
chronic illness and transplantation (Molzahn, Bruce and Sheilds 2008).  People on the 
waiting list for a kidney transplant are immersed in the experience of living with a chronic 
illness (Charmaz 1991) and endure  a restricted life, often for many years (Tong et al. 2015).  
Chronic illness has been described as living on someone else’s schedule (Mulcahy, Parry and 
Glover 2010) and people waiting for a kidney transplant develop a state of acceptance, 
acknowledging they have no influence over when a donor organ will become available 
(Sadala et al. 2012).  Denial and distraction have been found to be effective strategies 
people use to manage the experience of waiting (Brown et al. 2006; Mitchell et al. 2005; 
Naef and Bournes 2009; Sweeny and Cavanaugh 2012).   
The study found that after time, people come to accept the wait for a transplant as a 
normal part of life.  The initial excitement when people are first placed on the transplant 
waiting list eventually wanes and settles into a state of acceptance.  People carry on with 
their daily responsibilities and do not focus on the transplant.  They choose not to think 
about the transplant, and instead they distract themselves by carrying on with their normal 
activities of life such as work, spending time with family and maintaining dialysis.  Their use 
of metaphor illustrates how the wait was something they had accepted and normalised as 
an everyday part of life.  In congruence with the literature, this study’s findings 
demonstrate that waiting for a transplant becomes normalised and accepted as part of 
everyday life.  
7.3 Living with uncertainty  
In the literature uncertainty is often linked with the experience of waiting for a kidney 
transplant.  The systematic review showed as well as the psychological challenges of living 
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with a chronic illness, waiting for a kidney transplant itself affected a person’s mental 
wellbeing with uncertainty resulting in stress and anxiety for people who were waiting 
(Burns, Fernandez and Stephens 2015).  The wait for a kidney transplant contains many 
elements that contribute to feelings of uncertainty (Pelletier 2012).  The experience of 
living with a chronic illness such as ESKD has been described as unpredictable, with 
uncertainty “a continuous companion” (Sheilds et al. 2015, p. 210).  The outcome of the 
transplant is uncertain as there is no guarantee that it will fulfil the hopes and dreams of a 
return to ‘normal’ life (Baines and Jindal 2003).  Waiting itself is uncertain (Ellingsen et al. 
2013; Naef and Bournes 2009) with the unknown timing of the transplant meaning that 
people cannot plan for the future with any confidence (Australia and New Zealand Dialysis 
and Transplant Registry 2015e; Tong et al. 2015).   
7.3.1 An uncertain outcome 
The data show that people waiting for a kidney transplant experienced fear about whether 
or not the transplant would be successful and free them from dialysis as they hoped.  
Although they focused on the positive aspects of transplantation, they understood that 
sometimes a transplant had serious negative consequences that could lead to them 
returning to dialysis or even dying.  They experienced fear and uncertainty relating to the 
surgery, the medications, and the potential for the transplant to be lost.  They also 
expressed their fear of being denied the opportunity to wait for a transplant.  In seeking a 
transplant the participants hoped to return to the life they had before they became sick, 
free to do whatever they wanted without the restrictions of dialysis.  If their hoped-for 
transplant failed then they knew they would have to continue the rest of their lives on 
dialysis.  Uncertainty about the ultimate outcome of the transplant was part of the 
experience of waiting for a transplant.   
This finding is consistent with what is known in the literature.  While offering the hope of a 
way out, the uncertainty of waiting for a kidney transplant causes stress and anxiety (Silva 
et al. 2014).  People try to predict when the kidney will come and whether or not the 
transplant will truly give them the escape they hope for (Carr, Teucher and Casson 2014; 
Corruble et al. 2010).  The expectation that the transplant will return them to a normal life 
does not just bring assurance, but also anxiety and apprehension (Shih and Honey 2011; Yu 
and Petrini 2010).  As with the participants in the study the literature reports fears relates 
to the possibility of something going wrong with the surgery, or of some new health 
problem, such as cancer, emerging afterwards as a side effect of the medication (Lasker et 
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al. 2010; McDermott, Hardy and McCurry 2010).  Fear is also related to the prospect of 
losing their imagined future (Baines and Jindal 2003; Jonsén, Athlin and Suhr 2000) and 
facing their own mortality (Li et al. 2012).    
7.3.2 An ongoing wait 
In a study by Hajdarevic, Rasmussen and Hörnsten (2014), people in the initial stages of a 
chronic disease people felt lost and uncertain, followed by a period of “searching for solid 
ground” (Hadjaveric et al. 2014, p. 357).  In a similar fashion, the participants of the study 
were keen to suggest better ways of being kept informed, to provide them with some solid 
ground to prepare for the future.  The length of the wait for a kidney transplant can only be 
estimated by calculating the mean length of time that people wait (Australia and New 
Zealand Dialysis and Transplant Registry 2015e).  Several studies have shown that people 
have wrongly interpreted information about the mean waiting time as the actual waiting 
time and have been very disappointed when the length of their wait exceeds it (Moran, 
Scott and Darbyshire 2011; Yngman-Uhlin, Fogelberg and Uhlin 2015).  Providing people 
with information while they wait has been shown to both reduce uncertainty thereby 
lessening anxiety and frustration (Cheng and Tsai 2014; Guenter, Hetty van Emmerik and 
Schreurs 2014) and also in certain circumstances, be a source of increased stress (Stone et 
al. 2013).  In the case of waiting for a kidney transplant the length of the wait cannot be 
predicted in clock time, therefore it is not possible to relieve uncertainty about the timing 
by providing information about how long the wait will last.   
During the focus groups participants spoke about the difficulty of living with uncertainty.  
They were keen to have more information about the timing of the transplant so that they 
could plan for the future, but they also recognised that such knowledge could potentially be 
a source of stress and disappointment.  For example, if they knew they were close to 
getting a call but then didn’t get one quickly, the wait would be even more excruciating.  Or 
if they were told that they would not get a transplant for many years, they could lose hope 
and become demoralized.  Although information about the prospective length of the wait 
can help give people a better sense of control while waiting (Cheng and Tsai 2014), this is 
an example of how the sharing of information causes stress to increase (Stone et al. 2013).  
People waiting for a kidney transplant should be provided with as much information as 
possible while they wait.  Given the imprecise nature of the allocation process, information 
about the mean length of time that people wait is of limited value in reducing uncertainty.  
Other information such as details about the surgery and what they should expect to happen 
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when the call comes may have some value in reducing the effect of uncertainty while 
people wait (King, Dan and Johnstone 2006; Weems and Patterson 1989). 
7.4 Changing relationships: connecting and disconnecting 
The literature and the study findings make reference to how the experience of waiting for a 
kidney transplant impacts both positively and negatively on a person’s relationships.  
People welcome the support of friends and family while at the same time try to protect 
them from the full impact of the disease.  They feel isolated, but develop new friendships 
from within the dialysis community.  The dynamics of existing and future relationships are 
altered by the experience of waiting for a kidney transplant. 
7.4.1 Strengthened connections 
The data show how study participants experience a fresh appreciation of the importance of 
their family members while they live on dialysis and wait for a transplant.  By enabling them 
to endure the day to day challenges of life on dialysis the families are described as a 
“driving force”, a “support mechanism” and as the reason they continue with dialysis.  
Study data shows that love and encouragement from families was an important source of 
strength for people waiting for a kidney transplant. 
The systematic review also found that people waiting for a kidney transplant appreciate 
being part of a community and place value on relationships with family and friends (Burns, 
Fernandez and Stephens 2015).  While living with chronic illness, including ESKD, people re-
evaluate their priorities in life and place more value on relationships than they did before 
they were unwell (Bennett et al. 2013; Rasmussen and Elverdam 2007).  Families and 
relationships are seen as a source of strength and encouragement that help people to 
endure the wait for a transplant (Monaro, Stewart and Gullick 2014; Polaschek 2000; Tong 
et al. 2009). 
As well as appreciating the support of their friends and family members, people also 
develop new connections within the dialysis community which develop into valued 
alliances.  From the diagnosis of CKD, to starting dialysis and joining the transplant waiting 
list, people have contact with numerous medical practitioners, nursing staff, technicians, 
and support staff as well as other people with ESKD.  Regular communication with the 
medical community has been shown to reduce anxiety while people wait (Yngman-Uhlin, 
Fogelberg and Uhlin 2015; Yorke and Cameron-Traub 2008) while people who have little 
interaction with their caring physicians report feeling frustrated and forgotten (Brown et al. 
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2006; Jonsén, Athlin and Suhr 2000; Yngman-Uhlin, Fogelberg and Uhlin 2015).  Each 
member of the medical community imparts information which has an impact on the overall 
experience of waiting for a transplant (Wehrens 2014).  Likewise, meeting with other 
people who are waiting or who have received kidney transplants can be beneficial.  People 
can learn from the stories of others who have endured the same situation and be 
encouraged that they are not alone (Mulcahy, Parry and Glover 2010).  Information enables 
people to cope better with the experience of waiting for a kidney transplant (Calvey and 
Mee 2011) although facts gained from other dialysis patients may be out of date and 
inaccurate (Landreneau, Lee and Landreneau 2010). 
The data show that participants value their relationships with other people who were living 
on dialysis or who had received a kidney transplant.  While the literature says a lot about 
the beneficial effect of contact with the health care team, this study found that participants 
spoke more about the other patients that they knew, rather than any of the staff they 
encountered.  They watched and listened to the people around them and learned from the 
experiences of others.  Throughout the data, participants referred not just to their own 
experiences, but also to the experiences of other people they had met while on dialysis.  
The stories of these others were reported along with their own, and provided a reference 
framework to compare their own experiences with.   
7.4.2 Protective isolation 
The literature has described how people living with a chronic disease such as ESKD may feel 
socially isolated (Bonner, Wellard and Caltabiano 2010; Herlin and Wann-Hansson 2010; 
Kuluski et al. 2014; Polaschek 2000) and a burden to their loved ones (Calvey and Mee 
2011; Yngman-Uhlin, Fogelberg and Uhlin 2015).  Michael (1996) reported that people with 
a chronic illness felt a “loss of connectedness” and found it difficult to relate to others as 
they had done prior to their diagnosis (Michael 1996, p. 256).  A lack of common experience 
made it difficult for people to relate to each other as they had done before the diagnosis of 
a chronic disease (Michael 1996).  As well as the restrictions of the actual illness, treatment 
of the condition has also been described as punishing, taking away precious time and 
affecting not only the person with the disease but their family and friends too (Sav et al., 
2013).   
In some cases friends and family may become intolerant towards a person with a chronic 
disease when they continue to have the same problems and fail to get well (Bury 1982; 
Stewart and Sullivan 1982).  People with a chronic condition sometimes hide the true 
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extent of their symptoms or emotions in order not to be a burden and to protect their 
loved ones from worrying about them (Jowsey, Ward and Gardner 2013; Stephens, 
McKenzie and Jordens 2014).  This withholding of information in order not to burden others 
is a form of self-isolation (Monaro, Stewart and Gullick 2014; Öhman, Söderberg and 
Lundman 2003; Tong et al. 2009) that results in people living restricted and socially isolated 
lives (Charmaz 1983, P. 168). 
Study data showed that participants’ lives had been altered by ESKD and dialysis, meaning 
that they could no longer relate to their friends as they had before they were ill.  They 
lacked available time and energy to invest in relationships, because of the hours they had 
to spend on dialysis therapy, and they lacked common experiences as their lives were now 
taken up with managing their ESKD.   
As described in the literature, the data also show that as well as appreciating their family’s 
support, the study participants hid their true feelings from their loved ones because they 
did not want to burden them with all the details of their illness.  Every participant in the 
study had an example of a time they had lied or suppressed their feelings in order to 
prevent their family members worrying about them.  For some people that meant 
pretending they were well when their symptoms were bad.  For others it meant hiding their 
relief when family members were found to be unsuitable to proceed as live donors.  
Participants hid the truth about how they were feeling to protect their loved ones and by 
doing so they isolated themselves further. 
7.5 Dealing with the deceased donor  
For people who are on the waiting list, the transplant they are waiting for will only happen 
when someone dies.  Not only will someone have to die, but they will have to die in a 
specific set of circumstances; with a compatible blood group and tissue type; willing to 
donate their organs; and whose family allow the donation to take place.  The longed-for 
transplant happens at the expense of another person’s tragedy and involves a series of 
events that cannot be predicted and can hardly be hoped for.  People on the waiting list for 
a kidney transplant from a deceased donor are powerless to make the transplant happen 
more quickly and so they just wait and wish for the unthinkable.   
7.5.1 A practical solution with a high human cost 
The literature shows that people waiting for a kidney transplant are aware of the paradox 
of needing someone else to die so that they can live (Calvey and Mee 2011; Tong et al. 
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2015).  It has been noted that there is a culture of not discussing death within the dialysis 
setting (Sheilds et al. 2015) and fear of their own death has been cited as one of the 
reasons for increased anxiety in people with ESKD (Li et al. 2012; Silva et al. 2014).  Linked 
with the experience of facing their own mortality, people waiting for a kidney transplant 
understand that their transplant will only occur if somebody else dies.  
While it may be sensible to talk in abstract terms about using good organs from a donor 
who is deceased in order to benefit others, when people are faced with the thought of who 
that donor actually is, where they live, work and who their families are, it is more difficult 
to accept.  Wishing for a transplant becomes wishing for someone to die.  Studies have 
described the “moral guilt” experienced by people waiting for a kidney transplant (Tong et 
al. 2015, p. 771) where transplant recipients feel responsible for the donor’s death and 
worry that their survival is at the donor’s expense (Sanner 2003).  Grief reactions associated 
with survivor guilt have been observed among organ transplant recipients (Baines and 
Jindal 2003). 
The findings of this study captured both the practicality of using organs from people who 
are deceased, along with the sense of regret towards the donor and their family.  
Discussion about the deceased donor was limited and where comments were made the 
subject was not explored, seeming to confirm the literature which noted a culture of not 
discussing death within a dialysis setting.  Unlike the literature, none of the participants 
specifically expressed gratitude or guilt towards the donor.  Instead there was a sense that 
if the donor did not need their organs anymore because they were dead, then it was logical 
to pass on those organs to people who needed them.   
Despite their pragmatism several comments revealed that the study participants identified 
with the donor family’s loss.  Participants stated they did not feel guilty, but they felt bad 
for the family of the donor who would be suffering the grief of the loss of their loved one.  
One participant said she could not pray for someone to die so that she could get the kidney.  
Instead she practised denial by hoping if she was lucky one would “come nicely”.  It is a sad 
fact of transplantation that deceased donor organs do not come “nicely” but always involve 
a death.   
This study highlights the need for a flexible approach towards providing care for people 
who struggle with the thought of the human cost of transplantation.  In Australia there are 
guidelines that protect the anonymity of the donor and recipients (Transplantation Society 
of Australia and New Zealand (TSANZ) 2016).  Schemes exist that allow recipients to write 
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and thank their donor’s family after the transplant if they wish to (Donatelife 2014), but 
there is nothing in place for people while they are waiting.  The uncertainty surrounding the 
circumstances of the donor would make formal pre-transplant communication impossible, 
but there may be a place for psychological care to relieve anxiety in individuals who find the 
idea difficult to live with (Sheilds et al. 2015; Silva et al. 2014).   
The experience of waiting for a kidney transplant ends with the death of a donor.  For the 
group of people waiting for a kidney transplant, death is both the problem they are seeking 
to avoid, and the solution that they anxiously await.  While avoiding death by living on 
dialysis they hope for a transplant that can only come about by the death of a donor. 
7.6 Conclusion 
This study has found that the experience of waiting for a kidney transplant takes place 
within the context of life on dialysis which is the over-riding concern for people in this 
population.  The thought of receiving a kidney transplant gives people hope of one day 
escaping from dialysis and returning to ‘normal’ life with the freedom to work, travel and 
relate to people as they did before dialysis (Calvey and Mee 2011; Dekkers, Uerz and Wils 
2005; Hagren et al. 2001; Herlin and Wann-Hansson 2010; Moran 2008; Polaschek 2000; 
Rittman et al. 1993; Sadala et al. 2012).   
Waiting for a kidney transplant involves living with uncertainty, not knowing how long the 
wait will be or whether the transplant will result in the hoped for recovery (Calvey and Mee 
2011; Hagren et al. 2001; Herlin and Wann-Hansson 2010; Kaba et al. 2007; Moran 2008; 
Pelletier 2012; Polaschek 2000).  People fear they may never get a transplant or that 
something will go wrong with the transplant when it happens (Bjork and Naden 2008; 
Jonsén, Athlin and Suhr 2000; Shih and Honey 2011; Yu and Petrini 2010).  Underlying all 
these fears is the dread of life on dialysis without the hope of any escape (Baines and Jindal 
2003; Yngman-Uhlin, Fogelberg and Uhlin 2015). 
Waiting time can be estimated in clock time, but is actually experienced as an embodied 
and liminal experience, to be endured for as long as it takes; in between illness and health 
(Kierans 2005; Molzahn, Bruce and Sheilds 2008).  People who are waiting for a kidney 
transplant reconstruct their use of time and place greater value on relationships and 
activities that are important to them (Bennett et al. 2013; Yngman-Uhlin, Fogelberg and 
Uhlin 2015).  Support from other people (Brown et al. 2006; Jonsén, Athlin and Suhr 2000; 
Polaschek 2003b; Scott et al. 2011; Yorke and Cameron-Traub 2008); the acquisition of 
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knowledge (Stone et al. 2013); denial (Brown et al. 2006); and distraction (Naef and 
Bournes 2009) are strategies that people use to help them endure the wait.   
The key to getting a kidney transplant is a deceased donor.  It is an ironical fact that 
peoples’ efforts to avoid mortality by seeking a transplant are only achieved by the death of 
another (Calvey and Mee 2011; Tong et al. 2015).  Feelings towards the deceased donor 
may include gratitude and guilt (Baines and Jindal 2003; Li et al. 2012; Sanner 2003; Silva et 
al. 2014), although the results of this study showed a sense of pragmatism combined with 
concern for the donor’s family. 
7.7 Strengths of the study 
The study provides information about a significant patient population which few previous 
studies have specifically investigated, thereby helping to fill a gap in the literature.  
Purposive sampling was used to ensure the participants were appropriate to comment on 
the experience of waiting for a transplant from a deceased donor.  The sample included 
both male and female participants of varying ages and from a diverse range of cultural and 
professional backgrounds.  People who are living on dialysis are a time poor population 
with a commitment of at least 15 hours per week to their dialysis therapy on top of family 
commitments, work and medical appointments.  By scheduling the focus groups on 
different days of the week and different times of day, the number of people on in-centre or 
satellite haemodialysis who were able to attend was maximized.  Audio-recording of the 
focus groups followed by verbatim transcription of the recordings enhanced the credibility 
and authenticity of the data (Polit and Beck 2014).  The use of dual moderators in the focus 
groups ensured that the novice researcher was supported while leading a focus group for 
the first time, and allowed for all the needs of the participants to be met and all lines of 
discussion to be fully explored (Kamberelis and Dimitriadis 2011).  Participants showed they 
felt free to express a range of opinions by discussing both positive and negative outcomes 
of waiting for a transplant.  
7.8 Limitations of the study 
The main limitation of this study is the small sample size and the fact that it was a 
convenience sample made up of participants from one metropolitan hospital in Sydney, 
Australia.  Although data saturation was reached within this group, new findings may 
become apparent if the study were repeated with a larger sample size or with people under 
the care of another hospital or in another state or country.  The experience of waiting for a 
 
106 
kidney transplant may vary depending on the resources that people have available to them.  
For this reason these findings of this study cannot be said to be generalizable. 
7.9 What does this study add to the existing literature? 
The findings of this study have highlighted several areas that contribute to existing 
literature about waiting for a kidney transplant. 
 People who are waiting for a kidney transplant from a deceased donor accept the 
wait as a normal part of daily life.  The restrictions of living on dialysis have more 
impact on day-to-day living than the experience of waiting for a transplant.  
 The feelings of uncertainty experienced by people who are waiting for a kidney 
transplant relate to the timing of the transplant, and also whether or not it will be 
successful and give them the freedom to live a normal life. 
 Social relationships are highly valued by people waiting for a transplant.  They 
experience a renewed appreciation for the practical and emotional support of 
loved ones, but they also deliberately shield those people from the details of their 
disease so as not to cause excessive worry and concern. 
 People who are waiting for a kidney transplant learn from the stories and 
experiences of their peers in the dialysis community.  
 People who are waiting for a kidney transplant do not dwell on the situation of the 
donor because it is difficult to live with needing another person to die. 
7.10 Recommendations 
The findings of this study suggest several areas for further research:  
 What interventions are effective to support people while they wait for a kidney 
transplant from a deceased donor?  Specific areas which people may need 
assistance with include: living well with a chronic illness, psychological support to 
endure an indefinite wait, help with processing the concept of receiving an organ 
from a deceased person. 
 Given that the experience of waiting can be improved by good communication and 
the provision of information (Cheng and Tsai 2014; Guenter, Hetty van Emmerik 
and Schreurs 2014) how can people best be kept informed while waiting for a 
transplant?  The effectiveness of print and lecture based methods of imparting 
information could be assessed and alternative methods of communication, such as 
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story based, visual resources could be developed to cater for non-readers and 
people from different cultural and linguistic groups. 
 What are the most effective ways of supporting the development of therapeutically 
beneficial relationships within the community of family, friends, health care 
providers and fellow patients?  Possible interventions may include the use of social 
media to connect people with each other, newsletters incorporating patient stories 
and support groups.    
 The existing qualitative study could be repeated across multiple centres 
internationally to see whether any new findings emerge in different settings.  
Larger sample sizes may be achieved by adopting a method of data collection that 
is more accessible to members of the dialysis population such as individual 
interviews or through the use of social media (Lunnay et al. 2015). 
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  CONCLUSION TO THE THESIS CHAPTER 8
The aim of this thesis is to provide an account of what day-to-day life is like for people who 
are living on dialysis while waiting for a kidney transplant from a deceased donor.  This 
question is significant because it is estimated that over 170 000 people are waiting for a 
kidney transplant worldwide (Australia and New Zealand Dialysis and Transplant Registry 
2015a; Council of Europe 2014; NHS Blood and Transplant 2015; United States Renal Data 
System 2014a).  Donor organs are allocated to recipients by a computer algorithm that 
prioritises good tissue type matching over the length of time spent waiting, meaning that it 
is possible for people to get a kidney transplant after waiting only a short time.  It is 
impossible to predict when a person will receive an offer as it depends on variable factors 
such as the blood group and tissue typing of the donor organ and the compatibility of 
everyone else on the list at the time. 
A wide ranging literature review was conducted to inform the study, referring to literature 
describing the experience of living with chronic illness; the passage of time; the experience 
of waiting; and the concept of uncertainty.  It included qualitative and quantitative studies 
looking at the experience of waiting for different kinds of solid organ transplants such as 
liver, lungs and hearts.  Themes within this literature include waiting for a kidney transplant 
may cause people to feel high levels of stress and anxiety (Li et al. 2012; Santos 2011; Shih 
and Honey 2011; Yu and Petrini 2010).  This may be due to uncertainty about when the 
kidney transplant will come, concerns about whether the kidney transplant will work and 
because of feelings of guilt towards the donor who will have to die in order for the 
transplant to take place (Baines and Jindal 2003).  The literature indicates that feelings of 
anxiety and frustration while waiting may be reduced by good communication and by the 
provision of information regarding the wait (Cheng and Tsai 2014; Guenter, Hetty van 
Emmerik and Schreurs 2014).  In the case of waiting for a kidney transplant information 
about the length of the wait is not available, although good communication may relieve 
anxiety in this population (King, Dan and Johnstone 2006; Weems and Patterson 1989). 
Following the general literature review, a systematic review of the qualitative literature was  
undertaken, focusing on papers that described the experience of waiting for a kidney 
transplant (Burns, Fernandez and Stephens 2015).  Twelve studies were found for inclusion 
in the systematic review, and of those most were designed to examine the experience of 
living on dialysis with the experience of waiting for a kidney transplant reported 
incidentally.  The systematic review made three findings.  Firstly, people who are waiting 
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for a kidney transplant from a deceased donor are affected by the experience of living on 
dialysis with ESKD and its impact on their physical health and normal activities of living.  
Secondly, the experience of waiting for a kidney transplant from a deceased donor impacts 
a person’s psychological wellbeing.  Thirdly, people who are waiting for a kidney transplant 
from a deceased donor place value on relationships and being part of a community. 
Having established what is already reported about the experience of waiting for a kidney 
transplant in the literature, it became apparent that there was a gap in the knowledge for a 
study specifically designed to investigate that exact experience.  A qualitative descriptive 
study was conducted using focus groups to collect data from a purposive sample of patients 
based at one metropolitan hospital in southern Sydney.  Thematic analysis of the data 
identified four main themes, each with subthemes that described the experience of waiting 
for a kidney transplant from a deceased donor.   
Firstly people who are waiting for a kidney transplant view the transplant as a means of 
escape from the restrictions of their life on dialysis.  The hope of getting a transplant one 
day is widely reported in the literature, but in this study it was also noted that the actual 
wait becomes accepted as a normal part of daily life with dialysis the greatest cause of 
concern to participants.   
Secondly people who are waiting for a kidney transplant live with uncertainty.  This has 
been reported in other studies (Moran, Scott and Darbyshire 2011; Silva et al. 2014) and 
relates to both the uncertainty around the timing of the transplant and uncertainty about 
whether the transplant will work or not.  There is fear about the kidney failing and about 
being left with no option in life other that dialysis.   
Thirdly, the experience of waiting for a kidney transplant alters a person’s relationships 
with the people around them.  People waiting for a kidney transplant value those who give 
them help and encouragement, but also try to protect them from the full impact of the 
disease by downplaying the true extent of their symptoms and emotions.  People who are 
waiting for a kidney transplant find it hard to relate to people they knew before they 
started dialysis because of the disparity in life experience, but the data show that they 
enjoy developing new friendships from within the dialysis community and learn from the 
experiences of others.  The importance of relationships has been mentioned in the 
literature (Bennett et al. 2013; Monaro, Stewart and Gullick 2014) but the complex nature 
of connection with some people and disconnection from others, and the best way to utilise 
relationships in order to support people who are waiting. 
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Finally, people waiting for a kidney transplant experience complex emotions towards the 
deceased donor.  While on one level they strongly hope that an organ from a person who is 
deceased will become available quickly, they also appreciate the great cost to that person 
and their family.  Wishing for a transplant is like wishing for someone to die.   
8.1 Limitations of the thesis 
The individual elements within the thesis each had limitations.  In the systematic review 
only two of the twelve included studies specifically stated that all the participants were 
waiting for a transplant.  In the qualitative descriptive study only six of a potential 29 
participants attended the focus groups and they were all patients of one metropolitan 
hospital.  With the requirement to invest time in dialysis therapy on top of their existing 
commitments to family, employers and medical care, this group of people has limited spare 
time to attend extra appointments such as focus groups.  As a difficult group of people to 
reach this may explain why there is a lack of studies specifically relating to waiting for a 
transplant.   Future research with this group of people may benefit by considering the use 
of a more participant centred method of data collection such as individual interviews in the 
home or during dialysis session.  Repeating this research in different settings and different 
countries, may also provide different insights. 
8.2 Implications for practice 
The findings of the systematic review and the qualitative descriptive study have 
implications for the nurses who care for people who are waiting for a kidney transplant.  
Both the review and the study found that living on dialysis while waiting for a kidney 
transplant is physically and psychologically demanding.  This knowledge helps nurses 
working with this group of people and would suggest that every effort be made not to add 
to their therapeutic burden by the unnecessary scheduling of tests and appointments.  
Recognising that people experience a combination of both hope and fear while they wait 
calls for nurses to be sensitive.  For example, an angry response to being made interim on 
the list for a time may seem inappropriate, but the thesis findings would suggest that 
people may perceive that their hope is being taken away.  Similarly people’s reluctance to 
attend appointments or keep testing up to date may indicate fear about transplantation 
itself. 
The findings of the review and the study have both shown that waiting for a transplant 
affects a person’s relationships.  Supportive relationships are highly valued in this group 
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and may come from new directions such as within the dialysis community itself.  Nurses 
and other staff within the renal department should not only be sources of support 
themselves, but should also find ways to facilitate connection with others in the same 
situation. 
For some people on the waiting list the thought of waiting for a donor to die is difficult.  
Nurses should be able to provide people with information about the process of deceased 
donation in order to answer any questions or concerns a person may have, but this should 
be requested by the person as individual concerns vary. 
By identifying these themes and discussing them in the light of what is known in the 
literature, this study provides a descriptive summary of what it feels like to wait for a 
kidney transplant from a deceased donor from the perspective of the person waiting.  The 
descriptive summary and the systematic review of the literature are combined in this thesis 
to contribute to what is known about the experience of waiting for a kidney transplant from 
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APPENDIX 1: COMPARISON OF RENAL REPLACEMENT THERAPY MODALITIES 
Mortality  
Dialysis 13.1% (per 100 patient years) (Australia and New Zealand Dialysis and 
Transplant Registry 2015b) 
Kidney transplant 2.3% (per 100 patient years) (Australia and New Zealand Dialysis and 
Transplant Registry 2015b) 
Technique survival  
Haemodialysis 53% patient survival at 5 years, censored for transplant but not for patient 
death (Australia and New Zealand Dialysis and Transplant Registry 2015c) 
Peritoneal dialysis 21% technique survival at 5 years (Australia and New Zealand Dialysis and 
Transplant Registry 2015d) 
Kidney transplant 81% graft survival rate at 5 years after receiving a kidney transplant from a 
deceased donor (Australia and New Zealand Dialysis and Transplant Registry 
2015f) 
Physiological challenges 
Haemodialysis Shifts in fluid volume and changes to electrolyte concentrations during HD 
sessions can be difficult to tolerate and cause symptoms such as hypotension, 
headaches, nausea and loss of consciousness (Chao, Huang and Yen 2015; 
Pietribiasi et al. 2015).   
Peritoneal dialysis Physiological challenges of PD include mechanical complications such as hernia 
formation, dialysate leak, genital oedema and respiratory problems; and 
metabolic complications such as impaired glucose and lipid absorption and the 
gradual erosion of the peritoneal membrane (Blake and Daugirdas 2015). 
Kidney transplant The physiological challenges of transplantation relate to rejection of the 
transplanted organ, recurrence of the original disease in the new organ and 
the side effects of immunosuppressive medication. 
Rejection can be treated with immunosuppressive medication and does not 
always lead to the loss of the transplanted organ (Burton et al. 2015; Lo, 
Kaplan and Kirk 2014).  Hyper-acute reaction occurs within hours of the 
surgery and is an emergency situation requiring immediate removal of the 
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graft.  Acute rejection is also of sudden onset while chronic rejection develops 
more slowly over months or years.  Australian data shows that hyper-acute 
rejection accounts for <1% of graft losses whereas acute rejection occurs in 
16% of transplants although it only causes 3.2% of graft losses (Australia and 
New Zealand Dialysis and Transplant Registry 2015f).   
Graft loss due to disease recurrence depends upon the original disease 
(Delville et al. 2014; Henderson and O’Connell 2014).  Not all causes of kidney 
failure recur, and diseases that cause progressive damage over a prolonged 
period of time such as diabetes and hypertension are more strictly controlled 
after transplant to limit damage to the new organ.  It has been estimated that 
up to 30% people with an original kidney disease of a recurring type 
experience graft loss within 5-10 years (Floege et al. 2014).   
Immunosuppressive medication, while essential to prevent rejection in the 
grafted organ, is associated with a range of long term complications and 
comorbidities.  Incidence of all types of cancer in people who receive kidney 
transplants is around 14%, approximately double that of the general 
population (Wong, Germaine et al. 2013).   Cardiovascular disease accounts for 
approximately 25% of kidney transplant recipient deaths in Australia and 40% 
in New Zealand (Farrugia et al. 2014; McDonald 2013).  New-onset diabetes 
after transplant (NODAT) is a metabolic disorder believed to be related to the 
use of immunosuppressive medication which also affects post-transplant graft 
survival and mortality (Sarno, Muscogiuri and De Rosa 2012).   
Surgical challenges 
Haemodialysis Surgical challenges of haemodialysis relate to the maintenance of a functioning 
vascular access such as stenosis, infection or aneurysm (Rose, Sonaike and 
Hughes 2013). 
Peritoneal dialysis The insertion of a permanent PD catheter into the abdomen may take place 
under general or local anaesthesia.  Complications include infection and bowel 
perforation (Blake and Daugirdas 2015). 
Kidney transplant 
 
Kidney transplantation involves major surgery.  Surgical complications include 
delayed wound healing (Fockens et al. 2015) and leaking, blockage 
 
139 
(thrombosis), narrowing (stenosis) or breakdown (necrosis) of any of the joins 
in the blood vessels or ureters (Lempinen et al. 2015).  Surgical complications 
occur in up to 10% of cases (Bessede et al. 2012; Lentine et al. 2014; Naesens 
et al. 2013; Saeb-Parsy et al. 2010; Ziȩtek et al. 2007). 
Procedural challenges 
Haemodialysis Each dialysis session two cannulas are inserted into the fistula or graft to 
remove and return the blood.  Dialysis cannulas are large, usually 14-15 gauge, 
in order to accommodate the high blood flow rate required to facilitate the 
cleaning of large blood volumes (Parisotto et al. 2014).  Technical problems 
relating to the blood circuit include pain and difficulty cannulating, clotting of 
the blood lines, and needle displacement resulting in air embolus or 
haemorrhage (Tennankore et al. 2015).  People on home HD are trained to 
manage every aspect of their treatment independently including operating the 
HD machine, inserting the HD cannulas into their own fistulas and 
troubleshooting any medical or technical issues (Rajkomar et al. 2014). 
Peritoneal dialysis The maintenance of strict asepsis during connection to the PD machine is 
essential to prevent exit site infection and peritonitis (Blake and Daugirdas 
2015). 
Mechanical challenges 
Haemodialysis Haemodialysis machines consist of a pump and a filter containing the dialysis 
membrane.  The technology is constantly improving with online fluid 
monitoring, sodium and bicarbonate profiling and haemodiafiltration available 
to individualise treatment and optimise the clearance of waste products 
(Blankestijn 2013; Karkar 2012; McCausland, Brunelli and Waikar 2013).  
Problems may occur with the machine, the electricity and water supplies or 
with faulty dialysis products (Farrington and Greenwood 2011).   
Peritoneal dialysis Peritoneal dialysis is less complex than the HD and is offered as a home rather 
than a hospital based therapy. Those choosing to carry out automated PD 
(APD) at night must master the operation of the machine with phone support 
available to trouble-shoot (Blake and Daugirdas 2015).  As with HD, problems 




Haemodialysis Infection is a significant problem in all RRT options (McDonald 2013) but higher 
infection rates have been found to exist in people on dialysis possibly due to 
the continuous use of invasive procedures or indwelling devices (Bedendo et 
al. 2011).   
Peritoneal dialysis The most common complications of PD are infective including exit site 
infections at the point where the PD catheter protrudes from the skin, and 
peritonitis (Ellam and Wilkie 2011; Klarić and Knotek 2013). 
Kidney transplant Transplant recipients show higher rates of infection than the general 
population (Kyle 2014) while certain uncommon infections such as 
cytomegalovirus (CMV) (Helanterä et al. 2014), BK virus (Pham, Schaenman 
and Pham 2014) and pneumocystis jirovecii pneumonia (PJP) (Chen et al. 2014) 
cause very serious illness, graft loss and death within the transplant 
population.   
Lifestyle 
Haemodialysis People spend a minimum of 12 hours per week connected to the HD machine 
either at a hospital or satellite dialysis centre, or independently at home 
(Caring for Australasians with Renal Impairment 2005b; Hakim and Saha 2014).  
In addition to the time attached to the dialysis machine, people who have HD 
at a hospital or satellite unit have to add on travel time to the dialysis unit and 
waiting time to get connected to the machine (Moist et al. 2008; Moran 2008).  
Life on HD has been described as a restricted or a ‘lost’ life with the loss of 
spontaneity and of the person’s ability to contribute to family and community 
(Clarkson and Robinson 2010; Monaro, Stewart and Gullick 2014).   
Peritoneal dialysis Peritoneal dialysis is most commonly carried out overnight using an APD 
machine allowing people freedom to carry on with normal activities during the 
daytime.  Occasionally people prefer continuous ambulatory peritoneal dialysis 
(CAPD) where manual exchanges are performed throughout the day (Bieber et 
al. 2014; Hakim and Saha 2014).    
Kidney transplant Without the time constraints of dialysis therapy, people with functioning 
kidney transplants are more able to pursue employment and other activities 
(Murray et al. 2014).  Fatigue and activity levels are reportedly similar in 
people with CKD pre-dialysis, on HD and on PD,  while renal transplant 
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recipients report the least fatigue (Artom et al. 2014; Bonner, Wellard and 
Caltabiano 2010).   
Quality of life 
Dialysis Quality of life studies have found that people on dialysis show higher levels of 
anxiety and depression than the general population (Alavi, Aliakbarzadeh and 
Sharifi 2009; von der Lippe et al. 2014).  In a study of HRQOL in 72 people on 
HD in Scotland, Alshraifeen, McCreaddie and Evans (2014) found that people 
receiving HD therapy scored lower than the general population in all domains 
(Alshraifeen, McCreaddie and Evans 2014).   
Kidney transplant Studies have found that people with a functioning kidney transplant report a 
better QOL than those on dialysis (Alavi, Aliakbarzadeh and Sharifi 2009; 
Alvares et al. 2012; Landreneau, Lee and Landreneau 2010; von der Lippe et al. 
2014; Wyld et al. 2012).   
Cost of treatment 
Dialysis The costs associated with dialysis include paying for staff such as 
nephrologists, nurses and technicians; the technology, power and 
consumables, and the indirectly related costs of hospital admissions and 
transport (Cleemput and De Laet 2013; Karopadi et al. 2013).  Using data from 
the UK Renal Registry an economic analysis of the cost of CKD in the UK was 
carried out and found that the annual cost of a kidney transplant was £14618 
per patient, while the cost of HD was £24043 and PD £20078 (Kerr et al. 2012).  
These findings have since been confirmed in studies from around the world:  
hospital HD is the most expensive RRT option while the home dialysis options 
of PD and home HD are cheaper.   
Kidney transplant As well as staff and admission costs, transplantation also involves the cost of 
surgery and the ongoing expense of medications (Kerr et al. 2012). After the 
first 12 months transplant is the cheapest RRT option (Garcia et al. 2013; Haller 
et al. 2011; Rocha et al. 2012; van Holder, van Biesen and Lameire 2014).  It 
has been noted that savings made with kidney transplantation are dependent 
on the quality and longevity of the transplanted organs.  In recent years the 
donor pool has been increased by accepting extended criteria donors and 
these organs can be more expensive in the short term as more medical and 
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surgical interventions may be required to get them transplanted and working 
successfully.  They may also have a shorter survival time which will add to the 




APPENDIX 2: SYSTEMATIC REVIEW SEARCH STRATEGIES 
Medline search strategy  
1. kidney failure.mp. or exp Renal Insufficiency/ 
2. peritoneal dialysis.mp. or exp Peritoneal Dialysis/ 
3. kidney transplantation.mp. or exp Kidney Transplantation/ 
4. Kidney Failure, Chronic/ or Renal Dialysis/ or haemodialysis.mp. or Kidney Diseases/ 
5. renal dialysis.mp. or exp Renal Dialysis/ 
6. waiting list.mp. or exp Waiting Lists/ 
7. (tissue and organ procurement).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, protocol supplementary concept, rare disease supplementary concept, 
unique identifier] 
8. quality of life.mp. or exp "Quality of Life"/ 
9. experienc$.mp. or Social Support/ or Depression/ 
10. adaptation.mp. or Adaptation, Psychological/ or Adaptation, Physiological/ 
11. Attitude to Health/ or Attitude/ or Attitude to Death/ or attitude.mp. 
 
12. uncertainty.mp. or exp Uncertainty/ 
13. life change events.mp. or exp Life Change Events/ 
14. self care.mp. or exp Self Care/ 
15. self concept.mp. or exp Self Concept/ 
16. self efficacy.mp. or exp Self Efficacy/ 
17. interpersonal relations.mp. or exp Interpersonal Relations/ 
18. activities of daily living.mp. or exp "Activities of Daily Living"/ 
19. 1 or 2 or 3 or 4 or 5 or 6 
20. 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 
21. 19 and 20 
22. limit 21 to (english language and humans and "all adult (19 plus years)") 
23. limit 22 to ("qualitative (maximizes sensitivity)" or "qualitative (maximizes specificity)" or 




Embase search strategy 
1. kidney failure.mp. or exp kidney failure/ 
2. peritoneal dialysis.mp. or exp peritoneal dialysis/ 
3. kidney transplant$.mp. or exp kidney graft/ 
4. kidney failure.mp. or exp kidney failure/ 
5. renal dialysis.mp. or exp renal replacement therapy/ 
6. waiting list.mp. or exp hospital admission/ 
7. quality of life.mp. or exp "quality of life"/ 
8. society/ or experienc$.mp. or follow up/ 
9. local adaptation/ or social adaptation/ or adaptation/ or adaptation.mp. 
10. attitude to sexuality/ or social attitude/ or attitude to illness/ or attitude to death/ or 
attitude.mp. or attitude to health/ or attitude to life/ or attitude/ or attitude to change/ or 
attitude to disability/ or patient attitude/ 
11. Mishel Uncertainty in Illness Scale/ or uncertainty.mp. or uncertainty/ or Mishel Uncertainty in 
Illness Theory/ 
12. life change events.mp. or exp life event/ 
13. self care.mp. or exp self care/ 
14. self concept.mp. or exp self concept/ 
15. self efficacy.mp. or exp self concept/ 
16. interpersonal relations.mp. or exp human relation/ 
17. activities of daily living.mp. or exp daily life activity/ 
18. 1 or 2 or 3 or 4 or 5 or 6 
19. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 
20. 18 and 19 
21. limit 20 to (human and English language and adult <18 to 64 years>) 
22. limit 21 to ("qualitative (maximizes sensitivity)" or "qualitative (maximizes specificity)" or 







PsycINFO search strategy 
1 exp "activities of daily living"/ 
2 ("activities of daily living" or ADL).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
3 exp Behavior/ 
4 (behavior* or behaviour*).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
5 exp Cognition/ 
6 cognition.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
7 exp affective disorders/ 
8 mood*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
9 exp "Quality of Life"/ 
10 ("quality of life" or qol).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
11 exp interpersonal relationships/ 
12 "interpersonal relation*".mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
13 "social interaction*".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
14 "social support*".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
15 (wellbeing or "well being").mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
16 exp satisfaction/ 
17 exp Client Satisfaction/ 
18 satisfaction.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
19 stress*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
20 depress*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
21 exp adjustment/ 
22 psycholog*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
23 exp Emotions/ 
24 emotion*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
25 anxi*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
26 exp Lifestyle/ 
27 ("life style" or lifestyle*).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
28 exp Uncertainty/ 
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29 uncertaint*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
30 exp death attitudes/ 
31 exp Health Attitudes/ 
32 attitude.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
33 experience*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
34 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 
19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 
35 exp organ transplantation/ 
36 ((kidney* or renal) and (transplant* or donor* or provider* or survivor*)).mp. [mp=title, 
abstract, heading word, table of contents, key concepts, original title, tests & measures] 
37 35 or 36 
38 cadaveric.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
39 37 and 38 
40 (kidney* or renal).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
41 35 or 40 
42 exp tissue donation/ 
43 "unrelated donor*".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
44 42 or 43 
45 41 and 44 
46 39 or 45 
47 exp kidney diseases/ 
48 ("renal replacement therap*" or RRT or "dialysis patient*").mp. [mp=title, abstract, heading 
word, table of contents, key concepts, original title, tests & measures] 
49 ((renal or kidney*) and dialysis).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
50 hemodiafiltration.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
51 (hemodialysis or HD).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
52 ("peritoneal dialysis" or PD).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
53 hemofiltration.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
54 47 or 48 or 49 or 50 or 51 or 52 or 53 
55 "kidney failure".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
56 ("end stage renal" or "end-stage renal" or ESRF or ESRD).mp. [mp=title, abstract, heading 
word, table of contents, key concepts, original title, tests & measures] 
57 "chronic kidney".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
58 55 or 56 or 57 
59 54 or 58 
60 34 and 37 and 59 
61 ("300" or "320" or "340" or "360" or "380" or "390").ag. 
62 60 and 61 
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Cochrane Library search strategy 
1 MeSH descriptor: [Activities of Daily Living] explode all trees 3488 
2 "activities of daily living" or ADL  5596 
3 MeSH descriptor: [Behavior] explode all trees 43674 
4 behavior* or behaviour*  46843 
5 MeSH descriptor: [Cognition] explode all trees 6160 
6 cogniti*  25934 
7 MeSH descriptor: [Mood Disorders] explode all trees 8381 
8 mood*  8900 
9 MeSH descriptor: [Quality of Life] explode all trees 13007 
10 "quality of life" or qol  31258 
11 MeSH descriptor: [Interpersonal Relations] explode all trees 3707 
12 "interpersonal relation*"  1603 
13 "social interaction*"  672 
14 "social support*"  3413 
15 wellbeing or "well being"  5477 
16 MeSH descriptor: [Personal Satisfaction] explode all trees 373 
17 MeSH descriptor: [Patient Satisfaction] explode all trees 7896 
18 satisfaction  17684 
19 stress*  21813 
20 depress*  52675 
21 MeSH descriptor: [Adaptation, Psychological] explode all trees 3442 
22 psycholog*  58469 
23 MeSH descriptor: [Emotions] explode all trees 10387 
24 emotion*  7899 
25 anxi*  20388 
26 MeSH descriptor: [Life Style] explode all trees 2365 
27 "life style*" or lifestyle*  5086 
28 MeSH descriptor: [Uncertainty] explode all trees75 
29 uncertaint*  8838 
30 MeSH descriptor: [Attitude to Death] explode all trees 101 
31 MeSH descriptor: [Attitude to Health] explode all trees 21982 
32 attitude  11676 
33 experience*  39675 
34 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 
or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or 
#30 or #31 or #32 or #33  212836 
35 MeSH descriptor: [Kidney Transplantation] explode all trees 3147 
36 (kidney* or renal) and (transplant* or donor* or provider* or survivor*)  9940 
37 #35 or #36  9940 
38 cadaveric  692 
39 #37 and #38  519 
40 kidney* or renal  36166 
41 #35 or #40  36166 
42 MeSH descriptor: [Unrelated Donors] explode all trees 2 
43 "unrelated donor*"  195 
44 #42 or #43  195 
45 #41 and #44  25 
46 #39 or #45  542 
47 MeSH descriptor: [Renal Replacement Therapy] explode all trees 7312 
48 "renal replacement therap*" or RRT or "dialysis patient*"  1530 
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49 (renal or kidney) and dialysis  7982 
50 hemodiafiltration  311 
51 hemodialysis or HD  6993 
52 "peritoneal dialysis" or PD  15327 
53 hemofiltration  519 
54 #47 or #48 or #49 or #50 or #51 or #52 or #53  28910 
55 MeSH descriptor: [Kidney Failure, Chronic] explode all trees 3151 
56 "end stage renal" or "end-stage renal" or ESRF or ESRD  1723 
57 "chronic kidney"  1427 
58 #55 or #56 or #57  4948 
59 #54 or #58  30640 
60 (#34 and #37 and #59)  1125 
61 MeSH descriptor: [Living Donors] explode all trees 265 
62 #60 not #61  1089 
63 MeSH descriptor: [Empirical Research] explode all trees 358 
64 "qualitative research" or "qualitative stud*"  1230 
65 "interpretive research" or "interpretive stud*"  1 
66 "critical research" or "critical stud*"  33 
67 "qualitative descriptive"  15 
68 "grounded theor*"  53 
69 "case stud*"  1740 
70 "action research"  209 
71 ethnograph*  101 
72 phenomenolog*  142 
73 #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72  3373 
74 #60 and #73  31 
75 #62 and #73  28 
76 MeSH descriptor: [Waiting Lists] explode all trees 307 
77 MeSH descriptor: [Watchful Waiting] explode all trees 77 
78 wait*  5480 
79 #76 or #77 or #78  5480 
80 #60 and #79  88 
81 #62 and #79  88 
82 #74 and #79  15 
83 #75 and #79  15 
 
CINAHL search strategy 
1. kidney failure   
2. Renal Insufficiency   
3. peritoneal dialysis   
4. kidney transplantation   
5. Renal Dialysis   
6. haemodialysis   
7. Kidney Disease   
8. waiting list   
9. quality of life   
10. experience   
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11. adaptation   
12. Attitude to Death   
13. Attitude to Health   
14. uncertainty   
15. life change events   
16. self care   
17. self concept   
18. self efficacy   
19. interpersonal relations   
20. activities of daily living   
21. S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8  
22. S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20  
23. S21 and S22   
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APPENDIX 4: SYSTEMATIC REVIEW DATA EXTRACTION INSTRUMENTS 








APPENDIX 5: STUDIES EXCLUDED FROM THE SYSTEMATIC REVIEW 
Moran A, Scott A, Darbyshire P. Waiting for a kidney transplant: patients' experiences of 
haemodialysis therapy. Journal of Advanced Nursing. [Research Support, Non-U.S. Gov't]. 2011 
Mar;67(3):501-9. 
Reason for exclusion: Study reported in “Moran A. The person's experience of end stage renal 
disease and haemodialysis therapy [Ph.D.]. Ann Arbor: Dublin City University (Ireland); 2008” 
 
Murray LR, Conrad NE, Zarifian A. Perceptions of kidney transplant by persons with end stage renal 
disease/Research critique/Investigators' response. ANNA Journal. 1999;26(5):479-84+. 
Reason for exclusion: Methodological quality score falls below the threshold of 14.6. Congruity 
between philosophical perspective and research methodology not stated, the researcher’s 
cultural/theoretical perspective not stated and the influence of the researcher on the research and 
vice-versa not addressed. 
 
Polaschek N. Living on dialysis: concerns of clients in a renal setting. Journal of Advanced Nursing. 
2003;41(1):44-52. 
Reason for exclusion: Study reported in “Polaschek N. The concerns of Pakcha men living on home 
haemodialysis: a critical interpretive study. Wellington: Victoria University of Wellington; 2000.” 
 
Wells SA. Occupational performance of Mexican Americans with end-stage-renal-disease living on 
dialysis in the lower Rio Grande Valley [Dr.P.H.]. Ann Arbor: The University of Texas School of Public 
Health; 2009. 
Reason for exclusion: Methodological quality score falls below the threshold of 14.6. Lack of 
congruity between stated philosophical perspective and research methodology and between the 
research methodology, methods and interpretation of results.  The researcher’s 
cultural/theoretical perspective is not stated and the influence of the researcher on the research 




APPENDIX 6: TABLE OF FINDINGS EXTRACTED FROM STUDIES INCLUDED IN THE SYSTEMATIC REVIEW 
Data extraction table 
Reference Calvey D, Mee L. The lived experience of the person dependent on haemodialysis. Journal of Renal Care. 2011 Dec;37(4):201-7. 
Number 
Finding (verbatim from 
author) 




1 An uncertain future The enormity of life dependent on hemodialysis left the participants 
feeling as though there was no future ahead. They reported feelings of 
shock and fear, and finding themselves in a place of great uncertainty. pg 
202 
[Some] participants described experiences of having their future returned 






2 Lost dreams. The loss of 
dreams introduced elements 
of sadness leading to anger 
and bitterness in the 
descriptions of perceived loss 
of planned future dreams 
M, “watching my children growing up and not being able to go out with 
them and show them what to do … I never did that with my children … 
something I would have liked to give them .. .not being able to do that, sort 
of irks me now”. Pg 203  
U Loss 
3 Future hopes Hope for the future lay mostly in the prospect of one day receiving a 
transplant and getting back to a normal life. The hope of receiving a kidney 




4 Bodily self. Participants’ 
descriptions of how they 
perceived themselves and the 
physical changes they had 
gone through 
J, “my skin changed … you feel dirty … no matter if you have a shower … I 
never feel clean”. pg 204 
The physical bodily change due to the placement of the HD access in this 
study, for some, brought distress. Pg 204 
U Body image 
5 Mental self. Participant’s 
perceptions of themselves 
leading to feelings of 
powerlessness, worthlessness 
and low self-confidence.   
Strength and state of mind was thought to be of great importance. Pg 204 
Depression was seen by the participants of this study as the outcome of 
not maintaining a positive outlook.  … although they admitted feeling 
depressed at times, it certainly did not appear to be a leading concern. Pg 
204 
C Mental health 
6 Functional self. The impact on 
what participants perceived to 
be their normal routines and 
their varying roles in life. 
T, “you’re basically working around the dialysis, like it’s stuck in my head” 
Pg 204 
They saw their ability to do things hindered by the loss of three days from 
the week. The impact on functional self was more evident when the 
participants considered the negative effect on their ability to work, 
resulting in loss of wages and inability to be counted as reliable. Pg 204 
U Normal life/loss 
7 Social self. The impact of HD 
on family and friends and the 
impact of family and friends 
on the lives of participants 
M’ “Why did she marry me, if she married someone else she’d get out … 
she wouldn’t be living this kind of life … how unfortunate she was” Pg 204 






Many participants were finding it difficult becoming part of the social 
atmosphere, feeling alienated by things like fluid and dietary restrictions. 
Pg 204 
Some participants felt a responsibility to keep up a good face …Thus as 
well as being strong for themselves they had to be strong and support 
their families. Pg 204 
8 Mortality and the fragility of 
life 
J “I really thought I was finished … I saw the blood drain from my body into 
this machine ... I saw my life’s blood flow out, it was a shock an absolute 
shock.” Pg 205 
The participants in this study conveyed a strong realisation that life is 
fragile and can be lost very quickly. Pg 205 
C Mortality 
9 Mortality and the issue of 
transplantation 
The issue of kidney transplantation provided hope for all the participants.  
Mike had not only faced his own mortality but spared thoughts for the 
kidney donors respectfully acknowledging that for him to receive such a 
gift meant somebody would be losing their life. Pg 205 
A “somebody is dead and I’m alive with their kidney … that doesn’t seem 
right to me”. 
U Mortality 
10 Growing/learning self Participants described their experiences of commencing treatment, 
beginning with little or no knowledge of renal failure or dialysis, slowly 




adaptive to the changing routine. Pg 205 
Reference Dekkers W, Uerz I, Wils J-P. Living Well with End Stage Renal Disease: Patients' Narratives Interpreted from a Virtue Perspective. Ethic Theory Moral Prac. 
2005 2005/11/01;8(5):485-506. 
1 Gratitude – hope … participants explicitly mentioned that getting on dialysis had saved 
their lives. Pg 496 
Many felt grateful for the support they got from relatives and friends 
and for the care they got at the hospital. Pg 497 
Hope is important … one participant intentionally tried to be optimistic, 
to hope for the best, to look on the bright side. For her hope also 
meant getting a kidney transplan.t Pg 497 
U Hope 
Reference Hagren B, Pettersen I, Severinsson E, Lützén K, Clyne N. The haemodialysis machine as a lifeline: experiences of suffering from end-stage renal disease. 
Journal of Advanced Nursing. 2001;34(2):196-202. 
1 Gaining a sense of existential 
optimism 
Many [patients] experienced fear of what would happen if the HD did 
not work or if they could not get a new kidney. Pg 200 
However waiting for kidney transplantation and not knowing when this 
would be was a profound cause of suffering. But for some the 
possibility of getting a new kidney gave hope. 
C Mortality/hope 
Reference Herlin C, Wann-Hansson C. The experience of being 30-45 years of age and depending on haemodialysis treatment: a phenomenological study. 
Scandinavian Journal of Caring Sciences. 2010;24(4):693-9. 
1 Total lack of freedom The total lack of freedom was always present in the thoughts of the U Loss/future hope 
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patients and they were forced to learn to live with it. The participants 
expressed that they did not live fully. Pg 695 
“In the future when I am transplanted I think I will have more freedom. 
Then I can do what I want … leave town … order a vacation without 
thinking of the need of HD” 
2 Feelings of loneliness Three … had lost a partner after they started in HD treatment. Finding a 
partner after they started on HD treatment was … hard. Five … [said] 
having a job was helping them to feel less lonely. Pg 696 
“ …how do you say it? Should you say it at once? ‘I’m going in HD 
treatment and waiting for a new kidney!’ Or should you say it after a 
week or a month? Pg 696 
“To work is something I think is very important …. It is the social side … 
that you get out … otherwise it would have been hard … if I had no work 
to go to” Pg 696 
U Social life/loss 
3 Being on the waiting list for a 
kidney transplantation 
Being on the waiting list for many years and not knowing for how many 
years one had to wait was described as the worst part. Feelings of 
uncertainty because of not knowing if they would get a kidney or not 
were always on their mind. Pg 696 
“The future for me is a transplantation that I am waiting for, and then I 
hope that everything will work out fine” Pg 697 




worried of complications … such as rejection. Pg 696 
“To be transplanted means that I have to go through another 
complicated surgery … and after that it is not for sure that it will work 
out” 
Reference Kaba E, Bellou P, Iordanou P, Andrea S, Kyritsi E, Gerogianni G, et al. Renal nursing. Problems experienced by haemodialysis patients in Greece. British 
Journal of Nursing. 2007;16(14):868-72. 
1 Uncertainty Even though patients considered that their treatment was going well at 
that point, they all expressed some anxiety about potential problems 
that could arise or the prospect of premature death. Pg 870 
“This is a road with no return. You are walking in the path and there is 
only in front, there is no left, no right to go. Now I am trying a bit 
because my daughter-in-law is pregnant, and I have something nice to 
expect. I pray I can get a  transplantation soon so I can relax for 5 or 6 
years.”  Pg 870 
Although they had not yet received a transplant they were confident 
that they would do so and it would be successful, freeing them from 
dialysis. Pg 870 
U Mortality, anxiety, 
transplant gives hope 
for a normal life, 
uncertainty 
 
Reference Landreneau KJ, Ward-Smith P. Perceptions of adult patients on hemodialysis concerning choice among renal replacement therapies. Nephrology Nursing 
Journal. 2007;34(5):513. 
1 Knowledge Knowledge regarding renal replacement therapy was obtained from a 




care professionals, specifically the physician.  Another frequent source 
mentioned was the transplant surgeon. The dialysis nurses also 
mentioned as a source.  Pg 516 
“They asked me would you want a kidney transplant?  And I said yes I 
would because I didn’t want to do this all my life” Pg 516 
“They told me about the risks … and it’s just a risk between life and 
death. That’s mostly what I know about it you know.  They were nurses” 
Pg 516 
Much of the knowledge shared by participants revealed outdated and 
inaccurate medical information. Pg 516 
2 Choice One must consider and incorporate the medically appropriate time to 
present the types of renal replacement therapies and the patient’s 
option to choose. Pg 517 
“My choice was to have HD. And I am on the list for a kidney transplant, 
and I’ve been on the list for several years” 
… participants knew about transplantation after they started dialysis 
and talked with their ‘dialysis doctor’ about transplantation. This may 
be a factor of different physician’s opinions or philosophies concerning 





Reference Moran A. The person's experience of end stage renal disease and haemodialysis therapy [Ph.D.]. Ann Arbor: Dublin City University (Ireland); 2008. 
1 Waiting for a kidney: Living in 
hope 
The hope of a kidney transplant provided the participants with the 
possibility of returning to a normal life in the future. In addition, it 
provided them with the strength to endure the experience of being a 
renal patient. The information received from healthcare professionals 
in relation to the average waiting time for a kidney transplant 
contributed to the participants’ experience of living in hope. Pg 173 
Seeing other patients being called for a transplant and leave the dialysis 
unit contributed to Danny’s experience of hope. These patients served 
to reassure him that one day he would also be called for a transplant. 
Pg 174 
“You’re living in hope [of getting a transplant], you just feel like it could 
be tomorrow, it could be a year from tomorrow, it could be any 
day…That’s the way I think, it [the transplant] will happen but you have 
to wait.” Pg 176 
U Hope/knowledge 
2 Waiting for a kidney: 
Uncertainty 
The participants’ accounts specifically conveyed how the information 
they had received from the healthcare team about the average waiting 
time for a kidney transplant contributed to their uncertainty. Pg 178 
It is important to point out that the average waiting time for a kidney 
transplant is merely an estimate, and many patients wait well beyond 




interpreted the average waiting time to mean the “actual” waiting time 
for a kidney transplant. While this belief allowed the participants to live 
in hope as they initially waited for a kidney transplant, it did not sustain 
their hope in the long-term. When the participants either reached or 
exceeded the “expected” date for a kidney transplant, they became 
uncertain. Pg 178 
“I get days when just the thought of coming here…I could just turn the 
car around and drive off home and not bother…and you think well how 
come some people… I’ve seen them go and have a transplant and 
they’re gone, and I’m still here. “Why am I still here? Why am I here? 
Sometimes I think maybe I’m going to be waiting a long time, I better 
just get used to the idea. Pg 180 
“You just get to a stage where you think it’s [the transplant] never going 
to happen…you go into the dialysis unit and you hear somebody was 
called [for a transplant] and you’d be delighted for them but still your 
heart would drop when it wasn’t you.” Pg 181 
3 Waiting for a kidney: Being on 
hold 
As a result of the experience of uncertainty, some participants were 
unable to contemplate possibilities in the future. Moreover, the 
limitations and restrictions imposed by HD therapy prevented them 
from performing many of the everyday activities they took for granted 
in the past. Consequently, the participants described their experience 
of being on hold while they waited for a kidney transplant. Pg 185 




The absence of a definite endpoint to the wait meant that David was 
unable to contemplate any possibilities for the future. Pg 187 
Embedded in Jeff’s account of being on hold was the fear of missing out 
on the call for a kidney transplant. 
“You’re on hold so you are…it’s just a big waiting game now … waiting 
for that call [for a transplant]…you never leave the phone, you have the 
phone with you 24/7…” Pg 188 
He described his experience of waiting for a transplant as being held 
back in a time, which revolved around the repetitive regimen of dialysis 
therapy. Pg 188 
“My life is on hold…very, very much so…I can’t plan anything, can’t go 
anywhere…I’m waiting for the phone to ring…when are you going to get 
that call for a transplant”  Pg 189 
Reference Polaschek N. The concerns of Pakcha men living on home haemodialysis: a critical interpretive study. Wellington: Victoria University of Wellington; 2000. 
1 Suffering from the symptoms 
of CRF and dialysis pg 204 
Dialysis is supposed to remove the symptoms of CRF by replacing their 
renal function according to the dominant discourse. However, despite 
excellent treatment, all of these men reported some troubling 
symptoms while living on dialysis. Pg 204 
General lack of energy … an altered sleep pattern … itching and restless 
legs … hypotension … general non-specific malaise. Pgs 205-206 
U Physical health 
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Although these men suffered from a range of symptoms they generally 
tended to downplay them. The tendency to initially underestimate their 
symptoms probably reflects the fact that, as they live with the 
symptoms on an ongoing basis, they have become an aspect of their 
lives that are coped with in part by being “normalized”. Pg 207 
2 Negotiating the requirements 
of dialysis to fit their lifestyle 
and the limitations involved Pg 
210 
All of these men reported that it actually had a significant impact on 
their lifestyle. Pg 210 
"I jealously guard the in-between days, I hate them being taken away 
from me, I feel I've lost a day. It's my lifeline, but I want to have a 
normal life during the day" Pg 212 
All mentioned the inability to travel on holidays as the most obvious 
limitation caused by living on HD. Pg 213 
For most of the men the negotiation required to integrate the 
requirements of renal replacement therapy into their weekly schedule 
not only influenced their regular pattern of living but also resulted in 
some alteration of their dialysis or other aspects of the treatment 
regimen in order to manage it in their lives. Pg 214 
U Impact on normal 
life/knowledge/travel 
3 Experiencing life on dialysis as 
ongoing 
The many hours of their lives taken up by the treatment were the 
obvious focus of their sense of enduring a life on dialysis. …most felt it 
was time wasted which they could better use for other activities. Pg 
217 
U Loss (of time)  
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"it feels like a waste of time, on dialysis the machine runs your life." Pg 
218 
4 Uncertainty about the future A developing understanding, contrary to the optimism of the 
professional viewpoint, of the limitations of the efficaciousness of 
dialysis as a therapy for CRF gave rise to a sense of uncertainty about 
the future. Pg 219 
"I often wonder how long you can do this for..' there seems almost no 
hope of a transplant; in my age bracket perhaps the chances lessen, 
there's a certain amount of urgency as you get older." Pg 220 
“I might not have thought of going on if I had known that this would be 
the future, or come of at a certain point." Pg 221 
U Uncertainty 
5 The expectation of a 
transplant  
…these men looked forward to a different event that would both break 
the routine and address their uncertainty. They coped with the 
ongoingness and uncertainty of living on dialysis through their hope of 
a kidney transplant. Pg 222 
"Dialysis is a stepping stone until you get the transplant." Pg 222 
Other than Mark and Owen the men showed almost no recognition of 
the degree of uncertainty about receiving a transplant, let alone any 
awareness of the potential problems with transplantation itself not 
only the possibility of the transplanted kidney failing to function for 
some reason but also the long term complications associated with 
U Hope  
 
166 
transplantation such as increased risk of life threatening infections or 
cancers. Pg 223 
They coped through their hope that life on dialysis did not have to be 
accepted as permanent but was rather provisional, because they would 
in the future receive a transplant to enable them to escape from 
dialysis. Pg 224 
6 Changing personal 
relationships 
The men's accounts suggested that living on dialysis had affected their 
relationships with their families and friends. Generally they tended to 
emphasize the ordinary character of their relationships, such as the 
understanding of friends who accommodated their dialysis in planning 
social activities or the easy acceptance of their treatment by 
grandchildren playing around the machine while they were dialysing. Pg 
226 
…their relationship with their partners, all well established, remained 
strong, but had altered somewhat in character.  Their wives had 
adapted their own lifestyles to be present in the house when the men 
were doing their treatment. Pg226 
"…terrific amount of teamwork, it's so much easier with some helping, 
much more pleasurable, quicker if you work as team." Pg 227 
All of the men recognised some costs to their partners from them being 
on dialysis, whether in terms of limiting their own activities or the 





stress of having to cope with their husband's illness and its treatment. 
Pg 227 
7 Their new healthcare 
relationships 
While affirmed in their autonomy in managing their own dialysis at 
home, their awareness of the limited support actually available to them 
indicated their dependence on renal staff. Pg 228 
Although they felt positive about their relationship with health care 
professionals, these men were sensitive to any perceived lack of being 
fully informed about their condition, therapy or its effects. Sometimes 
they expressed a sense of having been misled by renal health 
professionals. Pg 230 
U Dependence/knowledge 
8 Dependence on the dialysis 
machine 
"I'd feel the extra day, my body tells me I need the dialysis machine, I 
don't deviate, it's not worth your while." Pg 231 
However, despite this common strategy of seeking to manage their 
lives on dialysis by maintaining a strict therapeutic regimen, they are 
still regularly reminded, by residual symptoms, limitations in their 
ordinary lives caused by the therapeutic regimen and occasional 
unexpected events underlining the uncertainty of life on dialysis, of 
their dependence on the therapeutic regimen for their continued 
wellbeing. Pg 232 
U Dependence 
Reference Rittman M, Northsea C, Hausauer N, Green C. Living with renal failure. ANNA Journal. 1993;20(3):327-31; discussion 32. 
1 Maintaining hope Patients described hope as a significant aspect of coping … having a U Hope/future 
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transplant, to get a job again, yet to be discovered treatments that 
would help them continue to live. Pg 329 
Suffering from the pain and disability of renal failure is attenuated by 
hope and sustains individuals in daily living. Pg 329 
Reference Sadala MLA, Bruzos GAdS, Pereira ER, Bucuvic EM. Patients' experiences of peritoneal dialysis at home: a phenomenological approach. Revista Latino-
Americano Enfermagem. [Article]. 2012;20(1):68-75. 
1 Facing the world of renal 
failure and dialysis treatment 
They described their anguish in the face of death; and the perception 
that they were launched into an unknown and frightening world, 
without escape. The treatment proposed by the healthcare team was 
the only way to survive but, in practice, it appeared painful and 
aggressive, drastically limiting their activities and social life. In addition, 
it would last for a long and unpredictable time, until an unlikely kidney 
appeared to have a transplant. Pg 71 
Forced changes encompassed the whole organization of their world, 
involving their home, job, social gatherings. Additionally, they 
financially affected the family: they had to leave or change their job. Pg 
72 
The young revealed hope in soon having a kidney transplant: dreaming 
of a future free from catheters, from bags and from the dialysis 
machine: “Well, what was more important to me was when I Joined the 
transplant waiting list to have an organ from a corpse. And I'm 




waiting.” Pg 72 
Reference Shih LC, Honey M. The impact of dialysis on rurally based Māori and their whānau/families. Nursing Praxis in New Zealand. 2011;27(2):4-15. 
1 Stress from HD Some participants admitted to reduced adherence to advised 
therapeutic regimens because of the costs of care. Pg 7 
Most participants could not maintain employment because of their 
poor health and the need for dialysis. Pg 7 
Participants and their families found the dialysis regimens and 
associated travelling stressful. Pg 7 
“You miss out on a lot of things you used to do in the past. You lose your 
social life, you can’t go visiting or go away.” Pg 7 
While being on the transplant list resulted in hope for participants, the 
consequences of long waiting times and perhaps not receiving a kidney 
transplant were very stressful. Pg 7 
“I tried hard to keep up on the waiting list for many years; I feel 
aggravated sometimes. I have been on the transplant list for many 
years and nothing happened. I hope the next one may be me but I am 
always disheartened” Pg 7 
Being on the kidney transplant list was found to bring hope; however 
the long wait for a kidney transplant is a stressful process. Pg 8 
U Effect of dialysis on 
life/hope/uncertainty 
Reference Yu H, Petrini MA. The HRQoL of Chinese patients undergoing haemodialysis. Journal of Clinical Nursing. 2010;19(5-6):658-65. 
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1 Psycho-social aspect: Anxiety Among [the patients waiting for a kidney transplant], the longest 
waiting time was nearly five years. All of them showed different level of 
anxiety when they talked about transplantation. Pg 662 
“I do not know how long I will have to wait, I have heard of some who 
had to wait more than eight years. I cannot imagine having to wait so 
long…I get upset and lose my temper when I think of that. But who can 













You are currently on dialysis under the care of a nephrologist at … hospital and are listed on 
the renal transplant waiting list. 
Our department is participating in research about experiences of patients on the kidney 
transplant waiting list; I would like to invite you to attend a focus group to discuss the 
experiences of patients who are waiting for a kidney transplant.  We are interested in 
finding out how people cope with waiting and what impact it has on their day to day lives.  
A participant information sheet and consent form is enclosed. 
The focus group will be held on    date/time    at     location    and will take about 1 ½ hours. 
If you would like to participate please return the signed consent form in the reply paid 
envelope. 









APPENDIX 8: QUALITATIVE DESCRIPTIVE STUDY PARTICIPANT INFORMATION SHEET 
PARTICIPANT INFORMATION SHEET AND CONSENT FORM 
The experiences of patients waiting for a kidney transplant 
Invitation 
You are invited to participate in a research study into the experiences of patients who are 
waiting for a kidney transplant. 
The study is being conducted by: name 
Before you decide whether or not you wish to participate in this study, it is important for 
you to understand why the research is being done and what it will involve. Please take the 
time to read the following information carefully and discuss it with others if you wish. 
1. ‘What is the purpose of this study?’ 
The purpose is to investigate the effect of waiting for a kidney transplant on patients’ day 
to day lives and how they feel about it. 
 
2. ‘Why have I been invited to participate in this study?’ 
You are eligible to participate in this study because you are on dialysis and you are on the 
kidney transplant waiting list.  
 
3. ‘What if I don’t want to take part in this study or if I want to withdraw later?’ 
Participation in this study is voluntary. It is up to you whether or not you participate. If you 
decide not to participate, it will not affect the treatment you receive now or in the future. 
Whatever your decision, it will not affect your relationship with the staff caring for you. 
If you wish to withdraw from the study once it has started, you can do so at any time 
without having to give a reason.  However, it may not be possible to withdraw your data 
from the study results if these have already had your identifying details removed. 
 
4. ‘What does this study involve?’ 




If you agree to participate in this research, you will then be asked to attend a focus group at 
location on the following dates and times ….to talk about your experiences of waiting for a 
kidney transplant.  The focus group will take approximately 90 minutes and will be recorded 
in order to accurately capture all your responses.   
 
5. ‘How is this study being paid for?’ 
There is no sponsorship for this study and the work is being undertaken in the investigator’s 
own time. 
 
6. ‘Are there risks to me in taking part in this study?’ 
You may find it distressing to discuss your feelings about dialysis and transplantation. 
Should you find the discussion distressing renal social worker will be available for support 
and counselling. 
 
7. ‘Will I benefit from the study?’ 
This study aims to further medical knowledge and may improve future treatment of 
patients who are waiting for a kidney transplant; however it may not directly benefit you.  
Participation in the study will have no impact on your wait for a transplant. 
 
8. ‘How will my confidentiality be protected?’ 
Any identifiable information that is collected about you in connection with this study will 
remain confidential and will be disclosed only with your permission, or except as required 
by law. All data will be stored in secure files for 5 years and then destroyed. 
 
9. ‘What happens with the results?’ 
If you give us your permission by signing the consent document, we plan to use the 
research to learn more about how we can better support patients who are waiting for a 




10. ‘What should I do if I want to discuss this study further before I decide?’ 
When you have read this information, the researcher name will discuss it with you and any 
queries you may have. If you would like to know more at any stage the contact number is … 
 
11. ‘Who should I contact if I have concerns about the conduct of this study?’ 
This study has been approved by the Human Research Ethics Committee of the district. Any 
person with concerns or complaints about the conduct of this study should contact the 
Research Support Office on number, or email address and quote reference number. 
 
Thank you for taking the time to consider this study. 
 
If you wish to take part in it, please contact name, phone number 




APPENDIX 9: QUALITATIVE DESCRIPTIVE STUDY PARTICIPANT CONSENT FORM 
 
CONSENT FORM 
The experiences of patients waiting for a kidney transplant 
1. I,    
 of 
agree to participate in the study described in the participant information statement set out 
above. 
2. I acknowledge that I have read the participant information statement, which 
explains why I have been selected, the aims of the study and the nature and the possible 
risks of the investigation, and the statement has been explained to me to my satisfaction. 
3. Before signing this consent form, I have been given the opportunity of asking any 
questions relating to any possible physical and mental harm I might suffer as a result of my 
participation and I have received satisfactory answers. 
4. I understand that I can withdraw from the study at any time without prejudice to 
my relationship to the … Hospital Renal Department or my medical attendants. 
5. I agree that research data gathered from the results of the study may be published, 
provided that I cannot be identified. 
6. I understand that if I have any questions relating to my participation in this 
research, I may contact name on telephone … who will be happy to answer them. 
7. I acknowledge receipt of a copy of this Consent Form and the Participant 
Information Statement. 
Complaints may be directed to the Research Ethics Secretariat, South Eastern Sydney Local 
Health District – Northern Sector, Prince of Wales Hospital, Randwick NSW 2031 Australia 
(phone 02-9382 3587, fax 02-9382 2813, email ethicsnhn@sesiahs.health.nsw.gov.au.  
 




Signature of witness   Please PRINT name   Date 
 
 





APPENDIX 10: QUALITATIVE DESCRIPTIVE STUDY REVOCATION OF CONSENT FORM 
 
REVOCATION OF CONSENT 
 
The experiences of patients waiting for a kidney transplant 
 
I hereby wish to WITHDRAW my consent to participate in the study described above and 
understand that such withdrawal WILL NOT jeopardise any treatment or my relationship 
with the … Hospital Renal Department or my medical attendants. 
 
 
Signature of participant   Please PRINT name  
 Date 
_________________________   _______________________   _______________ 
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